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Abstract 
 
Differentiation of human endometrial stromal cells (HESCs) into specialized decidual 
cells is critical for embryo implantation and maintenance of a successful pregnancy. 
Initiation of this differentiation process, termed decidualization, is strictly dependent 
on elevated cAMP levels, whereas its maintenance requires continuous progesterone 
signalling. Here I show that NADPH oxidase-dependent reactive oxygen species 
(ROS) play a critical role in initiating and maintaining the decidual process. I first 
show that cAMP-dependent induction of decidual marker genes can be attenuated or 
enhanced upon inhibition or activation of the NADPH oxidase complex, respectively. 
Time-course analysis demonstrated that cAMP enhances endogenous ROS 
production, apparent after 12 hours of stimulation, which coincides with a marked 
induction of differentiation markers. By a process of elimination, I identified NOX4 as 
the main catalytic subunit involved in decidualization. Silencing of NOX4, or its 
cofactor p22PHOX, impaired the decidual process. I then show that the NOX4/p22PHOX 
complex regulates the transcriptional activity of CCAAT/enhancer binding protein β, a 
key regulator of HESC differentiation. Furthermore, microarray analysis revealed that 
the NOX4/p22PHOX complex functions downstream FOXO1, a multifaceted 
transcription factor involved in antioxidant defences, DNA repair and cell cycle 
regulation. In agreement, knockdown of NOX4/p22PHOX complex disrupted 
endogenous ROS production and resulted in a paradoxical prooxidant stress 
response further characterized by activation of the DNA repair pathway in the 
absence of primary DNA damage or cell death. Finally, I provide preliminary data that 
p22PHOX is downregulated at the transcript and protein level in the eutopic 
endometrium of patients with endometriosis. In summary, endogenous ROS 
signalling is critical for the differentiation and redox homeostasis of HESCs. 
Furthermore, deregulation of endometrial NADPH oxidase-dependent ROS 
production and signalling may be a hallmark of endometriosis, a prevalent and 
debilitating reproductive disorder. 
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1. Introduction  
 
1.1 Decidualization of the human endometrial stroma 
 
1.1.1 The endometrium  
The endometrium is the mucosal layer that lines the lumen of the uterus. It is 
comprised of a single layer of luminal epithelial cells resting on a layer of stromal and 
glandular cells. During the reproductive phase, two layers can be distinguished in the 
endometrium, a basal layer that lies beneath a superficial layer (Figure 1.1). The 
superficial layer of the endometrium acts as the functional layer and is under 
extensive hormonal regulation (1). The basal layer of the endometrium contains 
progenitor cells that are critical for endometrial regeneration, which takes place after 
menstrual shedding of the superficial endometrial layer (2-4).  
 
The fluctuations in circulating levels of ovarian estrogen and progesterone induce 
profound changes in the endometrium, giving rise to the menstrual cycle, which 
averages 28 days. The first half of the cycle is referred to as the proliferative phase. 
This phase is characterized by increased estrogen levels, which induce the ordered 
growth of the endometrium (5). The second half of the cycle, day 14 - 28, is referred 
to as the secretory phase of the menstrual cycle. The secretory phase is 
characterized by a post-ovulatory rise in circulating progesterone levels, which inhibit 
the proliferation of the estrogen-primed endometrium and trigger its differentiation 
process, which is also termed as “decidualization” (5).  
 
Interestingly, as illustrated in figure 1.2, whole-genome molecular phenotyping of 
endometrial tissue biopsy samples taken across the menstrual cycle, revealed that 
the secretory phase can be classified into three functionally distinct stages: the early 
secretory phase (ESE), the mid-secretory phase (MSE) and the late secretory phase 
(LSE) (6). 
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Fig 1.1 The endometrium. During the reproductive years, two layers in the 
endometrium can be distinguished. The superficial layer, which represents the 
functional layer that responds to fluctuations in the levels of the circulating ovarian 
hormones estrogen and progesterone. The basal layer is more of a dormant layer 
that does not respond to hormonal stimuli, shows minimal proliferative activity and is 
deficient in mounting a predecidual reaction in the LSE phase of the cycle. (The 
illustration is adopted from www.lab.anhb.uwa.edu.au/mb140). 
}
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Fig 1.2 The menstrual cycle. The schematic diagram illustrates the different phases 
of the menstrual cycle. The proliferative phase is initiated after menstrual shedding 
(MS) of the superficial endometrial layer. This phase harbours the growth and 
proliferation of the endometrium. Some of the molecular functions enriched in this 
phase are DNA synthesis, cell cycle regulation and extracellular matrix structural 
constituents, all of which are consistent with the tissue growth and extracellular 
modeling that occurs in this phase. The secretory phase can be divided into ESE, 
MSE and LSE. The ESE phase is known for robust glycogen synthesis, high-energy 
demands and an increase in mitochondrial size and number. The genes enriched in 
this phase are involved in metabolism and biosynthesis of macromolecules such as 
cholesterol, amino acids and lipids. The MSE is the phase in which decidualization is 
initiated. Hence, the genes enriched in this phase are involved in cell communication, 
intracellular signalling cascades and negative regulation of cell proliferation to name 
but a few. The LSE phase in the absence of pregnancy is enriched for cell motility 
and communication, apoptosis and cell cycle regulation in favour of cell cycle arrest. 
Genes enriched in this phase are involved in endocytosis, phagocytosis, immune 
response as well as response to inflammation, pathogens and chemicals.  
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1.1.2 The decidual process 
 
Decidualization refers to the progesterone-dependent morphological and biochemical 
differentiation of the endometrial stromal fibroblasts into secretory, epithelioid-like 
decidual cells (7, 8). It occurs in all species in which embryo implantation 
necessitates breaching of the luminal epithelium (1, 8). In most organisms, 
decidualization is reliant on the presence of a blastocyst (5). However, in humans 
and very few other species, decidualization is a maternally driven process and occurs 
in each cycle, independently of pregnancy (1, 8).  
 
Decidualization in pre-menopausal women is initiated in the MSE phase of the 
menstrual cycle i.e. day 23 in an ideal 28-day cycle. Histologically, the 
commencement of the decidual process signals the end of the period of receptivity, 
also known as the “implantation window”. During this period embryo implantation can 
take place (5). Conversely however, it is widely believed that decidualization is 
required for endometrial receptivity. In fact, decidual marker genes such as prolactin 
(PRL) and insulin-like growth factor binding protein 1 (IGFBP1) are enhanced in vivo 
prior to the morphological changes (5, 9). In the absence of pregnancy, the fall of 
progesterone levels, in the LSE phase of the menstrual cycle, induces shedding of 
the decidualized superficial endometrial layer leading to menstruation (7). Hence, in 
their reproductive phase, women in developed countries undergo cyclic 
decidualization and menstrual shedding on average 400 times (5, 10). 
 
Due to the extensive trophoblast invasion which encompasses the endometrium as 
well as the uterine junctional zone, which refers to the inner third of the myometrium, 
decidualization in humans is very pronounced and includes all the various 
compartments of the uterus: the junctional zone myocytes, spiral arteries, local 
immune cells, the endometrial, epithelial and stromal compartments (1, 8). It should 
be pointed out that this is a broader definition of decidualization as it entails all the 
different changes that occur in all cellular compartments associated with pregnancy.  
 
The decidual process is a progressive event. Its onset is first apparent in stromal 
cells around the spiral arteries of the superficial endometrial layer. In the presence of 
pregnancy, the endometrium is under extensive regulation and influence from steroid 
hormones as well as maternally- and blastocyst-derived signals (5, 9). Consequently, 
the decidual process progressively continues to ultimately involve the endometrium 
as a whole (8). 
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1.1.3 Morphological differentiation of stromal cells 
 
Undifferentiated human endometrial stromal cells (HESCs) are mesenchymal cells 
with an elongated spindle-shaped fibroblastic appearance (7, 8, 10). Upon 
decidualization, HESCs are characterized by a marked enlargement in their size, 
rounding of the nucleus and expansion of the secretory machinery, which 
encompasses the rough endoplasmic reticulum and the Golgi complex, and finally 
cytoplasmic accumulation of glycogen and lipid droplets (10). Decidualizing HESCs 
are further morphologically characterized by the appearance of multiple club-shaped 
processes on their surface that extend to the extracelullar matrix (ECM) (8, 11). 
 
1.1.4 Biochemical differentiation of HESCs 
 
The morphological adaptations of decidualizing HESCs are underpinned by 
extensive molecular and biochemical changes that accompany the decidual process. 
Genome-wide microarray profiling studies, whether applied on endometrial biopsies 
taken during or post the window of implantation, or applied on HESCs subjected to 
decidual stimuli in vitro, have been instrumental in shedding light on the extensive 
gene networks that are regulated during the decidual process (6, 12-19). Based on 
these studies, decidualization can be defined as the sequential reprogramming of 
functionally related families of genes involved in extracellular and cytoskeletal 
organization, cell adhesion, signal transduction, steroid metabolism, differentiation 
and apoptosis (10, 20). Hence, upon decidualization, HESCs adopt new biochemical 
functions that are critical for embryo implantation and successful pregnancy. For 
instance, decidualizing HESCs acquire a secretory phenotype releasing various 
proteins and a myriad of cytokines and growth factors that are critical for maintaining 
and augmenting the decidual phenotype and regulating trophoblast invasion and 
placental formation (1, 20). Two major secreted proteins, PRL and IGBP1 are 
commonly used as markers of decidualization (8, 21-23). Interestingly, decidualizing 
HESCs appear to adopt a myofibroblastic phenotype as they express α-smooth 
muscle actin, desmin and vimentin (10, 21, 24-26). 
 
Decidual transformation of HESCs is an interesting example of mesenchymal-
epithelial transition (MET). MET is an important process that is involved in various 
developmental events like kidney organogenesis and somitogenesis (27, 28). It is the 
reverse of the epithelial-mesenchymal transition (EMT). The interconversion between 
the epithelial and mesenchymal phenotype through EMT and MET processes is 
essential for embryogenesis, organ development and most importantly for wound 
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healing like in liver injury and for cellular remodeling during differentiation (29-31). 
Epithelial cells are adherent cells that bestow cell-to-cell cohesion and integrity of 
multicellular organs, and form barriers separating external from internal environments 
(29, 31). Mesenchymal cells, in contrast, are highly mobile and have invasive 
properties (29, 31, 32). Upon decidualization, HESCs express a myriad of genes that 
are a characteristic of epithelial cells (8). MET has also been implicated in the 
generation of induced pluripotent stem cells (iPSCs) from mouse fibroblasts upon 
exogenous expression of octamer-binding transcription factor 4 (Oct4), SRY (sex 
determining region Y)-box 2 (Sox2), Krüppel-like factor (Klf4) and myelocytomatosis 
oncogene (c-Myc) (33). Interestingly, microarray analysis revealed that OCT4, KLF 
and MYC are upregulated upon decidualizing HESCs (18, 34). 
 
1.1.5 Functions of decidual HESCs 
 
Decidualization not only bestows cellular plasticity on endometrial cells but also other 
seemingly conflicting properties. For instance, decidual cells are capable of resisting 
cell death upon oxidative stress at the same time they possess the ability to undergo 
apoptosis in response to progesterone withdrawal (18, 35). Decidual cells are also 
able to regulate local immune responses, haemostasis and acquire invasive 
properties. Interestingly, those properties are also observed in ectopic implants that 
occur upon retrograde menstruation leading to the gynecological disorder 
endometriosis (36-38). Figure 1.3 illustrates the different functions of decidual 
HESCs.  
 
a. Embryo selection and implantation 
Recently, it has been reported that decidual HESCs act as biosensors capable of 
recognizing compromised embryos and subsequently preventing their implantation 
(39-41). Therefore, decidualization is not only critical for embryo implantation and 
placental formation, but may also play a role in maternal recognition and rejection of 
developmentally compromised human embryos.  
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Fig 1.3 Functions of decidualizing HESCs. Decidualization can be recapitulated in 
vitro by administering 8-bromoadenosine-3', 5'-cyclic monophosphate (8-br-cAMP) 
and medroxyprogesterone acetate (MPA). Decidual HESCs acquire a secretory 
phenotype and become specialized epithelioid cells that can regulate various 
biological functions that are cardinal for ensuring a successful pregnancy like embryo 
selection and implantation, trophoblast invasion, haemostasis, immunomodulation 
and oxidative stress defence mechanisms. 
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b. Trophoblast invasion 
Trophoblast invasion refers to the breaching of the luminal endometrial epithelial cells 
and forms the basis of implantation and placenta formation (8). This process is 
critical for remodeling the uterine spiral arteries in order to increase the maternal 
blood flow to the placenta and consequently supports fetal growth (9, 42). 
Decidualization can be viewed as the maternal defence mechanism that regulates 
trophoblast invasion and promotes attachment of the latter (9, 43). Trophoblast 
invasion is a tightly regulated process that involves the secretion of decidual-specific 
factors like transforming growth factor β (TGFβ) as well as the expression of matrix 
metalloproteinases (MMPs) and adhesive molecules on the trophoblasts (8, 43, 44).   
 
c. Haemostasis 
Decidualization involves remodeling of the spiral arteries, which entails endothelial 
swelling, vacuolation and disorganization of the smooth muscle media (34).  
Decidualizing HESCs secrete several factors that promote haemostasis before and 
during trophoblast invasion (34). An example of a secreted factor involved in 
haemostasis is tissue factor (TF), a membrane-bound glycoprotein that acts as a 
receptor for coagulation factor VII/VIIa (45, 46). Interestingly, during the decidual 
process, an influx of innate immune cells like macrophages and uterine natural killer 
cells (uNK) infiltrate the decidua (47, 48). These cells tolerate the semi-allogenic 
trophoblasts and are known to possess angiogenic properties due to their expression 
of several molecules that regulate trophoblast invasion and vascular remodeling such 
as angiogenic factors, endothelial cell mitogens and chemokines (34, 49, 50). 
 
d. Immunomodulation 
Pregnancy is an inflammatory-related process, which requires complex immuno-
regulation to prevent the fetal antigens being recognized by cytotoxic T-cells and to 
protect the feto-maternal interface (34). As mentioned before, decidualization is 
associated with an influx of uNK cells as a response to decidual-specific secreted 
chemoatractants (51). Interestingly, microarray studies revealed that uNK cells 
express immunomodulatory molecules that inhibit T-cell proliferation and survival and 
therefore protect the fetus from being recognized (34, 49). Further, decidual cells 
also express factors that attenuate T-cell dependent inflammatory responses. For 
example, decidual cells express tryptophan-catabolizing enzyme indole-amine 2,3-
dioxygenase (IDO), which has been suggested to have an important role in 
pregnancy by preventing inflammatory responses and protecting the fetus (52-55). 
Another factor decidual cells highly express is Fas ligand, which is a member of the 
Chapter 1: Introduction 
 29 
tumour necrosis factor (TNF) superfamily and acts as a death signal for activated T-
cells (34, 56). 
 
e. Oxidative stress defences 
In the course of a normal pregnancy, major fluctuations in oxygen (O2) 
concentrations take place at the feto-maternal interface. At the early stages of 
pregnancy, the invasion of the spiral arteries in the endovascular trophoblast protects 
the conceptus from exposure to reactive oxygen species (ROS) (57-59). As the 
pregnancy progresses, dislocation of the trophoblast occurs, which enables further 
transformation of the spiral arteries and the perfusion of the placental intervillous 
space (8). This results in a major increase in the partial O2 pressure within the 
placenta. For instance, at weeks 7 and 10 post gestation, the O2 partial pressure is 
less than 20 mm Hg. However, between weeks 11 and 14, which is when the 
maternal perfusion of the placenta is initiated, the partial O2 pressure increases to 50 
mm Hg resulting in a burst of ROS (8, 60). 
 
The significance of the decidual process in protecting the fetus is illustrated by the 
contrasting responses of undifferentiated and decidualizing HESCs to ROS. 
Undifferentiated HESCs are readily susceptible to oxidative cell death whereas 
decidualizing cells are remarkably resistant (35). The resistance of the decidual cells 
is attributed to several mechanisms that work in concert, to maintain the integrity of 
the decidua, during the extensive remodeling that takes place as a requirement for a 
functional feto-maternal interface. For example to prevent oxidative stress and 
subsequent damage that might occur at the feto-maternal interface, decidualized 
HESCs switch on the oxidative defence mechanisms that enable them to neutralize 
the effects of ROS and repair any damages caused by them (61, 62). For instance, 
decidualizing HESCs highly express antioxidant enzymes like superoxide dismutase 
2 (SOD2), thioredoxin (TXN), and glutathione peroxidase 3 (GPx3), all of which are 
free radical scavengers (6, 14, 17, 18, 35, 63, 64). In addition, oxidative stress 
signalling and activation of the stress-responsive c-Jun N-terminal kinase (JNK) 
pathway is attenuated in decidualizing HESCs (65). Moreover, differentiated HESCs 
highly express GADD45α (growth arrest and DNA damage alpha), a stress response 
gene involved in cell cycle arrest, chromatin remodeling and DNA repair (66, 67). 
Interestingly, decidualizing HESCs downregulate the proapoptotic member of the 
Forkhead family of transcription factors, FOXO3a, which is normally activated in 
undifferentiated HESCs subjected to a source of ROS like hydrogen peroxide (H2O2) 
(35). 
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Taken together, decidualization is not only critical for embryo implantation and 
placental formation, but also play a vital role in protection of the offspring as well as 
in maternal recognition and rejection of developmentally compromised human 
embryos. Hence, it goes without saying that perturbed decidualization can manifest 
in a range of reproductive disorders, including recurrent pregnancy loss and 
disorders associated with impaired placental formation, such as pre-eclampsia, fetal 
growth restriction, and preterm delivery. In fact a recent study suggested a role for 
the homeobox gene HOXA10 in maintenance of pregnancy (68). HOXA10 encodes 
for a transcription factor that plays a critical role in decidualization. Loss of HOXA10 
has been suggested to contribute to progestin resistance in preterm labour (68), 
indicating that preterm labour is not strictly a disease of the myometrium only. 
 
1.1.6 Cyclic adenosine monophosphate (cAMP) signalling in HESCs  
 
Although decidualization is known to be primarily progesterone-dependent, a 
plethora of evidence suggests that progesterone is not the primary trigger of the 
decidual process (25, 26, 69, 70). Progesterone, on the other hand, plays a pivotal 
role in maintaining and augmenting the decidual phenotype (25, 26). In vivo, PRL, a 
phenotypic marker of decidualization, and other decidual-specific genes, are only 
detectable in the superficial endometrial layer 10 days after the post-ovulatory rise of 
circulating progesterone levels (69, 71). This observation suggests that decidual-
specific genes are not under direct transcriptional control of activated progesterone 
receptor (PR). Activation by steroid hormone receptors is generally rapid and occurs 
usually within 1 - 4 hours post ligand stimulation (72). Furthermore, In vitro, 
progesterone alone or in combination with estradiol (E2) or relaxin can only induce 
decidualization of HESCs after at least 8 - 10 days of stimulation (7, 23, 72, 73).   
 
Overwhelming evidence suggests that initiation of the decidual process is dependent 
on increased cAMP signalling and sustained activation of the protein kinase A (PKA) 
pathway (7, 73, 74). cAMP is a ubiquitous second messenger that is formed from 
adenosine triphosphate (ATP). Binding of ligand to members of G-protein-coupled 
receptors activates adenylate cyclase, which consequently converts ATP to cAMP 
and pyrophosphate as a byproduct (74, 75). Several lines of evidence strongly 
support the notion that elevated cAMP levels sensitize HESCs to progesterone 
signalling. First, it has been reported that the cAMP content in endometrial biopsies 
obtained from patients in the secretory phase of the menstrual cycle is higher than 
the proliferative phase (76). Second, basal adenylate cyclase activity peaks in the 
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MSE phase of the menstrual cycle (76). Moreover, prostaglandin-stimulated 
adenylate cyclase activity is higher in secretory than proliferative endometrial 
biopsies (76). Fourth, in vitro studies investigating the effect of progesterone on 
cultured HESCs revealed that progesterone treatment elevates intracellular cAMP 
levels (71). Finally, in vitro studies comparing the independent and combined effects 
of cAMP and progesterone on the induction of the decidual marker gene PRL and its 
promoter activity revealed that cAMP is a potent inducer of the decidual phenotype. 
Progesterone, in comparison, is a much weaker stimulus, and its effects are apparent 
after a lag period of 10 or more days, as mentioned before (Figure 1.4) (25, 26, 69, 
77, 78). 
 
Various studies indicated that elevated cAMP levels during the secretory phase of 
the menstrual cycle is a response to the post-ovulatory exposure of the endometrium 
to local factors capable of inducing cAMP induction such as relaxin, corticotrophin-
releasing hormone, pituitary gonadotrophins and prostaglandin E2 (PGE2) (10, 79-
85). During pregnancy, maintenance of cAMP signalling in the decidua is speculated 
to occur due to the exposure to the massively secreted human chorionic 
gonadotrophin (hCG) (86). Intracellular cAMP concentrations are not only regulated 
by stimuli inducing its production, but again by intracellular phosphodiesterases 
(PDEs), which mediate its degradation and hydrolysis (83, 84). 
 
A major downstream effector of cAMP is PKA, a cytoplasmic holoenzyme, which in 
its inactive state is comprised of two regulatory and two catalytic subunits (7). The 
regulatory subunits inhibit the activity of the catalytic subunits when the holoenzyme 
is in its tetramer state. Upon binding of cAMP to the regulatory subunits, the catalytic 
subunits are released and consequently phosphorylate downstream targets of the 
PKA pathway leading to modulation in the activity of the modified proteins (73). Since 
cAMP is a ubiquitous second messenger, several mechanisms exist to control its 
signalling. In most cell systems, those mechanisms evolved to attenuate cellular 
responses to an ongoing external stimulus rendering cAMP signalling a transient 
event. Interestingly, decidualizing HESCs represent an exception to this rule. In other 
words, maintenance of the decidual phenotype requires sustained cAMP signalling 
and consequently, sustained activation of the PKA pathway (7, 74, 87).  
Chapter 1: Introduction 
 32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.4 Initiation of the decidual process is primarily dependent on cAMP. 
Treatment with cAMP alone markedly induces the decidual marker PRL, but is 
incapable of maintaining the decidual phenotype. Treatment with MPA alone induces 
PRL after a lag period of 8 to 10 days. However, treatment with cAMP in combination 
with MPA has a synergistic effect on PRL production characterized by a marked 
induction and maintenance of the decidual phenotype. (Adapted from (69)). 
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Major nuclear targets of the holoenzyme PKA are the cAMP response element 
binding protein (CREB) and the cAMP response element modulators (CREMs). 
CREB and CREM are transcription factors that exert their effects by binding to cAMP 
response elements (CREs) in promoters of target genes (87). Alternative splicing, 
translation initiation and promoter usage give rise to various CREM isoforms (87). 
Depending on the presence or absence of a transactivation domain, those CREM 
isoforms can act as transcriptional activators or repressors (88-90). Furthermore, the 
use of an alternative cAMP-inducible intronic promoter termed (P2), which is found 
on the CREM DNA binding domains (DBDs), generates the inducible early repressor 
(ICER) (89, 90). ICER is a powerful repressor of cAMP-induced transcription and 
negatively autoregulates its own transcription (88, 89, 91).  
 
Interestingly, cAMP signalling in decidualizing HESCs forms an exception to the 
above model. ICER transcripts were found to be strongly upregulated in decidualizing 
HESCs and their level was parallel to the induction of the decidual PRL (87). In other 
words, the induction of ICER is not transient but sustained, and the negative 
autoregulatory feedback loop is not established upon activation of the PKA pathway 
resulting in sustained cAMP signalling (87). 
 
Promoter studies revealed that cAMP activation of the decidual PRL promoter in 
HESC is a biphasic response characterized by an initial weak but rapid induction 
followed by a secondary, much more enhanced induction apparent after 12 hours of 
stimulation (73). Interestingly, further analysis of the decidual PRL promoter showed 
that the initial and delayed cAMP-dependent responses are dependent on distinct 
cAMP response elements (CREs). In fact, the initial rapid response is dependent on 
a non-palindromic CRE at position -12, whereas, the major but rather delayed 
activation of the decidual PRL promoter is dependent on a regulatory region that lies 
between position -332 and -270 (73). At this stage, it is noteworthy to point out that 
the decidual PRL transcript is initiated at an alternative start-site to that of the 
pituitary PRL (73, 77, 92, 93). The decidual PRL startsite is 6 kb upstream of the 
pituitary start-site, resulting in an elongated 5’-untranslated region within the decidual 
transcript, but gives rise to a decidual PRL protein that is identical to the pituitary PRL 
(73, 77, 92, 93).  
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1.1.7 Progesterone signalling in HESCs  
 
Progesterone is a steroid hormone that plays a critical role in the female reproductive 
system (94-98). It governs key events such as mammary gland development, 
ovulation, decidualization, implantation, menstruation and maintenance of pregnancy 
(99). Progesterone exerts its effects primarily through activation of PR. PR knockout 
mice show various reproduction defects including sexual behaviour, ovulation and 
implantation, supporting the notion that progesterone act as a pleiotropic regulator of 
diverse reproduction events (100, 101). 
 
PR belongs to the nuclear receptor superfamily of transcription factors (102). Two 
isoforms of PR exist, PR-A and PR-B. They arise from the same gene but are the 
result of alternative promoter usage and translation at two distinct start-sites (94, 
103). PR-A lacks an N-terminal stretch of 165 amino acids, which harbours a 
transactivation function that is specific to PR-B and is critical for activation of PR-B 
specific targets. PR-A also acts as a negative regulator of PR-B and other steroid 
receptors like the estrogen receptor (ER), and therefore, it is regarded as an 
important modulator of hormone receptor action (95, 104, 105). Interestingly, PR-A 
knockout mice are infertile, exhibit perturbed ovulation and cannot undergo 
decidualization, suggesting that the two isoforms are not functionally redundant in so 
far that PR-B on its own is incapable of maintaining normal reproductive events (103) 
(106, 107). In agreement with this notion, both PR isoforms are expressed in the 
endometrium, however, PR-A was the predominant isoform in the stromal 
compartment (108).  
 
Upon binding of ligand, PR undergoes a conformational change, which consequently 
leads to its phosphorylation and dissociation from heat shock proteins. Subsequently, 
PR dimerizes and binds to specific response elements in the promoter region of 
target genes. The latter event requires interaction with steroid receptor co-activators 
(SRCs), which in turn recruit SRC-associated histone acetyltransferases (CBP and 
pCAF) and co-activator associated methyltransferases (CARM1) that are responsible 
for modifying the chromatin landscape to enable transcription initiation (7, 109-112).   
 
An increasing body of evidence has indicated that post-translational modifications 
play a critical role in regulating steroid receptor activity. PR is not an exception and 
its ligand-dependent and ligand-independent activity is regulated by post-translational 
modifications such as phosphorylation, ubiquitination, methylation, acetylation and 
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sumoylation (70, 113-117). Unlike ubiquitination, sumoylation of transcription factors 
does not lead to their degradation but has a significance effects on their stability, 
cellular localization, protein-protein interaction and transcriptional activity (118-120). 
Sumoylation is a dynamic and reversal post-translational modification. Generally, 
sumoylation of transcription factors, including PR, results in stabilization of the 
protein and repression of its transcriptional activity (113). Interestingly, upon 
decidualization, cAMP signalling attenuates PR sumoylation leading to increased 
transcription activity of the receptor and enhanced turnover (70). In other words, a 
decrease in PR sumoylation is, at least in part, responsible for sensitizing HESCs to 
progesterone signalling (70).   
 
1.1.8 Transcription factors involved in decidualization 
 
An Increasing body of experimental evidence has implicated a number of 
transcription factors in the decidual process. In addition to PR, Forkhead transcription 
factor (FOXO1), signal transducers and activators of transcription (STATs), 
CCAAT/enhancer binding protein beta (C/EBPβ), activating protein 1 (AP1), Ets 
transcription factors, Sp1, HOXA10, HOXA11 and the tumour suppressor p53 have 
all been shown to play a role in the differentiation of HESCs into decidual cells (121-
135).  
  
Multiple experiments have demonstrated that PR interacts with various transcription 
factors that play a critical role in mediating the decidual response. For instance, PR 
interacts C/EBPβ, and this interaction is responsible for enhancing C/EBPβ-
dependent induction of the decidual promoter (121, 136).  
 
In addition to C/EBPβ, PR also interacts with STAT5, which is a cAMP-induced 
transcription factor that plays a vital role in decidualization (121, 125, 137). STAT5 
have been show to enhance the activity of the decidual PRL promoter (121, 125). 
 
Another transcription factor that interacts with PR and has been shown to enhance 
the activity of the decidual PRL promoter is FOXO1 (121, 125). FOXO proteins 
belong to the Forkhead family of transcription factors, which are characterized by a 
conserved DNA-binding domain known as “Forkhead box” or “FOX” (138). The 
members of the FOX family are further classified into subgroups that range from 
FOXA to FOXR according to sequence similarity (138). Members of the FOXO class 
include FOXO1, FOXO3 and FOXO4 and are regulated by the protein kinase B 
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(PKB)/AKT signalling pathway (139). Upon phosphorylation by PKB/AKT, FOXO 
proteins are translocated to the cytoplasm, repressing their transcriptional activity 
(140, 141). Another factor that regulates FOXO proteins is the serum glucocorticoid 
kinase (SGK1), which is closely related to PKB/AKT (139). FOXO transcription 
factors are critical regulators of cardinal cellular processes such as cell fate and 
apoptosis, cell cycle progression, differentiation and oxidative stress resistance (138, 
139).  
 
Interestingly, genome-wide microarray studies comparing decidualizing HESCs 
subjected to siRNA-mediated knockdown of FOXO1 to those containing the 
endogenous transcription factor revealed that FOXO1 in HESCs has an anti-
proliferative effects and is involved in important cellular processes such as cell cycle 
regulation, cellular assembly and organization as well as DNA replication, 
recombination and repair (18). 
 
1.1.9 Cross-talk of cAMP and progesterone signalling in HESCs 
   
PR interactions with FOXO1, C/EBPβ and STAT5 led to the hypothesis that PR 
provides a platform for the formation of the decidual-specific transcription complex, 
which is responsible for regulating the expression of decidual-specific genes (Figure 
1.5) (7). Further evidence suggests that cAMP sensitizes HESCs to progesterone 
signalling. First, cAMP signalling and activation of the PKA pathway dissociates PR 
from it co-repressors N-CoR and SMRT and facilitates the recruitment of its co-
activator SRC-1 (142, 143). Second, the expression and/or activation of FOXO1, 
C/EBPβ and STAT5, is known to be induced by cAMP signalling (121, 122, 125, 136, 
144, 145). 
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Fig 1.5 The decidual-specific transcription complex. PR forms a platform for the 
interaction of the different transcription factors, co-activators and the pre-initiation 
complex involved in the decidual-specific transcription machinery. (Adapted from Al 
Sabbagh et al, Mol Cell Endocrinol, Submitted). 
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1.1.10 Summary 
 
Decidualization is a highly regulated event and is cardinal for the maintenance of a 
successful pregnancy. It encompasses various morphological responses 
underpinned by extensive biochemical changes. The signalling cascades involved in 
this differentiation process are complex and intertwined and rely heavily on the 
synergy and crosstalk between cAMP and progesterone signalling which in turn 
triggers a cascade of events and regulates a number of transcription factors. 
Decidualization also confers resistance of HESCs to environmental cues rendering 
them robust for embryo implantation and further trophoblast invasion and placental 
formation. 
 
Taken together, failure to mount an adequate decidual response perturbs a cascade 
of events which can manifest in various reproductive and pregnancy disorders like 
recurrent miscarriages, pre-eclampsia, pre-term labour and fetal growth restriction.   
 
1.2 Reactive oxygen species (ROS) 
 
1.2.1 Effects of ROS  
 
ROS, such as superoxide anion (O2-), hydroxyl radical (-OH) and H2O2, are highly 
reactive and relatively unstable small molecules that are the natural by-products of 
aerobic metabolism (146, 147). Those free radicals are the metabolite of molecular 
O2, which are formed during various electron transfer reactions (62). Electron transfer 
reactions, also known as “redox” reactions, refer to the process by which one or more 
electrons move from one molecule to another. For instance, O2- and H2O2 are 
partially reduced to molecular O2 through one- and two-electron reduction reactions 
(62, 148). Other reactive metabolites require the presence of transition metal ions, 
such as iron (Fe), to be formed. An example of which is -OH (62, 148). 
 
Denham Harman, in 1956, described ROS as a “Pandora’s box of evil” as they can 
induce cellular damage, mutagenesis, cancer, degenerative processes and aging 
(147, 149-152). Since then, ROS were predominantly known for their toxic cellular 
effects that can damage macromolecules like DNA, proteins and lipids, disrupting 
cellular functions and leading to a wide spectrum of human diseases (62, 147, 153, 
154). 
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More recently however, a large body of evidence has emerged implicating ROS in 
physiological cellular processes and signalling, including cell cycle progression, the 
immune response against infectious agents, differentiation and apoptosis (153, 155, 
156).  
 
The term “redox signalling” is used to describe the cascade of events in which ROS 
mediate signal transductions and protein modifications that are essential for various 
physiological functions (149). Beneficial redox signalling occurs at low/moderate but 
measurable concentrations of ROS in the cell (149, 153, 157, 158). Pathological 
disorders, however, are associated with higher, persistent and deregulated 
concentrations of ROS (149, 157, 158). Interestingly, a shift in the oxidative status of 
the cell towards a higher concentration of ROS may not necessarily lead to a 
pathological disorder but reflect a natural cellular progression like aging (149, 157-
159).  
 
1.2.2 Cellular oxidative defence mechanisms 
 
To protect against the potential detrimental effects of ROS, unicellular and 
multicellular organisms have evolved multiple levels of defence mechanisms (160). 
Antioxidant enzymes, like SOD, which dismutase O2- to O2 and H2O2, and catalase, 
which decomposes H2O2 to water (H2O) and O2, form the main line of defence in 
multicellular organisms together with GPx and TXN (153, 160).  Those enzymes 
squelch highly reactive ROS, thereby protecting the cell from potential damages (62). 
Other non-enzymatic antioxidants include α-tocopherol (vitamin E), β-carotene, 
ascorbic acid (vitamin C) and glutathione (149, 160). 
 
1.2.3 Redox homeostasis 
 
Since ROS are involved in various physiological processes, their complete ablation 
could hinder and perturb ROS-dependent physiological functions (158). Therefore, in 
a normally functioning cell, there is always a delicate balance between ROS 
production and the various antioxidant enzymes, indicative of the dual role of 
antioxidants defense enzymes in protecting the cells from damage and facilitating the 
beneficial use of free radicals in physiological functions (153). It follows then, that an 
imbalance between the antioxidant capacity of the cell and the amount of oxidants 
produced leads to oxidative stress (62). In other words, oxidative stress could be 
defined as the disturbance in the equilibrium status of prooxidant and antioxidant 
molecules in favour of prooxidants, in a biological system (153, 160, 161). Oxidative 
Chapter 1: Introduction 
 40 
stress has been implicated in various pathological disorders such as cardiovascular 
diseases, atherosclerosis, rheumatoid arthritis, cancer, inflammatory diseases, 
diabetes, neurodegenerative diseases like Alzheimer’s and Parkinson’s disease 
(148, 153, 162-171). Oxidative stress is also implicated in several reproductive 
disorders, ranging from endometriosis to infertility, early pregnancy loss and 
preeclampsia (57, 60, 172-175). 
 
The maintenance of the oxidative equilibrium status, also known as “redox 
homeostasis” is an important feature of biological systems and is achieved through a 
mechanism called “redox regulation” (149, 153). Spatial and temporal regulation of 
the redox homeostasis may occur. For instance, different amount of antioxidant 
enzymes exist at different subcellular locations (160). Moreover, different cell types 
possess different types and concentrations of antioxidants (160). The redox status of 
a cell will vary when it goes through different processes, such as proliferation, 
differentiation, aging and senescence (176), reflecting changes in antioxidant 
capacity and/or ROS production.    
 
1.2.4 ROS as signalling molecules 
 
There are several characteristics that define a signalling molecule. First, its 
production should be a response to a stimulus. Second, it has to exert an effect 
either in the cell in which it was produced or on adjacent cells. Third, its production 
and signalling can be switched off upon another stimulus or a change of cellular 
condition (146).  
 
In the case of ROS, which act as second messengers in signalling cascades, the 
second condition is the hardest to comply with, as most of the free radicals are highly 
reactive with very short half-lives (154, 160). Exceptions are O2- and H2O2, as various 
reports have implicated them in signalling cascades (157, 177-181). H2O2 is relatively 
more stable than O2- and it has been suggested in various reports that although in a 
cell O2- is the primary source of ROS, it is rapidly further reduced/dismutated by SOD 
to H2O2, which is regarded as a secondary source of ROS that acts as a signalling 
molecule (147, 149, 154, 157, 178). Interestingly, the relative stability (relatively long 
half-life compared to other free radicals) of H2O2 enables it to diffuse through the cell 
plasma membrane to adjacent cells, where it can act as a signalling intermediate 
(149, 154, 169).  
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Regardless of their harmful effects in cells, it is now well established that 
endogenously generated ROS act as a second messenger relaying various signals 
involved in cell cycle progression, apoptosis, and differentiation (147, 153, 156, 158, 
159, 181, 182). Various cytokines and growth factors have been implicated in 
triggering the production of intracellular ROS (147, 157). 
 
1.2.5 Measurement of intracellular ROS 
 
Due to their high reactivity and relative instability, it is difficult to measure intracellular 
ROS concentrations (62, 183). All current methods are indirect and depend on 
measuring the end products that results from DNA, lipid or protein interactions with 
ROS. The most commonly used methods depend on the reaction of ROS with an 
oxidant-sensing detector molecule that emit fluorescence or light upon oxidation (62, 
183).  
 
Lucigenin is an aromatic compound with chemiluminescent properties. It is used as a 
detector molecule for O2- (183). Upon oxidation, lucigenin is reduced, rendering its 
electrons in an excited state and consequently emitting light, which can be detected 
by a luminometer (184). Lucigenin has been used to detect O2- produced from 
various intracellular free radical sources in various biological systems, including 
phagocytic cells, fibroblasts and smooth muscle cells (62, 183-187). However, one 
major limitation of lucigenin is its ability to auto-oxidize and generate O2- upon 
interaction with molecular O2 (62, 183, 188). Another minor limitation is reflected in its 
specificity of measuring O2- and not H2O2. In most biological systems, not only does 
H2O2 represent the prime free radical signalling molecule, but, as mentioned earlier, 
O2- is rapidly dismutated to O2 and H2O2. To measure the oxidative status of the cell, 
it is better therefore to select a detector that is sensitive to both O2- and H2O2. 
 
A second detector molecule for measuring intracellular ROS is dihydrorhodamine 
123 (DHR 123). DHR 123 is an uncharged and non-fluorescent membrane 
permeable oxidant-sensing probe. Upon oxidation by ROS, DHR 123 is oxidized to 
the fluorescent compound rhodamine 123, which in turn exhibits green fluorescence 
(189, 190).  
 
A third and commonly used detector molecule is dihydrofluroscein diacetate (DCFH-
DA) (191). DCFH-DA is a membrane permeable non-fluorescent molecule. Once it is 
in the cytosol, it gets cleaved by cellular estrases converting it to the membrane 
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impermeable molecule DCFH. Upon interaction with ROS, DCFH is converted to the 
fluorescent probe DCF, which emits fluorescent signal that can be measured and 
monitored over time by a fluorometer (192). Figure 1.6 illustrates the mechanism of 
action of DCFH-DA. The amount of fluorescence emitted is proportional to the 
amount of ROS produced in the cell. 
 
1.2.6 Sources of ROS production in the mammalian cell 
 
Although it is widely assumed that the main source of ROS in the cell is their 
production as byproducts from the mitochondrial electron transport chain, a plethora 
of evidence points to the nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase complex as the prime source of ROS (147, 148, 153, 167, 193). Superoxide 
generation is not the prime purpose of the mitochondria, but a byproduct of the 
electron transport chain, a mechanism by which several electrons are transferred 
between molecules in order to produce chemical energy (167). The NADPH oxidase 
complex, on the contrary, has evolved for the prime reason of ROS production (147, 
194). Other sources of free radicals in the cell are the nitric oxide synthase (NOS) 
and the xanthine oxidase (XO). NOS is the prime source for nitric oxide (NO) in cells. 
NO is rapidly oxidized, and consequently, derives the production of other reactive 
nitric species (RNS) (147, 195). XO is another source of ROS in cells. It catalyses the 
oxidation of hypoxanthine to xanthine as well as the oxidation of xanthine to uric acid, 
generating H2O2 as a by-product in both reactions (167, 193, 196). A large body of 
experimental evidence has implicated the NADPH oxidase complex in physiological 
functions such as proliferation and differentiation as well as pathological disorders 
like cardiovascular diseases (197-202).   
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Fig 1.6 The Mechanism of action of the oxidant-sensing probe DCFH-DA. 
DCFH-DA is a non-fluorescent membrane permeable probe. Once it diffuses through 
the cell, DCFH-DA gets cleaved to DCFH by cellular esterases, rendering it 
membrane impermeable. Upon interaction with ROS, DCFH gets oxidized to the 
fluorescent probe DCF. The amount of fluorescence emitted is proportional to the 
amount of ROS in the cell.     
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1.3 The NADPH oxidase complex 
 
The NADPH oxidase complex was first discovered in phagocytes as an enzymatic 
system with the prime function of generating O2- (147, 203, 204). The later discovery 
of homologues of the catalytic subunit NOX2 (NOX: NADPH oxidase) of the NADPH 
oxidase complex in various other cell types like fibroblats, demonstrated that 
endogenous ROS production is not limited to phagocytic cells (147, 203, 205).  
 
1.3.1 The phagocytic NADPH oxidase complex 
 
 The NADPH oxidase complex is responsible for the respiratory burst in phagocytic 
cells (147, 204). The respiratory burst refers to the rapid release of ROS (O2- and 
H2O2) from cells such as monocytes, leukocytes and neutrophils, as part of the 
immune response against pathogenic agents and antigens, such as bacteria and 
fungi. In other words, the respiratory bursts functions as a bactericidal capacity in 
phagocytic cells (147, 206).  
 
Clinically, a diminished capacity to generate a respiratory burst in phagocytic cells is 
associated with recurrent infections. This condition is known as chronic 
granulomatous disease (CGD), a hereditary disease in which innate immunity is 
impaired due to an inability to produce a respiratory burst in response to pathogens 
(147, 194, 203, 206, 207). Interestingly, other functions of the immune cells, like 
phagocytosis, chemotaxix and degranulation, appear not to be affected in patients 
with CGD (147). In many affected patients, the catalytic subunit NOX2 or its cofactor 
p22PHOX is mutated in leukocytes, leading to inactivation of the NADPH oxidase 
complex (147, 194, 203).  
 
1.3.2 Structure of the phagocytic NADPH oxidase complex 
 
The phagocytic NADPH oxidase complex produces superoxide through catalyzing 
the one-electron reaction of molecular O2, using NADPH oxidase as an electron 
donor (194, 203). As illustrated in Figure 1.7, the NADPH oxidase complex is 
composed of two transmembrane proteins, three cytosolic regulatory proteins and 
the Rho family member RAC. The transmembrane proteins are NOX2, previously 
known as gp91PHOX, and p22PHOX, encoded by CYBA (208, 209). The PHOX 
superscript originally referred to Phagocyte OXidase (203). The three cytosolic 
components of the complex are p47PHOX, p67PHOX and p40PHOX.  
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The transmembrane components of the NADPH oxidase complex NOX2 and p22PHOX 
form a heterodimeric flavohemoprotein known as cytochrome b558 (203, 209). The 
formation of the heterodimer is essential for the stability and activity of the NADPH 
oxidase complex (203, 210, 211). This heterodimer contains one flavin adenine 
dinucleotide (FAD)-binding domain, two heme domains and an NADPH-binding 
region (194, 203, 212). 
 
In the inactive state, the cytosolic regulatory proteins dissociate from the phagocytic 
cytochrome b558 and remain in the cytoplasm. Upon activation of the complex through 
cellular interactions with chemoattractants, chemokines and pathogenic particles, the 
cytosolic components p47PHOX, p67PHOX, p40PHOX and RAC translocate to the 
membrane to assemble the enzyme in its active state (Figure 1.7) (194, 203, 213). 
The translocation of the cytosolic components is triggered by phosphorylation of 
p47PHOX, which occurs when the phagocytic cell is exposed to an activating stimulus 
(147, 203). Furthermore, in the inactive state, RAC resides in the cytoplasm bound to 
guanine nucleotide-dissociation inhibitor (GDI). Once the cell is stimulated, the 
guanine exchange factors (GEFs) enable the disassociation of RAC from GDI and 
interact with guanine triphosphate GTP. It has been reported that activation of RAC is 
involved in translocating the NADPH oxidase cytosolic components to the membrane 
of the stimulated cell (203, 213, 214).  
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Fig 1.7 The phagocytic NADPH oxidase complex. In the absence of a stimulus, 
the complex dissociates and the regulatory subunits RAC, p47PHOX, p67PHOX and 
p40PHOX reside in the cytoplasm. Upon activation of the complex, the cytosolic 
components are translocated to the membrane assembling the enzyme in its active 
state. 
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1.3.3 Non-phagocytic NADPH oxidase complexes 
 
After its initial discovery in immune cells, several lines of evidence indicated the 
presence of an NADPH oxidase complex in non-phagocytic cells. First, various 
observations reported the ability of non-phagocytic cells to produce moderate 
amounts of endogenous ROS. Second, p22PHOX is found ubiquitously in almost all 
cells (194). Third, the discovery of homologues of the NOX2 in various different non-
phagocytic cells like fibroblasts, smooth muscle cells and endothelial cells has 
indicated the presence of alternative NADPH oxidase complexes (168, 185, 194, 
203, 212, 215-217). 
 
To date, there are 7 known NOX homologues in non-phagocytic cells. The 
phagocytic NOX2 is the prototypic NOX subunit. The other homologues are named 
NOX1, NOX3, NOX4, NOX5, DUOX1 and DUOX2. Each homologue is encoded by a 
designated gene, and the degree of homology with the prototypic NOX2 differ 
between the various homologues (218, 219). The numbering of the NOX homologues 
reflects the order of discovery (147). 
 
The NOX2 homologues can be categorized into three different subgroups. The first 
group consists of NOX1, NOX3 and NOX4. Members of this group closely resemble 
NOX2 in terms of structure, consisting of a FAD domain, two heme domains, an 
NADPH-binding region and 6 transmembrane domains. The second group has only a 
single member, NOX5. This homologue has two additional calcium (Ca2+)-binding EF 
hand motifs in its N-terminal. The third group consists of DUOX1 and DUOX2. Those 
homologues are larger than the others as they contain a peroxidase domain in their 
N-terminal in addition to the two Ca2+-binding EF hand motifs. Further, the DUOX 
enzymes contain an additional transmembrane domain separating the peroxidase 
region from the dual EF hand motifs (194).  
 
Another method of categorizing the NOX homologues is based on their dependency 
on the various cytosolic regulatory components. As illustrated in the schematic 
diagram (Fig 1.8), NOX1, NOX2, NOX3 and NOX4 are p22PHOX-dependent whereas 
NOX5 is not. Instead, NOX5 and the dual DUOX subunits are Ca2+-dependent, 
reflecting the presence of the dual EF hand motifs present in their structures (147, 
208). Moreover, only NOX1, NOX2 and, to a lesser extent, NOX3 are RAC1-
dependent. NOX4 represents an exception as its activation only requires p22PHOX 
and it does not interact with any other regulatory components of the oxidase (208, 
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220). Interestingly, these characteristics render NOX4 constitutively active, 
generating ROS continuously at a very moderate level (218, 220). However, the 
capacity of NOX4 to generate ROS can be stimulated by various compounds and 
signals (191, 217, 221).   
 
The expression of the NOX homologues in non-phagocytic cells is not necessarily 
restricted to one homologue per cell type (217, 222). The relative ratios of the NOX 
homologues also vary. For instance, in vascular smooth muscle cells, NOX4 
expression is 40-fold higher than NOX1 (218, 222). Moreover, the cellular location of 
each NOX homologue can be distinct within one cell, differ between an 
undifferentiated and differentiated cell, as well as between different cell types (218, 
222). For example, NOX4, in vascular smooth muscle cells co-localizes with vinculin, 
an actin-binding protein used as a marker for focal adhesion plaques that links 
integrin adhesion molecules to the actin cytoskeleton (218, 222, 223). In endothelial 
cells however, NOX4 was found to localize to the endoplasmic reticulum (218, 224). 
Interestingly, the distinct subcellular localization of the NOX homologues fits nicely 
with the observation that endogenous ROS production is highly compartmentalized 
and often restricted to the subcellular location at which free radicals exert their 
physiological signalling effects (222, 225). It also fits with some experimental 
evidence demonstrating that different NOX homologues mediate their effects through 
distinct signalling pathways (221). In fact, various cytokines, growth factors and 
signalling cascades have different impact on distinct NOX homologues (222, 224). 
This indicates that ROS generation from different NOX homologues trigger distinct 
signalling cascades in a highly cell-specific and environmentally specific context 
(222, 224, 225). Moreover, there is evidence to suggest that different NOX 
homologues may produce different species of ROS. For instance, it has been 
reported that NOX4 generates H2O2 instead of O2- (217, 220).  
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Fig 1.8 Non-phagocytic NADPH oxidase. The different NOX homologues differ in 
their requirement of the cytosolic regulatory components. NOXA1, NOXO1 and p41 
are the homologues for p67PHOX, p47PHOX and p40PHOX respectively, in non-phagocytic 
cells. 
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1.3.4 Phagocytic vs non-phagocytic NADPH oxidase complex 
 
The phagocytic and non-phagocytic NADPH oxidase complexes share similarities in 
their structure and function; however, they differ in their biochemical characteristics 
(185). The first difference manifests in the amount of O2- produced. The phagocytic 
NADPH oxidase produces a relatively high amount of O2- but only during the 
respiratory burst. The non-phagocytic NADPH oxidase, on the other hand, generates 
O2-, sometimes constitutively, at low levels (185, 226). A second difference lies in the 
kinetics of the complex. The phagocytic complex generates O2- instantaneously upon 
stimulation by a pathogenic particle or a chemokine signal, whereas there is a lag 
period that can span minutes to hours between the stimulation of the non-phagocytic 
NADPH oxidase and subsequent ROS generation (185-187, 227). 
 
1.3.5 Activators and inhibitors of the NADPH oxidase complex 
 
The activity of the NADPH oxidase complex can be modulated using various 
chemicals that can stimulate or abolish the activity of the phagocytic and non-
phagocytic NADPH oxidase complex. Manipulation of the complex is important to 
determine the physiological and pathophysiological role of NADPH oxidase-
dependent ROS signalling in various cell types. One limitation of the NADPH oxidase 
inhibitors is their lack of specificity (147). Most inhibitors can block ROS production 
from other sources in the cell, like the XO or NOS. However, this limitation can be 
circumvented by using inhibitors for other sources of ROS in the cell, and comparing 
their effect with that of the NADPH oxidase inhibitor. Alternatively, NADPH oxidase-
dependent ROS production can be disabled using siRNA-mediated knockdown of 
one or more of the complex subunits (220, 224). 
 
The following are some of the most commonly used inhibitors and or activators of the 
complex: 
 
a. Diphenylene iodonium (DPI) 
DPI is the most commonly used inhibitor of the NADPH oxidase complex. DPI acts 
by removing an electron from an electron transporter and forming a radical, which 
covalently binds to the FAD-binding domain of the cytochrome b558 (147, 218, 228). 
The mechanism of action of DPI renders it not only an inhibitor for all NOX 
homologues but also for other flavin-containing enzymatic sources of ROS, such as 
the XO, the mitochondrial electron transport chain and NOS (228, 229). As 
mentioned, lack of specificity of DPI can be circumvented by carrying out well
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controlled experiments that involve all the appropriate controls and specific inhibitors 
for other sources of ROS (Figure 1.9) (147, 228). Moreover, DPI, at efficient 
concentrations, does not confer cell toxicity and has no oxidant scavenging potential 
(228). 
 
b. Apocynin 
Apocynin is a phenol compound 4-hydroxy-3-methoxyacetophenone extracted from 
the roots of the medicinal plant Picrorhiza kurroa (147, 230). It has the ability of 
inhibiting the respiratory burst in phagocytic cells (230). The mechanism of action of 
apocynin depends on preventing the translocation of the regulatory components of 
the NADPH oxidase complex to the plasma membrane and therefore blocking the 
assembly of the complex in stimulated cells (147, 231, 232).   
 
Although apocynin is a selective NADPH oxidase inhibitor, there is strong evidence 
that it can also activate the complex in certain cell types (228, 230). For instance, 
apocynin induces superoxide production in vascular fibroblasts (Figure 1.10) (233). 
The reason behind apocynin’s dual function in different biological systems lies in its 
mechanism of action. It has been reported that in the presence of H2O2 or 
myeloperoxidase, apocynin forms a dimer, which inhibits the NADPH oxidase 
complex (232, 234). This dimerization occurs after a lag period. Accordingly, 
exposure of phagocytes to apocynin transiently increases ROS production followed 
by a decrease in ROS concentrations below basal levels (232, 234). The initial short 
period of ROS production that precedes the inhibition of the NADPH oxidase 
complex represents the effect of apocynin as a monomer (232). Therefore, in cells 
that lack myeloperoxidases such as vascular fibroblasts, apocynin as a monomer 
activates the NADPH oxidase complex. However, pretreatment of apocynin with 
H2O2 or horseradish peroxidase (HRP), prior to incubating it with vascular fibroblasts, 
inhibited superoxide production (233). Like DPI, it has been reported that apocynin 
does not have cytotoxic effects (228). 
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Fig 1.9 DPI is not a specific inhibitor of the NADPH oxidase complex. Lack of 
specific NADPH oxidase complex inhibitors, can be circumvented by inhibiting other 
sources of ROS, using specific compounds. Allopurinol specifically inhibits O2- 
production from the XO and L-Name is a specific inhibitor of NOS. AEBSF is an 
alternative inhibitor of the NADPH oxidase but, as a serine protease, it can affect a 
wide spectrum of other proteins.  
!"#$
%&!"'$
()*+,-.$
%/0$
1/$
23%,4.$
&55(678*9(5$&:;0<$
Chapter 1: Introduction 
 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.10 Apocynin and DPI modulate the activity of the NADPH oxidase 
complex. DPI is a potent inhibitor of the phagocytic and non-phagocytic NADPH 
oxidase complex. On the contrary, the effect of apocynin (Apo) differs between cell 
types. Generally, it acts as an inhibitor of the phagocytic NADPH oxidase but an 
activator of the non-phagocytic complex. 
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c. AEBSF 
AEBSF, 4-(2-Aminoethyl)benzenesulfonylfluoride, is another NADPH oxidase 
inhibitor. It is a serine protease inhibitor that interferes with the translocation of the 
cytosolic components of the NADPH oxidase and consequently perturbs the 
assembly of the enzyme (147). The exact mechanism of action of the compound is 
not yet elucidated. Further, since it is a serine protease inhibitor, it can affect various 
other proteins unrelated to the NADPH oxidase complex (147).  
 
1.3.6 Non-phagocytic NADPH oxidase complex: biology and disease  
 
An increasing body of evidence implicates NADPH oxidase-dependent ROS 
signalling in a spectrum of physiological functions. For instance, NADPH oxidase 
activity is important for endothelial activation, a process that is pivotal to inflammatory 
responses and enables endothelial-leukocyte interactions and permeability (208, 
235). NADPH-dependent ROS signalling also play a role in angiogenesis, 
proliferation and differentiation (156, 217). Conversely, perturbation in the NADPH 
oxidase complex expression or activity, either through genetic mutations or in 
response to an adverse cellular environment, leads to pathological disorders and 
diseases. For example, aberrant NADPH-dependent ROS production is widely 
implicated in cardiovascular diseases and cancer (185, 211, 218).  
 
1.4 Endometriosis 
 
1.4.1 Endometriosis: definition and diagnosis 
 
Endometriosis is a common, benign, estrogen-dependent inflammatory disease 
characterized by the presence of endometrium-like tissue outside the uterus, 
primarily on the pelvic peritoneum and ovaries (236, 237). Endometriosis is a chronic 
systemic disease that affects 6 -10 % of women of reproductive age (236, 238). It is a 
complex disease that may be asymptomatic or present as pelvic pain and/or 
subfertility.  Overall, the symptoms associated with pelvic endometriosis are non-
specific and surgical assessment, by laparoscopy or laparotomy, is still viewed as the 
gold standard for diagnosis (237, 239).  
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1.4.2 The pathogenesis of endometriosis 
 
The exact cause of endometriosis is unknown, but there are a number of theories, 
including retrograde menstruation, immune dysfunction, genetic predisposition, 
endometrial cells spreading through the bloodstream or lymphatic system, 
environmental causes, and metaplasia (239-242). Although retrograde transport of 
viable endometrial debris at the time of menstruation, and subsequent implantation of 
endometrial cells at ectopic sites, is widely viewed as the most common cause of 
endometriosis (243), this phenomenon occurs in 90% of women. Hence, it appears 
likely that multiple factors contribute to the pathogenesis of endometriosis as a 
chronic disease. For example, environmental factors, toxins like dioxin and 
phytoestrogens, have been implicated in the pathogenesis of endometriosis (236, 
242, 244), although the evidence remains controversial. Genetic inheritance has also 
been recognized as a feature of the disease and several genome wide association 
studies demonstrated linkage between SNPs and specific loci with risk of 
endometriosis (245, 246). The risk for women whose first-degree relatives suffer from 
severe endometriosis has also been reported to be six times higher than women with 
unaffected female relatives (237).  
 
Further, several molecular defects and/or immunologic abnormalities have been 
associated with endometriosis (236, 247, 248), which may account for the defective 
immunoclearance of endometrial cells in the peritoneal cavity and subsequent 
implantation and progression of the ectopic lesions (249). Further, various studies 
have associated the endometrium of patients with endometriosis with molecular 
defects like activation of oncogenic pathways and increased production of hormones 
and cytokines (236, 250-252). In addition, some epigenetic markers like methylation 
as well as the enzymes involved in maintenance of DNA methylation (DNMTs) are 
deregulated in the eutopic endometrium from patients with endometriosis compared 
to healthy individuals (248, 253). 
 
1.4.3 The immune system and endometriosis 
As mentioned briefly above, defective immune response and immunosurveillance of 
menstrual tissue in the peritoneal area has been associated with endometriosis. 
Natural killer (NK) cells have been implicated in clearing the peritoneal cavity from 
any ectopic tissue that ends there as a result of retrograde menstruation (249). NK 
cells can recognize and destroy tumour cells, pathogen-infected cells and foreign 
cells that have been transplanted in the body (249). One explanation for how NK 
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cells in healthy women can recognize autologous cells and respond to normal self-
antigens depends on endometrial cells in the peritoneal area secreting different 
cytokines to which the natural killer cells can respond to (244). In women with 
endometriosis however, NK cells have reduced activity and cytotoxicity against such 
foreign bodies (249, 254-256). Interestingly, this reduction in activity was correlated 
with the severity of the disease (254).  
 
Another mechanism that may be responsible for the defective immunosurveillance in 
women with endometriosis is the release of factors, like intercellular adhesion 
molecule 1 (ICAM1), from the ectopic endometriotic implants that prevent their 
recognition by the NK cells (249).   
 
1.4.4 Progesterone resistance and endometriosis 
 
Another characteristic of the eutopic endometrium of patients with endometriosis is 
resistance to progesterone signalling. There is an increasing body of evidence 
suggesting that the postovulatory rise in progesterone does not trigger profound gene 
regulation in the eutopic endometrium as it is seen with healthy individuals (257). 
Genome wide microarray analysis comparing biopsies taken in the MSE phase of the 
menstrual cycle from women with and without endometriosis revealed that over 200 
genes were aberrantly regulated in endometriosis samples (258). A subsequent 
study comparing global gene expression and regulation through the different phases 
of the menstrual cycle between eutopic endometrial cells from women with and 
without endometriois not only confirmed the attenuated progesterone response but 
also indicated that endometriosis cells show perturbation in the proliferative-to-
secretory transition, which is a hallmark of decidualization (257). Moreover, this study 
also showed that endometriosis cells possess enhanced cellular survival and 
continual expression of genes involved in DNA synthesis and mitogenic pathway 
(257). Another study applying genome wide microarray analysis in comparing the 
response of eutopic HESCs from women with and without endometriosis to 8-br-
cAMP, revealed that cAMP downregulates genes involved in cell cycle progression 
and upregulates genes involved in cytoskeletal changes (238). However, this 
response was deregulated in samples from women with endometriosis, confirming 
the observation that endometriosis cells possess persistent proliferative phenotype 
regardless of exposure to decidual stimuli (238).  
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The deregulation of a subset of progesterone-dependent genes in the endometrium 
of patients with endometriosis has been termed as “progesterone resistance”. 
However, one should interpret this concept with caution. Progesterone controls a 
myriad of reproductive events including ovulation, embryo implantation, 
decidualization and menstruation, which is associated with influx of uNK cells and 
controlled inflammatory response. A recent microarray study comparing purified 
eutopic HESCs from patients with and without endometriosis upon progesterone 
stimulation revealed that aberrant gene expression is not confined to progesterone 
response but is also evident in unstimulated cultures (259). This observation, in 
addition to the aberrant gene expression level upon cAMP stimulation indicate that 
the basal transcriptome in endometriosis samples is perturbed and might suggest 
aberrant epigenetic regulation that affect the chromatin landscape.   
 
1.4.5 Oxidative stress and endometriosis 
 
Oxidative stress is associated with various pathological disorders including 
endometriosis (260). It is yet not clear how ROS may contribute to the pathogenesis 
of endometriosis; however, several studies suggested that higher concentrations of 
ROS might induce proliferation and adhesiveness of eutopic endometrial cells in the 
peritoneal cavity (261-263). Some studies have attributed enhanced ROS 
concentrations in the peritoneal cavity to the increase in infiltrating macrophages 
(264-266). However, the findings of these studies are controversial with others that 
did not find association with oxidative stress (261, 264, 267, 268). The controversy in 
the findings has been attributed to differences in the biomarkers used to assess 
oxidative stress and the methods of investigation utilized in these studies (260, 261, 
264). Regardless of such controversy, emerging evidence is increasingly linking high 
ROS concentrations in eutopic endometriosis HESCs with the disease (172). 
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1.5 Hypothesis and Aims 
 
Recently, endogenous ROS signalling has been implicated in different physiological 
functions like proliferation and differentiation in various biological systems. I 
hypothesize that endogenous ROS production and signalling play an integral role in 
the differentiation of HESCs into decidualized cells. Conversely, aberrant 
endogenous ROS production may play an important role in chronic inflammatory 
disorders of the female reproductive tract, such as pelvic endometriosis. 
 
The specific aims of this project are: 
• To determine the main source of endogenous ROS production in HESCs. 
• To investigate the role and mechanism of endogenous ROS signalling in 
initiating and maintaining the decidual process. 
• To investigate whether aberrant ROS production and signalling in eutopic 
endometrium play a role in the pathogenesis of endometriosis. 
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2. Materials and Methods 
 
2.1 Materials 
 
2.1.1 Primary antibodies 
Catalase Rabbit anti-Catalase (ab76024; Abcam). Used for western blot 
(WB) at 1:10000 in phosphate buffered saline (PBS) 
C/EPBβ Rabbit anti-C/EPBβ (Sc-150 X; Santa Cruz Biotechnology Inc.). 
Used for WB at 1:400 dilution in 5% non-fat dry milk 
weight/volume (w/v) in 1% Tris buffered saline-Tween TBS-T 
volume/volume (v/v)  (5% non-fat dry milk in TBS-T) and for 
supershift analysis at 2 µg per 5 µg of nuclear protein extract 
FOXO1 Rabbit anti-FOXO1 (C29H4; Cell Signalling Technology). Used 
for WB at 1:1000 dilution in 5% BSA (w/v) in 1% TBS-T (v/v) (5% 
BSA in TBS-T) 
JNK Rabbit anti-JNK (56G8; Cell Signalling Technology). Used for WB 
at 1:1000 dilution in 5% BSA in TBS-T 
Lamin B Mouse anti-Lamin B (N412; Calbiochem). Used for WB at 1:5000 
dilution in 5% non-fat dry milk in TBS-T 
MKP1 Rabbit anti-MKP1 (c-370; Santa Cruz Biotechnology). Used for 
WB at 1:1000 dilution in 5% non-fat dry milk in TBS-T 
NOX4 Rabbit anti-NOX4 (Kind gift from Prof. D. Lambeth, Emory 
University, Atlanta, GA). Used for WB at 1:1000 dilution in 5% 
non-fat dry milk (w/v) in 1% TBS-T (v/v) 
p-ATM Rabbit anti-p-ATM (5883; Cell Signalling Technology). Used for 
WB at 1:1000 dilution in 5% BSA in TBS-T 
p-ATR Rabbit anti-p-ATR (2853; Cell Signalling Technology). Used for 
WB at 1:1000 dilution in 5% BSA in TBS-T 
p-BRCA1 Rabbit antil-p-BRCA1 (9009; Cell Signalling Technology). Used 
for WB at 1:1000 dilution in 5% BSA in TBS-T 
p-CHK1 Rabbit antii-p-CHK1 (2349; Cell Signalling Technology). Used for 
WB at 1:1000 dilution in 5% BSA in TBS-T 
p-CHK2 Rabbit antil-p-CHK2 (2661; Cell Signalling Technology). Used for 
WB at 1:1000 dilution in 5% non-fat dry milk in TBS-T 
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p-H2A.X Rabbit anti-p-Histone H2A.X (9718; Cell Signalling Technology). 
Used for WB at 1:1000 dilution in 5% BSA in 1% TBS-T and for 
immunofluorescence (IF) 1:120 in 5% normal goat serum in PBS 
p-JNK Rabbit anti-phospho-JNK (98F2; Cell Signalling Technology). 
Used for WB at 1:1000 dilution in 5% BSA in TBS-T 
PR Mouse anti-PR (NCL-L-PGR-312; Novocastra Laboratories). 
Used for WB at 1/1667 in PBS 
p22PHOX Rabbit anti-p22PHOX (FL-195; Santa Cruz Biotechnology Inc.). 
Used for WB at 1:200 in 5% non-fat dry milk in 1% TBS-T 
RAC1 Mouse anti-RAC1 (MAB3735; Chemicon/Merck KGaA). Used for 
WB at 1:1000 in PBS 
STAT-5 Rabbit anti-STAT5 (Upstate/ Merck KGaA). Used for WB at 
1:1000 dilution in 5% non-fat dry milk in TBS-T 
SUMO Rabbit anti-SUMO1 (Zymed, Burlingame). Used for WB at 1:1000 
dilution in 5% non-fat dry milk in TBS-T 
SRC Mouse anti-SRC (L4A1; Cell Signalling Technology). Used for 
WB at 1:1000 in 5% non-fat dry milk in 1% TBS-T 
α-tubulin Mouse anti-α-tubulin (sc-8035; Santa Cruz Biotechnology Inc.). 
Used for WB at 1:1000 dilution in 5% non-fat dry milk in TBS-T 
β-actin Mouse anti-β-actin (A1978; Sigma Aldrich). Used for WB at 
1:1000000 dilution in 5% non-fat dry milk in TBS-T 
  
 
2.1.2 Secondary antibodies 
HRP-conjugated anti-rabbit  Goat anti-rabbit IgG HRP (P0448; Dako UK Ltd.). 
Used for WB at 1:2000 dilution in 5% non-fat dry 
milk in TBS-T 
HRP-conjugated anti-mouse  Goat anti-mouse IgG HRP (P0447; Dako UK Ltd). 
Used for WB at 1:2000 dilution in 5% non-fat dry 
milk in TBS-T 
FITC-conjugated anti-rabbit Goat anti-rabbit IgG FITC (H17101; Invitrogen). 
Used for IF at 1:500 dilution in 5% goat serum in 
PBS 
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2.1.3 Plasmids 
(C/EBP)-pGL4 (C/EBP)-pGL4 reporter construct (a kind gift from Prof. P. 
Bennett, Imperial College London, London UK) 
(FOXO)-PGL4 (FOXO1)-pGL4 reporter construct previously described in 
(121) 
pcDNA3-catalase Catalase overexpression vector (a kind gift from Dr. S. 
Grimm, Imperial College London) 
pcDNA3-FOXO1 FOXO1 overexpression vector has been previously described 
in (121) 
pcH110 Control vector used for constitutive β-galactosidase 
expression (a kind gift from Prof. M. parker, Imperial College 
London) 
pSG-C/EBP C/EBP selective expression vector has been previously 
described in (126)   
2.1.4 siRNA 
Non-targeting siRNA siGENOME Non-targeting siRNA #2, D-001210-02-
20; Dharmacon  
FOXO1 siRNA siGENOME SMART pool M-003006-03, Human 
FOXO1, NM_002015; Dharmacon 
NOX4 siRNA siGENOME SMART pool M-010194-00, Human 
NOX4, NM_016931; Dharmacon 
p22PHOX siRNA siGENOME SMART pool M-011020-01, Human 
CYBA, NM_000101; Dharmacon 
RAC1 siRNA siGENOME SMART pool M-003560-02-0005, 
Human RAC1, NM_018890; Dharmacon  
 
2.1.5 Cell lines 
HESC Human endometrial stromal cells (HESCs - Primary culture) 
Hela Immortalised cell line derived from cervical cancer cells 
 
 
2.1.6 Cell culture materials and media 
Antibiotic/Antimycotic solution, Invitrogen 
Charcoal, Sigma 
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Collagenase type A1, Sigma 
Dextran, Sigma 
DNaseI, Roche 
Dulbecco’s Modified Eagles Medium (DMEM):F-12, Invitrogen 
Fetal Bovine Serum (FBS), Sigma 
Insulin, Sigma 
L-glutamine, Invitrogen 
Trypsin/EDTA, Invitrogen 
 
 
2.1.7 Chemicals and reagents 
17α-Medroxyprogesterone acetate (MPA), Sigma 
2′,7′-dichlorofluorescein-diacetate (DCFH-DA), Molecular Probes, Invitrogen 
2-Butanol, Sigma 
30% Acrylamide/bis-acrylamide (37.5:1), Bio-Rad 
30% Hydrogen peroxide (H2O2), Fluka 
4-(2-Aminoethyl)benzenesulfonylfluoride (AEBSF), Sigma 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Sigma 
Acetone, BDH  
Allopurinol, Sigma 
Ammonium persulphate (APS), Sigma 
Ampicillin, Sigma 
Apocynin, Sigma 
Bovine serum albumin (BSA), Sigma 
Bradford assay reagent, Bio-Rad 
Bromophenol blue, Sigma 
Calcium chloride (CaCl2), Sigma 
Charcoal, Sigma 
Chloroform, Sigma 
Complete protease inhibitor, Roche 
Diethylpyrocarbonate (DEPC)-treated water, Ambion 
Dihydrorhodamine 123 (DHR 123), Invitrogen 
Dimethyl suloxide (DMSO), Sigma 
Diphenyleneiodonium (DPI), Invitrogen 
Dithiothreitol (DTT), Bio-Rad 
DNase I, amplification grade, Invitrogen 
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Estradiol, Sigma 
Ethanol, BDH 
Ethylenediamine tetraacetic acid (EDTA), Sigma 
Glycerol, Sigma 
Glycine, Sigma 
Hydroxyureas, Sigma 
Imidazole, BDH 
Insulin, Sigma 
Isopropanol, Sigma 
Kanamycin, SIgma 
Low melting point agarose (LMA), Promega 
Luciferase assay reagent, Promega 
Magnesium chloride (MgCl2), Sigma 
Methanol, BDH 
N-omega-Nitro-L-arginine methyl ester 
Nonidet P-40 (NP-40), BDH 
Normal goat serum, Dako 
Normal melting agarose (NMA), Promega 
Paraformaldehyde (PFA), Sigma 
Polyvinylidene fluoride (PVDF), GE Healthcare 
Potasium cloride (KCL), Sigma 
Phenylmethylsulfonyl floride (PMSF), Sigma 
Reporter assay lysis buffer, Promega 
RNA STAT-60 reagent, AMS Biotechnology 
Skimmed milk powder, Fulka 
Sodium Chloride (NaCl), BDH 
Sodium dodecylsulphate (SDS), BDH 
STAT-60, AMS Biotechnology 
SYBR green PCR master mix, Applied Biosystem 
Tetramethylethylenediamine (TEMED), Sigma 
Trishydroxymethylaminomethane (Tris), BDH 
Triton-X, Sigma 
β-mercaptoethanol, Sigma 
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2.1.8 Kits 
Amersham™ ECL™ Plus Chemiluminescence, Amersham 
ApoTox-Glo™ Triplex Assay, Promega 
CellTiter 96® AQueous One Solution Cell Proliferation Assay, Promega 
DNA Damage Antibody Sampler Kit, Cell Signalling Technology 
Galacto-Light PlusTM System, Applied Biosystems 
HiSpeed Plasmid Maxi Kit, Qiagen 
ProFection® Mammalian Transfection System - Calcium Phosphate, Promega 
RNeasy MinElute Cleanup Kit, Qiagen 
SuperScript® First-Strand Synthesis System for RT-PCR, Invitrogen 
  
 
2.2 Methods 
 
2.2.1 Cell Culture 
 
2.2.1.1 Human endometrial tissue samples 
 
Endometrial samples were obtained from premenopausal women without uterine 
pathology. All the women were not on hormonal treatment and had regular menstrual 
cycles. Where the tissue was directly used for measuring basal levels of proteins and 
mRNA transcripts of interest, the samples were classified as “proliferative” if taken 
within the first 14 days of the last menstrual period, and as “secretory” if taken on day 
15 or later. For establishing primary cultures, biopsies from both phases of the 
menstrual cycles were used. Written informed consent was obtained from all 
participating subjects before tissue collection. The study was approved by the 
Research Ethics Committee of Hammersmith and Queen Charlotte's Hospital NHS 
Trust. 
 
2.2.1.2 Dextran coated charcoal (DCC) stripped serum preparation 
 
Fetal bovine serum (FBS) normally added to cell medium contains endogenous 
steroid hormones that may mask the effect of exogenously added ligands. Therefore, 
FBS used for cell culture is stripped of small molecules. This is achieved by adding 
1.25 g charcoal and 125 mg dextran to 500 ml of FBS. The mixture was then 
incubated in a waterbath for two hours at 56°C, inverting at regular intervals. 
Subsequently, the mixture was centrifuged at 4000 g for 30 minutes. The resulting 
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supernatant was sterilized by passing it through a 0.2 µm bottle-neck filter using 
suction, aliquoted and stored at -20°C. 
 
2.2.1.3 Primary cell culture 
 
Endometrial biopsies from independent patients were transferred to a Petri dish and 
cut finely using scalpels. Subsequently, the finely cut tissue was transferred into a 25 
cm2 flask with digestion media. The digestion media consisted of 10 ml of additive-
free Dulbecco’s Modified Eagles Medium (DMEM) F-12 with phenol red 
supplemented with 0.5 mg/ml collagenase type 1A and 0.1 mg/ml DNase 1. The 
collagenase was used in order to breakdown the extracellular matrix whereas the 
DNase was used to remove the viscous DNA released during the digestion process 
as a result of a small percentage of cell death. Digestion was allowed to proceed for 
one hour at 37°C in a humid atmosphere with 5% v/v carbon dioxide (CO2) with 
vigorous shaking every 20 minutes. Following the one-hour incubation period, 10 ml 
of 10%  v/v DCC/DMEM with phenol red was added to the digestion media in order to 
stop the action of the collagenase and the mix was centrifuged at 180 g for 5 
minutes. The pellet which contained stromal, epithelial and blood cells was 
resuspended in 12 ml of 10% DCC/DMEM with phenol red supplemented with 2 mM 
L-glutamine, antibiotic/antimycotic solution, 1 nM estradiol and 2 mg/ml insulin, and 
transferred into a flask, the size of which depends on the size of the digested biopsy, 
and maintained in a humidified cell culture incubator at 37°C with 5% v/v CO2. 
Stromal endometrial cells attach to the culture flask earlier than the epithelial cells. 
This allowes for the separation of the two types of cells by transferring the media, 
which largely contains blood and epithelial cells, after one hour of incubation into a 
new flask. The initial flask, which contains mostly stromal cells, is washed and 
incubated with 10% DCC/DMEM with phenol red supplemented with all the above. 
The 10% DCC/DMEM with phenol red supplemented with 2 mM L-glutamine, 
antibiotic/antimycotic solution, 1 nM estradiol and 2 mg/ml insulin, will be referred to 
as 10% DCC/DMEM medium. This 10% DCC/DMEM medium was used to propagate 
the HESCs and was changed every other day.  
 
Once the cultures reach confluency they were passaged. This was carried out by 
aspirating the media and washing the cells with 3 ml of trypsin-EDTA (Invitrogen). 
Subsequently, cultures were incubated with 5 ml trypsin-EDTA for five minutes at 
37°C. Following incubation, the flat was tapped genetly to dislodge the cells and 5 ml 
of 10% DCC/DMEM was added to the cultures to stop the action of the trypsin. Cells 
Chapter 2: Materials and Methods 
 67 
were pelleted by centrifugation at 180 g for five minutes and the pellet was 
resuspended in 10% DCC/DMEM. HESCs suspension was cultured at a suitable 
dilution, normally 1:2.  
 
To investigate the early events involved in the differentiation of HESCs into decidual 
cells, confluent cultures were treated with 0.5 mM 8-bromoadenosine-3', 5'-cyclic 
monophosphate in 2% DCC/DMEM without phenol red and supplemented with 
antibiotic/antimycotic solution. The 2% DMEM without phenol red and supplemented 
with antibiotic/antimycotic solution will be referred to as 2% DCC/DMEM medium. 
Prolonged decidualization was achieved by treating HESCs with 0.5 mM 8-br-cAMP 
and 1 µM 17α-Medroxyprogesterone acetate (MPA) in 2% DCC/DMEM. MPA was 
made up in ethanol whereas 8-br-cAMP was made in DMEM without additives. 
Therefore, ethanol was used as vehicle for MPA in control samples. 
 
To activate and inhibit the NADPH oxidase complex, HESCs were treated with 1.5 
mM apocynin and 10 µM diphenyleneiodonium (DPI) respectively. AEBSF (4-(2-
Aminoethyl)benzenesulfonylfluoride), an alternative NADPH oxidase inhibitor was 
used at 250 µM. The xanthine oxidase (XO) activity was inhibited using allopurinol at 
100 µM and the nitric oxide synthase (NOS) activity was inhibited using N-omega-
Nitro-L-arginine methyl ester (L-Name) at 500 µM. Dimethyl sulfoxide (DMSO) was 
used to dilute apocynin, DPI and allopurinol whereas L-NAME and AEBSF were 
diluted in distilled water (dH2O). All treatments were carried out in 2% DCC/DMEM.  
 
2.2.1.4 Immortalized cells 
 
Hela cells were propagated in 10% FBS/DMEM and maintained and treated in 2% 
FBS/DMEM. Hela cell line was only used as a control for DNA damage induction by 
hydroxyurea.  
 
2.2.2 Transient transfections 
 
2.2.2.1 Transfection of primary HESCs using the calcium phosphate co-
precipitation method 
 
Primary HESCs were transiently transfected using the ProFection® Mammalian 
Transfection System, which is based on the calcium phosphate (CaPO4) co-
precipitation method. Calcium phosphate-mediated transfection facilitates the binding 
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of Deoxyribonucleic acid (DNA) or oligonucleotides to the cell membrane and the 
entry of the DNA or oligonucleotides into the cell by endocytosis. This method entails 
mixing the DNA directly with calcium cloride (CaCl2) and a phosphate buffer to form a 
fine precipitate, which is dispersed over the cultured cells. Prior to transfecting the 
cells, primary HESCs were seeded into 6-, 24- or 96-well plates and propagated with 
10% DCC/DMEM until the cultures reach 80% confluency. The day before the 
transfection was carried out, the cells were serum-starved by replacing the 10% 
DCC/DMEM with 2% DCC/ DMEM. Serum-starving the cells enhances the uptake of 
DNA or oligonucleotides into the cells and therefore, increases the transfection 
efficiency. The following day, one hour before the transfection, the 2% DCC/DMEM 
was replaced with 5% DCC/DMEM in half the normal volume: 1 ml, 250 µl or 100 µl 
in a well of a 6-, 24- or 96-well plate respectively. The transfection mix was prepared 
as follows: solution A was made by adding the required amount of DNA or 
oligonucleotides to sterile, deionized water and mixing well by vortexing before 
adding CaCl2 to the mix at a concentration of 245 mM, then vortexing again and 
incubating the mix for five minutes at room temperature. Solution B is prepared by 
adding 2x HEPES-buffered saline in equal volume to solution A. Solution A was then 
added drop-wise to solution B while the latter was being vortexed. The transfection 
mix was then incubated at room temperature for 30 minutes to allow formation of 
CaPO4 precipitate. The transfection mix is then vortexed and dispersed on the cells 
in the following volumes 480 µl, 120 µl or 48 µl in a well of 6-well plate, 24-well plate 
or 96 well plates respectively. The cells were incubated with the transfection mix for 
six to nine hours and subsequently washed and left untreated overnight. Treatments 
were carried out the following day.  
 
2.2.2.2 Reporter Assay 
 
Luciferase reporter assays were performed on primary HESCs transfected in 24-well 
plates using the ProFection® Mammalian Transfection System. The final 
concentration of the luciferase reporter constructs and expression vectors added to 
the cells was 500 and 125 ng respectively. PCH110, an expression vector encoding 
for β-galactosidase, which leads to constitutive β-galactosidase expression, was 
used to compare transfection efficiency between samples and was transfected at a 
final concentration of 50 ng. Before harvesting, the media was aspirated and cells 
were washed with 1 ml PBS prior to adding 50 µl of reporter lysis buffer to each well. 
The plate was then placed on an orbital shaker on a low setting for 15 minutes at 4°C 
and then frozen at -80°C for at least 30 minutes. Following thawing at room 
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temperature, the lysates were transferred to eppendorfs and centrifuged at 16000 g 
for two minutes to pellet the cellular debris. Subsequently, 10 µl of the lysate was 
transferred in duplicate into a 96-well opaque plate and 50 µl of luciferase assay 
reagent containing substrate and assay buffer was added. Luminescence was 
measured using a Victor II plate reader (PerkinElmer).     
 
β-galactosidase activity was measured using the Galacto-Light PlusTM System, a 
chemiluminescent reporter assay system designed for rapid and sensitive detection 
of β-galactosidase reporter enzyme in cell lysates. Galacton-Plus substrate in the 
reaction buffer is cleaved by β-galactosidase enzyme. The Accelerator-II reagent is 
added to the samples in the reaction buffer to terminate the enzyme activity and to 
trigger light emission from the cleaved substrate.  Galacton-Plus chemiluminescent 
substrate emits light at a near constant level with a half-life of approximately 180 
minutes after the addition of Accelerator-II, rendering it ideal for use with instruments 
without reagent injectors.  
 
To carry out the assay, protein lysates were first heated for 50 - 60 minutes at 48°C 
to inactivate endogenous β-galactosidase that can be present in cells. Endogenous 
β-galactosidase activity can result in high background reading and decrease the 
sensitivity of the assay. Following the inactivation step, 10 µl of the lysate was 
transferred to an optically clear flat-bottom 96-well plate and 70 µl of Reactiion 
Buffer, which consists of Dilute Galacton-Plus substrate diluted 1:100 with Reaction 
Buffer Diluent, was added to each well. Following incubation of the plate for 30 
minutes at room temperature, 100 µl of Accelerator-II was added to each well and 
luminescence was read using a Victor II plate reader (PerkinElmer). This protocol is 
according to the manufacturer’s instructions.  
 
2.2.2.3 Small interfering RNA (siRNA) 
 
siRNA technology was used to knockdown expression of genes of interest in primary 
HESCs. The ProFection® Mammalian Transfection System was used to transfect 
siRNA into HESCs. All targeting and non-targeting (NT) siRNA were siGENOME 
SMART pool duplexes purchased from Dharmacon and were used at a 100 nm 
concentration.  
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2.2.3 Western blot analysis 
 
2.2.3.1 Protein extraction 
 
For protein extraction, primary HESCs were cultured and treated in 6-well plates. 
Whole cell lysates were harvested using Laemmeli buffer (0.5 M Tris-HCL, pH 6.8, 
0.5 M Imidazole, pH 6.8, 10% SDS, 10% glycerol, 2% β-mercatoethanol, 0.5% 
Bromophenol blue). To harvest whole cell lysates, the media was aspirated and 60 µl 
of Laemmili buffer, boiled to 100°C, was added to each well. Cells were scraped 
using cell scraper and the viscous lysate was transferred into eppendorfs using a 200 
µl pipette tip with a snipped tip. The samples were then boiled to 100°C, centrifuged 
at 16000 g for 1 minute and stored at -80°C.  
 
For cytosolic/nuclear extraction, primary HESCs were cultured and treated in 6-well 
plates. To harvest, the media was aspirated and 70 µl of Cytosolic Buffer A (10 mM 
HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT, 1% v/v NP-40 and 
complete protease inhibitor tablets) was added to each well and cells were scraped 
using a cell scraper. Subsequently, lysates were transferred to an eppendorf and 
incubated for 5 - 20 minutes on ice. Following vortexing of the lysates for 10 minutes 
at full speed, samples were then centrifuged at 16,000 g for 30 seconds at 4°C. The 
supernatants, resembling the cytosolic extracts, were transferred to an eppendorf 
and stored at -80°C. The remaining pellets were resuspended in 20 µl of Nuclear 
Buffer B (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT, 400 
mM NaCl, 1% v/v NP-40 and complete protease inhibitor tablets). The samples were 
then stored on ice with minimal shaking for 15 minutes and subsequently centrifuged 
at 16,000 g for 5 minutes at 4°C. The supernatants, resembling the nuclear extract, 
were transferred to a new eppendorf and stored at -80°C. 
 
To extract protein from tissue biopsies, High Salt Homogenisation Buffer (0.4M KCl, 
20 mM HEPES pH 7.4, 20% v/v glycerol, 1 mM DTT, 1 mM PMSF, 1x mini complete 
protease inhibitor cocktail) was used. To each tissue biopsy, 1 ml of High Salt buffer 
was added and homogenised mechanically. Lysates were then centrifuged at 
maximum speed to pellet the debri, and the supernatent was transferred to a new 
eppendorf. Samples were then stored at -80°C. 
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2.2.3.2 Measurement of protein concentration 
 
Protein concentration of lysates was quantified using the Bradford assay. The 
Bradford assay is a colorimetric protein assay, which is based on the absorbance 
shift of the dye Coommassie Blue. Upon binding to arginine and hydrophobic amino 
acid residues present in proteins, the Commassie Blue dye found in the Bradford 
Reagent (Bio-Rad) is converted from red to blue. The binding of the protein stabilizes 
the blue form of the dye. The bound form of the dye has an absorption spectrum 
maximum at 595 nm. The increase in absorbance is proportional to the amount of 
bound dye and therefore is proportional to the concentration of protein in the sample. 
To carry out the assay, a set of standards in a volume of 800 µl was prepared using 
bovine serum albumin (BSA) dissolved in and diluted with dH2O to the following 
concentration: 0, 0.005, 0.01, 0.02, 0.04, 0.06, 0.08 and 0.1 µg.  The protein samples 
to be quantified were diluted 1:400 in 800 µl of distilled water. To each sample and 
standards, 200 µl of Bradford reagent was added and mixed well by vortexing. 
Samples and standards were incubated for 15 minutes at room temperature. 
Following vortexing, 200 µl of each standard and sample was transferred in duplicate 
into a flat-bottom, optically clear 96-well plate and the absorbance at 595 nm was 
measured. The protein concentration in the samples was quantified by reference to 
the standards. 
 
2.2.3.3 SDS-PAGE and western blot analysis 
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was used to resolve proteins 
on a discontinuous polyacrylamide gel using the Invitrogen XCell SureLock Mini-Cell. 
Gels were prepared in disposable plastic cassettes (invitorgen) from two solutions to 
form the lower resolving gel (375 mM Tris-HCl pH 8.9, 1% w/v SDS, 10 or 7.5% v/v 
acrylamide/bis-acrylamide (37.5:1), 0.03% w/v APS, TEMED added 1/500) and the 
upper stacking gel (80 mM Tris-HCl, pH 6.8, 80 mM Imidazol, pH 6.8, 0.06% w/v 
SDS, 5% acrylamide/bis-acrylamide (37.5:1), 0.11% w/v APS, TEMED added 1/500). 
The lower resolving gel solution is first poured into the disposable cassette until it 
reaches within 1 cm from the base of the prospective wells and overlaid with dH2O 
butanol and was left for one hour to polymerize. When polymerization was complete, 
the butanol was rinsed off with dH2O and the upper stacking gel solution was poured 
on top of the polymerized resolving gel and a comb with the appropriate number of 
wells was inserted. The gel was left to polymerize for 30 minutes. Once the stacking 
gel had set, the cassette was fitted in the electrophoresis tank and running buffer (25 
mM Tris, 190 mM glycine, 0.1% w/v SDS) was loaded. Protein lysates in loading 
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buffer, with equal volume and concentration, were loaded into the wells alongside 
prestained molecular weight markers. The gels were first run at 80 V for 30 minutes 
to allow slower, even entry of the loaded samples into the stacking gel. The 
difference in density and pH of the two gels allowes compaction of the samples at 
their border and provides crisp resolution on the resolving gel. The gels were further 
run at 135 V for approximately one hour and 15 minutes or until the prestained 
molecular weight marker reaches the desired resolving state. 
 
When SDS-PAGE was completed, the cassette was opened and the resolving gel 
removed for western blotting. Protein samples resolved on the stacking gel were 
transferred to a PVDF membrane for immunoblotting using the semidry blotting 
method. A sandwich was assembled consisting of two sheets of Mini Trans-blot filter 
paper (Invitrogen) pre-equilibrated in transfer buffer (11.66 g Tris, 5.8 g glycine, 20% 
methanol v/v, and 7.5 ml 10% SDS for a 2 L stock made up with dH2O), followed by 
the PVDF membrane activated in methanol and pre-equilibrated in dH2O then 
transfer buffer, followed by the resolving gel and finally two sheets of Mini Trans-blot 
filter papers pre-equilibrated in transfer buffer. Every sheet of filter paper and the 
PVDF membrane was rolled to eliminate any bubbles. Semidry transfer was 
performed with a constant voltage at 25 V for one hour and five minutes. When the 
transfer was completed, the PVDF membrane was allowed to air-dry, then it was 
activated in methanol and washed briefly in 1x TBS (130 mM NaCl, 20 mM Tris, pH 
7.6). The membrane was then blocked with 5% non-fat dry milk for one hour at room 
temperature while rotating on an orbital shaker. Following washing of the membrane 
with 1x TBS, the desired primary antibody in the appropriate dilution was added to 
the membrane and left rotating overnight at 4°C. The following day, the membrane 
was subjected to three washes of 10 minutes each in 1x TBS-T (0.1% Tween-20 in 
TBS). The appropriate secondary antibody was then added to the membrane and the 
membrane was incubated for one hour at room temperature. The membrane was 
then washed three times for 10 minutes per wash with 1x TBS-T, and detergent was 
rinsed of with 1x TBS. Chemiluminescent signals were visualized by using the ECL 
Plus Western Blotting Detection System according to instructions provided by the 
manufacturer.   
 
2.2.3.4 Densitometry 
 
Densitometry was carried out to quantify the protein bands in a Western blot. The 
software ImageJ was used for this purpose (www.rsb.info.nih.gov/ij/index.html). 
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2.2.4 Reverse transcription polymerase chain reaction (PCR)  
 
2.2.4.1 RNA Extraction 
 
Total RNA was extracted from primary HESCs cultured in 6-well plates using the 
RNA STAT-60 reagent, which is composed of a phenol and guanidinium thiocyanate 
in a mono phase solution. Following aspiration of the culture media, 500 µl of RNA 
STAT-60 reagent was added to each well, spread over the whole culture surface 
using a cell scraper and incubated at room temperature for five minutes. The lysate 
was then transferred to RNase-free 1.5 ml centrifuge tubes and then pipetted 
repetitively to ensure the complete dissociation of nucleoprotein complexes. Next, to 
each tube, prechilled chloroform was added in fifth the volume of the STAT-60 
reagent, mixed well by vortexing for 15 seconds, incubated at room temperature for 
two minutes and centrifuged at 12000 g for 30 minutes at 4°C. This allows the 
separation of the solution into an upper colourless aqueous phase and a lower red 
phenol organic phase. RNA remains exclusively in the aqueous phase whereas DNA 
and proteins are in the interphase and organic phase. The aqueous phase is then 
transferred to a fresh 1.5 ml centrifuge tube, pre-chilled isopropanol in half the 
volume of STAT-60 was added to each tube, and samples were incubated at room 
temperature for five minutes in order to precipitate the RNA. Subsequently the RNA 
was pelleted by centrifugation at 12000 g for 20 minutes at 4°C, washed with 70% 
v/v prechilled ethanol.  The final pellet was left to air-dry and was dissolved in a 
suitable volume of DEPC-treated RNase free dH2O.  
 
RNA concentration was measured using the Nanodrop 1000 spectrophotometer 
(Thermoscientific), and RNA purity was assessed by determining the ratio of 
absorbance at 260/280 nm. Satisfactory values were considered equal or greater to 
1.8, indicative of highly purified RNA free from contaminating protein. RNA samples 
were stored at -80°C. 
 
2.2.4.2 cDNA synthesis 
 
Prior to cDNA synthesis, total RNA harvested from primary HESCs was subjected to 
deoxyribonuclease I (DNase) treatment in order to remove any contaminating 
genomic DNA, which could be amplified along with the targeted mRNA during Real-
time quantitative PCR. To 1 µg of total RNA, 1 U of amplification grade DNase I was 
added to each sample, in the presence of 1x DNase I reaction buffer in a total 
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volume of 10 µl made up with DEPC-treated water. Following incubation of samples 
for 15 minutes at room temperature, DNase I was inactivated by the addition of 1 µl 
of 25 mM EDTA and heating to 65°C for 10 minutes. 
 
cDNA synthesis was carried out using the superscript First-Strand Synthesis for RT-
PCR. To each 8 µl of DNase treated RNA sample (about 800 ng in total), 1 µl of 500 
ng/µl oligo(dTs) primers and 1 µl dNTP mix (added to a final concentration of 1 mM) 
was added. Samples were incubated at 65°C for five minutes to remove the 
secondary structure within the RNA template. Following incubation, samples were 
immediately incubated on ice for at least one minutes to prevent secondary structure 
from reforming. For each sample, a master reaction mixture was prepared with the 
following components: 2 µl 10x RT buffer, 4 µl 25 mM MgCl2, 2 µl 0.1 M DTT and 1 µl 
RNase OUT (40 U/µl), a recombinant RNase Inhibitor. To each sample, 9 µl of the 
master reaction mixture was added, mixed gently and incubated at 42°C for 2 
minutes. Subsequently, 50 U of SuperScript II reverse transcriptase were added to 
each sample and reincubated at 42°C for 50 minutes to allow cDNA synthesis. The 
reaction was then terminated by incubating the samples at 70°C for 15 minutes, and 
subsequently chilling them on ice. To remove the RNA template from samples and to 
increase the sensitivity of subsequent PCRs, 2 U of RNase H were added to each 
sample an the mixture was incubated at 37°C for 20 minutes. Prior to storing 
samples at -20°C, an aliquote of each sample was used to create a pooled cDNA 
sample, which was used for setting up a set of standards for RTQ-PCR and was also 
stored at -20°C. 
 
2.2.4.3 Real-time quantitative PCR (RTQ-PCR) 
 
RTQ-PCR was performed to measure mRNA transcript of genes of interest as an 
indication of gene expression. Specific primers to the gene of interest were used and 
RTQ-PCR was performed using the Applied Biosystems StepOneTM Real Time PCR 
System. The PCR reactions were performed in a 96-well plate thermal cycler and the 
amplified products were detected by the presence of fluorescence resulting from the 
intercalating fluorescent dye SYBR Green I. SYBR Green in its free form is non-
fluorescent, however, once incorporated into double stranded DNA it fluoresces. 
Therefore, as the PCR progresses, more double-stranded DNA products of the gene 
of interest accumulate. Consequently, more SYBR Green is intercalated within the 
DNA strengthening the fluorescence signal. Background fluorescence is determined 
between PCR cycles 3 and 15 and provides a baseline measurement from which the 
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software can then calculate a change in fluorescence intensity (ΔRn) during each 
cylce. An amplification plot of ΔRn versus the cycle number is generated and a 
threshold is chosen to coincide with the exponential phase of the reaction. The cycle 
number at which the increasing ΔRn crosses this threshold is defined as the 
threshold cycle (Ct) and is used as a measurement of mRNA abundance. Therefore 
the lower the Ct value, the more highly expressed a gene is. This real time 
monitoring of exponential nucleic acid amplification is more accurate and sensitive 
than the assessment of the final product in the conventional PCR method. 
 
The RTQ-PCR reaction was performed in a total volume of 15 µl in a MicroAmp® 
Fast Optical 96-Well Reaction Plate (Applied Biosystems). The reaction mixture 
composed of: 7.5 µl of SYBR Green PCR Master Mix (Applied Biosystem), optimized 
primer pairs and the reaction was made up to a total of 12 µl using DEPC-treated 
water. In each well, 3 µl of cDNA diluted 6 X with DEPC-treated water was added to 
12 µl of the Master Mix. Each sample was run in triplicate. A serial five-fold dilution of 
pooled cDNA was set up as standards. In three reactions, no cDNA template was 
added to control for the formation of primer dimmers and to act as negative controls. 
The RTQ-PCR was carried out under the following conditions: an initial denaturing 
step at 95°C for 10 minutes, 40 cycles of denaturation at 95°C for 15 seconds, and 
60°C for 1 minute for annealing and extension. 
 
Quantification of amplified products was carried out by the relative standard curve 
method. Arbitrary units were assigned to the Ct values of the serially diluted 
standards to generate a standard curve whereby the Ct values of the known samples 
were referenced. The universally expressed ribosomal protein L19 represented a 
non-regulated gene and its expression served as an internal control and was used for 
data normalisation. Primer sequences used in this thesis can be found in Appendix 1. 
 
2.2.4.4 Primer design and testing for real-time quantitative PCR 
 
Primers were designed with the Primer3 software (Whitehead Institute for Biomedical 
Research, MIT, US), using sequences from the Ensembl genome database 
(www.ensembl.org). The following design criteria were used: amplicon size of 90 - 
120 bp, GC content 40 - 50% and melting temperature 58 - 62°C. In order to reduce 
the possibility of amplifying genomic DNA that has not been completely eliminated 
from the sample, the primer pairs were designed within a short sequence of DNA 
crossing an intron-exon boundary. Prior to ordering the primer set from Invitrogen, 
Chapter 2: Materials and Methods 
 76 
using the Basic Local Alignmet Sequence Tool (BLAST), primers were compared 
with all human sequences in the gene database of the National Centre for 
Biotechnology Information (NCBI) to confirm there is no significant homology with 
other genes. Primers were dissolved to a storage concentration of 100 pmol/µl, and 
the appropriate working concentration was used to reach the optimized final 
concentration of primers.  
 
2.2.5 Electron mobility shift assay (EMSA)  
 
EMSA is a common affinity electrophoresis technique that was used to study protein-
DNA interactions. Briefly, 5 µg of nuclear protein extracts was incubated for one hour 
with non-radiolabeled non-specific and specific oligonucleotides in binding buffer 
(20% v/v glycerol; 5 mM MgCl2, 2 mM EDTA; 50 mM Tris-HCl, pH 7.5; 250 mM NaCl; 
and 2 mM DTT), followed by a 45-minute incubation with 0.035 pmol􏰛[γ-32P] ATP 
ended-labeled oligonucleotide probes. The non-specific oligonucleotides would not 
be competing with the radiolabeled specific oligonucleotides and therefore a slower 
migrating band would be visualized by autoradiography as a result of labeled 
oligonucleotides forming specific DNA-protein complexes with the target protein. On 
the other hand, excess non-labeled oligonucleotides to the nuclear protein and 
labeled specific oligonucleotides mix would be competing with the labeled 
oligonucleotides forming specific DNA-protein complexes and therefore, no band will 
be visualized. To check for the specificity of the protein, supershift analysis was 
carried out, where samples were incubated with 2 µg with antibody against the 
protein of interest for one hour on ice prior to incubation with the probe. DNA-protein 
complexes were separated from unbound DNA probe on a 4% nondenaturing 
acrylamide gel in 0.25x TBE running buffer (9 mM Tris-borate and 0.2 mM EDTA, pH 
8.0). Gels were vacuum dried and exposed to Amersham MP films at -80°C for 16-48 
hours. The consensus oligonucleotides for OCT1 were purchased from Promega Life 
Science (E 3241), and from Santa Cruz Biotechnology for CEBP (sc-2525). 
 
2.2.6 Immunofluorescence analysis and confocal microscopy imaging 
 
Primary HESCs were cultured on 4-chamber culture slides. For fixing the cells, the 
media was removed, the cells were washed once with 1x PBS and 1 ml of 4% 
paraformaldehyde (PFA) was added to each well and the slide was incubated for 15 
minutes at room temperature. PFA was then removed and the cells were washed 3x 
with PBS, permeabilized with 0.1% v/v Triton X-100 in filtered PBS for 30 minutes 
and finally the slide was washed 3x with PBS. Cells were blocked with 250 µl of 5% 
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normal goat serum in PBS for 45 minutes at room temperature. Following incubation, 
primary antibody against the protein of interest is diluted to the appropriate 
concentration in 0.01% v/v normal goat serum in PBS and 250 µl of the antibody was 
added to each well. As a negative control, one well had 250 µl of 0.01% v/v normal 
goat serum in PBS added without the primary antibody. The culture slide was 
incubated overnight at 4°C. The following day, the slide was washed 3x with PBS 
and secondary antibody diluted 1:500 in 0.01% v/v normal goat serum in PBS and 
was added to each well and incubated for one hour at room temperature in the dark. 
The slide was then washed 3x with PBS, the chambers were detached from the slide 
using the apparatus provided by the manufacturer and the slide was left to air-dry. A 
coverslip was then mounted on the slide using Vectashield with DAPI. The staining 
was visualized under the SP5 Leica confocal microscope. 
 
2.2.7 Measurement of cellular reactive oxygen species (ROS) 
 
2',7'-dichlorodihydrofluoresein diacetate (DCFH-DA) was used to measure 
intracellular ROS in primary HESCs. DCFH-DA is membrane permeable, colourless 
and non-fluorescent until the acetate group is cleaved by intracellular esterases 
rendering it membrane impermeable. Oxidation of the compound, yields the 
fluorescent fluorophore, 5-(and-6)-carboxy-2',7'-dichlorofluorescein (DCF). The 
amount of fluorescence is proportional to the oxidation of the compound, which is 
proportional to the amount of ROS in the cell. 
 
To carry out the assay, cultured HESCs were seeded in 96-well black plates with 
clear bases and maintained in 10% DCC/DMEM until they become confluent. Cells 
where either decidualized or left untreated. Thirty minutes before terminating the 
treatments, cultured HESCs were loaded with (DCFH-DA) at a final concentration of 
30 µM and incubated at 37°C in a cell culture incubator in a humid condition with 5% 
v/v CO2 for 30 minutes. The cells were then washed twice with PBS and the 
appropriate media with or without the treatment was added to the cells. Hydrogen 
peroxide (H2O2) was used as a positive control, to ensure the validity of the DCFH-
DA probe. Measurement was then taken using the fluorometer at an excitation and 
emission wavelengths of λ = 485 and λ = 535, respectively, every two minutes for a 
30 minute period. To control for the amount of cells in each well, the media was 
aspirated and the cells were washed twice with PBS. Consequently, the cells were 
stained with propodium iodide (PI) prepared in a 1% NP40-PI 10 µg per ml solution. 
The plate was placed on an orbital shaker for 15 minutes at room temperature. 
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Measurement was then taken using the flourometer at an excitation wavelength λ = 
535, and emission wavelength λ = 600.  
 
When DCF fluorescence was measured using flow cytometry, HESCs were cultured 
and treated in 6-well plates. The cells were then stained with DCF-DA/PI (30 µM/10 
µg) in suspension for 30 minute, washed and resuspended in PBS. Subsequently 
DCF and PI fluorescence were measured using the following flow cytometer 
detectors respectively FL-H1 and RL-3H.  
 
The same protocol was used to assess the alternative oxidant-sensing probe DHR 
123, which was also used at a final concentration of 30 µM. 
 
2.2.8 Measurement of cell proliferation and viability 
 
2.2.8.1 CellTiter 96 AQueous One Solution Cell Proliferation Assay 
 
The CellTiter 96® AQueous One Solution Cell Proliferation Assay is a colorimetric 
assay used to determine the number of viable cells in proliferation or cytotoxicity 
studies. The CellTiter 96® AQueous One Solution Reagent contains a novel tetrazolium 
compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)- 2-(4-
sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron coupling reagent 
phenazine ethosulfate (PES). PES has enhanced chemical stability, which allows it to 
be combined with MTS to form a stable solution. The MTS tetrazolium compound is 
bioreduced by cells into a coloured formazan product that is soluble in tissue culture 
medium, and has an absorbance spectrum of 490 nm. The quantity of formazan 
product, therefore, measured by the absorbance at 490 nm is directly proportional to 
the number of living cells in culture. 
 
To carry out the assay, primary cultures were seeded in optically clear flat-bottom 96-
well plates and treated as desired. When the treatment period is completed, 20 µl of 
CellTiter 96® AQueous One Solution Reagent was pipetted into each well of the 96-well 
assay plate containing the samples in 200 µl of culture medium. The plate was 
incubated for three hours in a humid condition with 5% CO2 v/v at 37°C. Following 
the incubation period, absorbance was measured at 490 nm using a 
spectrophotometer. 
 
Chapter 2: Materials and Methods 
 79 
2.2.8.2 Apo Tox-GloTM Triplex Assay 
 
The Apo Tox-GloTM is an alternative method of assessing cell viability. The assay 
measures a marker of cell viability and another marker for cytotoxicity. The cell 
viability marker is a cell protease that is restricted to viable cells and is measured by 
a cell-permeable probe that fluoresces once it is cleaved by the protease. The cell 
cytotoxicity marker is a dead-cell protease that is released from cells once they lose 
their membrane integrity. It is measured by a cell-impermeable probe that fluoresces 
once it gets cleaved by the dead-cell protease. The two probes have different 
excitation and emission wavelengths allowing their simultaneous addition to the cells. 
To carry out the assay, cells were seeded in 96-well black plates and treated as 
desired. When the treatment period was completed, 20 µl of the Viability/Cytotoxicity 
reagents were added to each well and the plate was briefly mixed by an orbital 
shaker. Subsequently, the cells were incubated for one hour at 37°C with 5% v/v CO2 
in a humidified incubator. Viability was quantified by measuring the fluorescence 
signal at 400Ex/505Em and cytotoxicity was quantified by measuring the fluorescence 
signal at 485Ex/520Em. H2O2 was used as a positive control. 
 
2.2.9 Comet assay 
 
The comet assay, also known as single cell gel electrophoresis (SCGE) is a 
technique for analyzing DNA damage in individual cells. A cell with DNA damage 
would resemble a “comet” shape with distinct head and tail, the head of the comet 
represents the intact DNA whereas the tail consists of damaged DNA. TO carry out 
the assay, HESCs were cultured in 6-well plates and once they reached 80% 
confluency they were transfected with NT siRNA or siRNA targeting NOX4 and 
p22PHOX. Two days post transfection, cultures were either left untreated or treated 
with 8-br-cAMP and MPA for 72 hours. As a positive control for DNA damage, cells 
were treated with 1 µM of epirubicin overnight. The following day, microscopy slides 
were coated with thin agarose gel (1% NMA w/v in dH2O). HESCs from each well 
were pelleted and resuspended in 100 µl of 1x PBS, and between 2 - 10 µl of cell 
suspension was added to each agarose coated slide and 85 µl of 0.7% LMA in PBS 
was poured on top of the cells and a coverslip was placed on top in order to separate 
the cells. The slide was stored at 4°C for 10 minutes. Following incubation, the 
coverslip was removed another 85 µl of 0.7% LMA in PBS was poured. The slide 
was incubated for another 10 minutes. Subsequently, the cells were lysed by 
removing the coverslips and placed the slide containg the cells in a slide merging 
flask containg the lysis buffer (146.1 g NaCl, 37.2 g NaEDTA, 1.2 g Tris-HCl, 25.88 
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ml N-lausarcosylsarcosinte, 10 g NaOH, 1% Triton-X and 10% DMSO) which was 
kept at 4°C. The slide was incubated in the slide merging flask for one hour at 4°C in 
the dark. Following incubation, the slide was dried by placing it on an absorbing 
material. Subsequently, the slide was inserted in an electrophorsis tank with the 
electrophoresis buffer (0.555 g NaEDTA and 10 g NaOH in dH2O), which was placed 
on ice and covered with foil for 20 minutes. Electrophoresis was carried out on ice for 
15 minutes at 300 mA. To stop the electrophoresis process, the slides were 
neutralized by adding 2x neutralization buffer (48% Tris HCl in dH2O). To mount the 
coverslips, 30 µl of Vectashield with DAPI was added and the slides were stored in a 
humid and dark environment until the slides were analyzed under a fluorescence 
microscope.  
 
2.2.10 Bacterial propagation of plasmids  
 
The Escherichia coli strain DH5α was used to propagate plasmids. Bacteria were 
streaked out on L-agar plates (1% w/v bactotryptone, 0.5% w/v yeast extract, 0.5% 
w/v NaCl, 0.1% w/v glucose, 1.5% w/v bactoagar) and incubated at 37°C overnight. 
A single colony was used to inoculate 5 ml of L-agar with the appropriate antibiotic 
which was then incubated for eight hours at 37°C with continuous shaking. 
Subsequently, 50 µl of the culture was transferred to 200 ml L-agar with the 
appropriate antibiotic and incubated overnight at 37°C with continuous shaking. The 
following day, the bacteria were harvested by centrifugation at 3300 g, at 4°C for 15 
minutes. The final pellet was resuspended in 2.5 ml ice-cold sterile solution 
consisting of 20% v/v glycerol and 0.1 M CaCl2. The cell suspension was aliquoted 
into 100 µl, snap frozen on dry ice and stored at -80°C.  
 
2.2.10.1 Transformation of competent bacteria by heat shock  
 
Escherichia coli strain DH5α was used to propagate plasmids. A 100 µl aliquot of 
DH5α supercompetent cells was thawed on ice and subsequently 5 µl of plasmid 
solution, containing 2-10 ng/µl DNA was added to the cell suspension, mixed gently 
and incubated on ice for 30 minutes. Heat shock was performed by incubation in a 
waterbath at 42°C for 45 seconds and the bacteria were then placed on ice for two 
minutes. Subsequently, 680 µl of L-agar medium (1% w/v bactotryptone, 0.5% w/v 
yeast extract, 0.5% w/v NaCl, 0.1% w/v glucose, 1.5% w/v bactoagar) were added to 
the cell suspension which was then incubated in a waterbath at 37°C for one hour. 
All expression vectors used carried either an ampicillin or kanamycin resistance 
gene. Consequently, the cells were spread for selection on L-agar plates (1% w/v 
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bactotryptone, 0.5% w/v yeast extract, 0.5% w/v NaCl, 0.1% w/v glucose, 1.5% w/v 
bactoagar) with 100 µg/ml ampicillin or 30 µg/ml kanamyacin and incubated at 37°C 
overnight. 
 
2.2.10.2 Large-scale preparation of plasmid DNA (maxiprep)  
 
The Qiagen HiSpeed Maxi Kit was used to prepare up to 500 µg of high-copy 
plasmid DNA. A single colony was used to inoculate 5 ml of L-agar containing 100 
µg/ml ampicillin or 30 µg/ml kanamyacin and incubated for eight hours at 37°C with 
continuous shaking. Subsequently, 50 µl of the culture was transferred to 200 ml L-
agar with the appropriate antibiotic and incubated overnight at 37°C with continuous 
shaking. The following day, the bacteria were harvested by centrifugation at 4300 g, 
at 4°C for 15 minutes. The final pellet was resuspended in 2.5 ml ice-cold sterile 
solution consisting of 20% v/v glycerol and 0.1 M CaCl2. The cell suspension was 
aliquoted into 100 µl, snap frozen on dry ice and stored at -80°C. The pellet was then 
stored at -20°C for a 1 week maximum or processed using the Qiagen HiSpeed 
Plasmid Maxi Kit and according to manufacturer instructions. 
 
2.2.10.3 Preparation of glycerol stocks  
 
Bacterial transformants were grown in L-broth containing 100 µg/ml ampicillin or 30 
µg/ml kanamyacin. A 300 µl aliquot was mixed with an equal volume of 40% v/v 
glycerol in L-agar autoclaved solution, snap frozen on dry ice and stored at -80°C. 
 
2.2.11 Statistical analysis 
 
Statisitcal analysis was performed on quantitative data categorized in two groups. 
Students t-test was applied and values were considered significant if p < 0.05. 
 
2.2.12 Gene expression analysis using Affymetrix microarrays 
 
Microarray analysis was employed to address the following question: 
 
Which genes are regulated by the NOX4/p22PHOX complex in decidualizing HESCs? 
 
Three independent primary HESC cultures were set up from biopsies obtained from 
three different patients. From each biopsy, passage 2 was plated in 4 6-well plates. 
Upon reaching 80% confluency, the cells were transfected with non-targeting siRNA 
or siRNA targeting NOX4/p22PHOX. HESCs were treated two days post transfection 
with 8-br-cAMP and MPA for 72 hours. Total RNA was harvested using the STAT-60 
Chapter 2: Materials and Methods 
 82 
reagent. RNA quality and integrity was checked using the Nanodrop and the Agilent 
2100 Bioanalyzer respectively. The RNA was then cleaned up using the RNeasy 
MinElute Cleanup Kit. Subsequent sample manipulation and data analysis was 
outsourced to Almac Diagnostics. The methodologies employed are briefly described 
below. 
 
2.2.12.1 Sample preparation and selection 
RNA extraction was performed using the standard protocol mentioned above and 
stored at -80°C. To ensure that cultures responded adequately to treatment, aliquots 
were used for first-strand synthesis followed by RTQ-PCR to determine the transcript 
levels of both decidual markers PRL and IGFBP1 as well as to determine the 
efficiency of NOX4 and p22PHOX silencing on the mRNA level. All three samples used 
for the microarray analysis responded well to the decidual stimuli and showed 
efficient knockdown at the mRNA level. 
 
2.2.12.2 RNA quality control  
 
The purity of the total RNA was assessed using the Nanodrop, where the samples 
generated a 260/280 nm absorbance ration range of 2.02 – 2.07. The RNA integrity 
was inspected qualitatively with an Agilent 2100 bioanalyzer. All samples displayed 
distinct 18S/28S peaks indicative of non-fragmented RNA. 
 
2.2.12.3 Laboratory methodologies employed by Almac Diagnostics 
 
a. Eukaryotic target preparation 
All eukaryotic target preparations using the project-appropriate NuGEN™ RNA 
Amplification System in combination with the FL-Ovation™ cDNA Biotin Module V2 
were performed in accordance with the NuGEN™ protocol. 
 
b. Amplification of total RNA 
Total RNA was amplified using the NuGEN™ WT-Ovation™ Pico System. First-
strand synthesis of cDNA was performed using a unique first-strand DNA/RNA 
chimeric primer mix, resulting in cDNA/mRNA hybrid molecules. Following 
fragmentation of the mRNA component of the cDNA/mRNA molecules, second-
strand synthesis was performed and double-stranded cDNA was formed with a 
unique DNA/RNA heteroduplex at one end. In the final amplification step, RNA within 
the heteroduplex was degraded using RNaseH, and replication of the resultant 
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single-stranded cDNA was achieved through DNA/RNA chimeric primer binding and 
DNA polymerase enzymatic activity. The amplified single-stranded cDNA was 
purified for accurate quantitation of the cDNA and to ensure optimal performance 
during the fragmentation and labelling process. The single stranded cDNA was 
assessed using spectrophotometric methods in combination with the Agilent 
Bioanalyzer. 
 
c. Exon Processing 
The NuGEN WT-Ovation™ Exon Module is used to enable global gene expression 
analysis of RNA samples on Affymetrix GeneChip® Exon arrays.  For this system, 
total RNA was amplified first with the WT-Ovation™ FFPE System, and then the 
Exon Module was used to generate sense-strand cDNA targets ready for 
fragmentation and labelling with NuGEN’s FL-Ovation™ cDNA Biotin Module V2. 
 
d. Fragmentation and labelling of amplified single-stranded cDNA 
The appropriate amount of amplified single-stranded cDNA was fragmented and 
labeled using the FL-Ovation™ cDNA Biotin Module V2. The enzymatically and 
chemically fragmented product (50-100 nt) was labeled via the attachment of 
biotinylated nucleotides onto the 3'-end of the fragmented cDNA. 
 
e. Hybridization, washing, staining and scanning of labeled cDNA 
The resultant fragmented and labeled cDNA was added to the hybridization cocktail 
in accordance with the NuGEN™ guidelines for hybridization onto Affymetrix 
GeneChip® arrays. Following the hybridization for 16-18 hours at 45°C in an 
Affymetrix GeneChip® Hybridization Oven 640, the array was washed and stained 
on the GeneChip® Fluidics Station 450 using the appropriate fluidics script, before 
being inserted into the Affymetrix autoloader carousel and scanned using the 
GeneChip® Scanner 3000. 
 
f. Quality control of the generated data 
Following raw data generation and scan assessment,  GeneChip® quality metric 
assessment and data integrity assessment was performed. The GeneChip® quality 
metrics allow for the evaluation of assay and hybridisation performance, whereas the 
data integrity assessment ensures the suitability of the data for analysis and that 
there are no underlying variables causing unexpected patterns in the data.  
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g. Data normalization, differential gene selection and data analysis 
Raw data was normalized by applying the Robust Multichip Average (RMA) algorithm 
to generate the processed data. Differentially expressed transcripts were selected 
using a number of fold change and hypothesis testing filters. An ANOVA with post-
hoc testing (Partek) was performed to generate the statistical p-values for the 
pairwise comparison. The data was first filtered on p-value and then on fold change. 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Introduction 
 
Decidualization is critical for embryo implantation and placental formation. In 
humans, the signals that trigger this differentiation process are entirely maternal, and 
therefore decidualization of the stromal compartment is a spontaneous autonomous 
maternally driven process that occurs even in the absence of pregnancy. There is 
overwhelming evidence that initiation of the decidual process is dependent upon 
increased cellular cAMP levels and sustained activation of the PKA pathway (7). 
Progesterone, on the other hand, is not the primary trigger of the decidual process, 
but is essential to maintain and enhance the differentiated phenotype (69). Upon 
decidualization HESCs acquire a secretory phenotype, characterized by the 
expression of various marker genes such as PRL and IGFBP1. 
 
Conventionally, ROS were known for their cytotoxic effects in biological systems, 
which manifest in damage to macromolecules such as DNA, proteins and lipids (62). 
More recently however, accumulating evidence has implicated redox signalling in a 
variety of physiological and cellular processes such as cell proliferation, 
differentiation and migration, apoptosis, angiogenesis and tissue repair (155, 156).  
 
One of the main sources of ROS in non-phagocytic cells is the NADPH oxidase 
complex, a multi-component enzyme that transfers electron to molecular oxygen 
using NADPH as an electron donor to generate O2- by one-electron reduction 
reaction (207). The NADPH oxidase complex and the mechanisms by which it gets 
activated are more extensively studied in phagocytic than in non-phagocytic cells. 
The phagocytic NADPH complex comprises of two membrane associated proteins, 
gp91phox (NOX2) and p22pPHOX, three cytosolic components, p47PHOX, p67PHOX and 
p40PHOX, in addition to the small GTPase molecule RAC1 (214). Homologues of the 
catalytic subunit NOX2 have been identified in non-phagocytic cells: NOX1, NOX3, 
NOX4, NOX5, DOUX1 and DOUX2. As alluded to previously in chapter 1, NADPH 
oxidase-produced ROS has been implicated in various cellular processes like 
proliferation, cell cycle regulation and differentiation (200, 201).   
 
In this chapter, I look at the main source of endogenous ROS in HESCs. I also 
investigate the role of endogenous ROS signalling in initiating the decidual process. I 
further look at the mechanism by which ROS exert their signalling effects in 
decidualizing HESCs. 
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3.1 Measuring intracellular ROS in HESCs 
 
ROS are difficult to measure due to their high reactivity and relative instability. As 
mentioned previously in chapter 1, current approaches for assessing the amount of 
endogenous ROS are all indirect. One of the most commonly applied method is 
based on the use of oxidant-sensing detector molecules that react with ROS and 
result in emission of light or fluorescence. DCFH-DA and DHR 123 are two examples 
of fluorescent oxidant-sensing detector molecules.   
 
DCFH-DA is a colourless membrane permeable non-fluorescent probe. Once DCFH-
DA permeates the cell membrane, it is subjected to deacetylation by intracellular 
estrases forming the now membrane-impermeable DCFH. Subsequent interaction 
with ROS oxidizes the non-fluorescent DCFH probe into the highly fluorescent 
product DCF. Therefore, the amount of fluorescent signals emitted is proportional to 
the concentration of ROS in the cell (62, 192). Fluorescence of DCF can be 
monitored using a fluorometer or microplate reader at excitation of λ = 485 nm and 
emission at λ = 535 nm.  
 
DHR 123 is another cell-permeable fluorogenic probe that is used to detect ROS. 
Upon oxidization, DHR 123 is converted to the fluorescent compound Rhodamine 
123. Unlike DCFH-DA, DHR 123 is not subjected to any biochemical reaction such 
as deacetylation. Therefore, DHR 123 does not require loading into the cell prior to 
measuring ROS and can be converted to Rhodamine 123 by interacting with O2- that 
is generated on the plasma membrane to be exteriorly released. Similar to DCF, 
fluorescence of Rhodamine 123 can be monitored using a fluorometer or microplate 
reader at excitation of λ = 500 nm and emission at λ = 536 nm.   
 
To investigate the role of endogenous ROS in differentiation of HESCs, I first had to 
establish a reliable method of measuring endogenous ROS in our cell system. To do 
so, I compared the efficacy of DCFH-DA and DHR 123 in measuring the oxidative 
status of HESCs. Undifferentiated and decidualizing primary cultures were therefore 
loaded with DCFH-DA or DHR 123 for 25 minutes, pulsed with an increasing 
concentration of H2O2, and fluorescence was measured every 2 minutes over a 30-
minute period using a fluorometric plate-reader. As shown in Figure 3.1, although 
both probes showed increased fluorescence in undifferentiated HESCs with higher 
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Fig 3.1 Comparing the efficacy of DCFH-DA and DHR 123 in measuring ROS in 
HESCs. Undifferentiated HESCs or decidualized with 8-br-cAMP and MPA for 72 
hours were loaded with DHR123 or DCFH-DA for 25 minutes, washed twice with 
PBS and pulsed with an increasing concentration of H2O2 (250 µM, 500 µM and 1 
mM). H2O was used as a vehicle. The fluorescence was measured every 2 minutes 
over a 30-minute period using a fluorometric plate reader. Data are normalized to PI 
reading and represent the mean DCF or DHR 123 oxidation level (± SEM) at each 
interval. This experiment is a representative of three biological samples. 
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H2O2 concentrations, DCFH-DA yielded tighter fluorescent reading when cells were 
not stimulated with H2O2. Interestingly, with both fluorescent probes, there was no 
increase in fluorescence when decidualizing HESCs were stimulated with increasing 
concentrations of H2O2, which may point to the high resistance of decidualizing 
HESCs to oxidative stress.  
 
Based on these observations, I decided to use the detector probe DCFH-DA for 
detecting endogenous ROS in HESCs. There were a number of additional 
considerations for favouring the DCFH-DA as an oxidant-sensing molecule over 
DHR123. First, it has been claimed that in some cell systems, DHR 123 is less 
sensitive to O2- and is oxidized to the fluorescent product Rhodamine 123 mainly by 
H2O2 (189, 190, 269). Moreover, the conversion of DHR 123 to Rhodamine 123 is a 
slow reaction unless catalyzed by peroxidase (190). It has also been reported that 
DHR 123 is not a suitable probe for distinguishing between intracellular and 
extracellular ROS (190). This may be attributed to what I mentioned before about 
DHR 123 not being subjected to any biochemical modification and therefore it can be 
converted to the fluorescent product Rhodamine 123 without diffusing into the cell. 
DCFH-DA on the other hand is sensitive to H2O2 as well as O2-, and is also specific to 
intracellular ROS, as the cleavage by esterases traps the fluorescent probe within the 
cell rendering it inaccessible to H2O2 or O2- generated at the plasma membrane to be 
released exteriorly (62, 190, 192). 
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3.2 Modulation of the NADPH oxidase activity in HESCs by apocynin and 
DPI 
 
The activity of the NADPH oxidase complex can be modulated using chemical 
inhibitors or activators. DPI, for instance, is the most commonly used inhibitor of the 
NADPH oxidase complex. DPI works by removing an electron from an electron donor 
and forming a radical, which in turn would inhibit the activity of the respective electron 
donor through a covalent interaction (147). The mechanism of action of DPI forms 
the basis of its major limitation, rendering it a nonspecific inhibitor of various electron 
transporters such as NOS and XO. 
 
Apocynin effects, on the other hand, are cell-type specific. For example, apocynin 
acts as an inhibitor of the NADPH oxidase complex in phagocytes such as 
neutrophils and macrophages but stimulates ROS production in other non-phagocytic 
cells, including vascular fibroblasts (147, 231, 233).  
 
To determine whether apocynin acts as an activator or inhibitor of the NADPH 
oxidase complex in HESCs, undifferentiated primary cultures were loaded with 
DCFH-DA for 25 minutes, then pulsed with apocynin, DPI or DMSO as a vehicle, and 
ROS measurement were taken every 2 minutes over a 30-minute period. As shown 
in Figure 3.2, apocynin strongly induced intracellular ROS production in 
undifferentiated HESCs, whereas DPI had no discernible effects. These observations 
suggest two things: first, HESCs contain functional NADPH oxidase complexes and 
the activity of which can be stimulated by apocyinin; second, basal NADPH oxidase-
dependent ROS production appears low in undifferentiated HESCs cells. 
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Fig 3.2 Apocynin activates the NADPH oxidase complex in HESCs. 
Undifferentiated primary HESCs were loaded with DCFH-DA for 25 minutes and then 
pulsed with apocynin (Apo) or DPI. DCF fluorescence was measured every 2 
minutes over a 30-minute period. The data represent the mean DCF oxidation level 
of sextuplicate determinations (± SEM) at each interval. N = 3, ***, P < 0.001. 
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3.3 NADPH oxidase-dependent ROS play a role in HESC differentiation 
 
Once I established that the NADPH oxidase complex can be activated in HESCs 
using the chemical apocynin; and based on the well-established inhibitory effects of 
DPI (185, 191), I had identified the tools to examine if NADPH oxidase-dependent 
ROS signalling plays a role in decidualization.  
 
As mentioned previously, there is a plethora of evidence suggesting that initiation of 
the decidual process is dependent upon increased cellular cAMP levels and 
sustained activation of the PKA pathway (7, 73, 74). Progesterone on the other hand, 
is essential for maintaining and enhancing the decidual process (69, 70, 270). To 
study the role of the NADPH oxidase-dependent ROS signalling in decidualization, I 
first examined if endogenous ROS play a role in the early stages of the decidual 
process.  
 
To test this hypothesis, primary cultures were treated with 8-br-cAMP for 24 hours, in 
the presence or absence of apocynin or DPI, total RNA was harvested and RTQ-
PCR analysis was carried out to look at the transcript levels of the two decidual 
marker genes, IGFBP1 and PRL. As shown in Figure 3.3, the synergistic effect of 
apocynin and 8-br-cAMP on the induction of both decidual marker genes was very 
striking. The transcript level of IGFBP1 and PRL was increased over 8000 fold and ∼ 
200 fold respectively, when cultures were treated with 8-br-cAMP in the presence of 
apocynin. DPI on the other hand exerted an inhibitory effect on the induction of PRL 
and IGFBP1 transcript levels.  
 
As mentioned previously, a major limitation of using DPI as an inhibitor of the 
NADPH oxidase complex is its lack of specificity to the complex. However, this 
limitation can be circumvented by using specific inhibitors to other sources of ROS in 
the cell, such as NOS and XO. Specific inhibitors for NOS and XO exist. Therefore, 
to determine the mechanism of the inhibitory effect of DPI on the decidual process 
and test whether the ROS involved in the differentiation of HESCs are NADPH 
oxidase-specific, HESCs were treated with 8-br-cAMP for 24 hours in the presence 
or absence of a XO inhibitor allopurinol, the NOS inhibitor L-NAME, an alternative 
NADPH oxidase inhibitor AEBSF and apocynin. As illustrated in Figure 3.4, 
allopurinol and L-Name failed to antagonize IGFBP1 and PRL expression, whereas 
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treatment with AEBSF, mimicked the effects of DPI, indicating that the production of 
ROS involved in decidualization is NADPH-specific. 
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Fig 3.3 NADPH oxidase-dependent ROS play a critical role in the differentiation 
of HESCs into decidual cells. HESCs were maintained untreated or treated with 8-
br-cAMP in the presence or absence of apocynin (Apo) or DPI for 24 hours. RTQ-
PCR analysis was carried out for PRL and IGFBP1 mRNA levels normalized to L19 
mRNA. Data are depicted as fold induction relative to transcript levels of untreated 
samples and represent means (± SD) of triplicate determinations from three different 
biological samples. ***, P < 0.001. 
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In view of the potent effects of apocynin on cAMP-dependent induction of PRL and 
IGFBP1 expression in HESCs, I tested if activation of the NADPH oxidase complex, 
either alone or in combination with MPA treatment, would be sufficient to trigger 
decidualization. To test this conjecture, primary cultures were treated with 8-br-cAMP 
or MPA in the presence or absence of apocynin or with apocynin alone. All the 
treatments were carried out for a period of 24 hours. Subsequently, RTQ-PCR was 
carried out to measure the transcript levels of PRL and IGFBP1. However, as shown 
in Figure 3.5, treatment with apocynin, alone or in combination with MPA, was 
insufficient to induce either IGFBP1 or PRL mRNA expression, indicating that the 
effect of endogenous ROS signalling on HESC differentiation is dependent on 
simultaneous activation of the cAMP pathway. I therefore concluded that treatment 
with apocynin does not sensitize the cells to progesterone signalling.   
 
Although the activated NADPH oxidase generates O2- from molecular oxygen, this 
can be rapidly dismutated to H2O2 and both radicals have been implicated in cellular 
signal transduction. To further validate that endogenous ROS play a critical role in 
the initial decidual process, HESCs were transfected with a vector encoding catalase, 
a highly efficient enzyme that converts H2O2 to H2O and O2. Subsequently, total RNA 
was harvested and the transcript level of the decidual markers was measured using 
RTQ-PCR. Interestingly, overexpression of catalase also attenuated the cAMP-
dependent induction of PRL and IGFBP1, as shown in Figure 3.6, providing further 
evidence that endogenous ROS signalling plays an integral role in initiating the 
decidual response. 
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Fig 3.4 The NADPH oxidase complex is the main source of ROS involved in the 
decidual process. Primary HESCs were maintained untreated or treated with 8-br-
cAMP in the presence or absence of apocynin (Apo), allopurinol, L-Name or AEBSF. 
RTQ-PCR analysis was carried out for PRL and IGFBP1 mRNA levels normalized to 
L19 mRNA. Data are depicted as fold induction relative to transcript levels of 
undifferentiated samples and represent means (± SD) of triplicate determinations 
from three different biological samples. ***, P < 0.001. 
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Fig 3.5 Effects of apocynin on decidualization. HESCs were either maintained 
untreated or treated with 8-br-cAMP or MPA in the presence or absence of apocynin 
(Apo), or with apocynin alone for 24 hours. Total RNA was harvested and RTQ-PCR 
analysis was carried out for IGFBP1 and PRL, normalized to L19 transcript levels. 
Data are depicted as fold induction relative to transcript levels of untreated samples 
and represent means (± SD) of triplicate determinations from three different biological 
samples. **, P < 0.01, ***, P < 0.001. 
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Fig 3.6 Overexpression of catalase attenuates the cAMP-dependent induction 
of IGFBP1 and PRL. A, Primary cultures were transfected with a catalase 
expression vector or empty vector. The cells were treated two days later with 8-br-
cAMP for 24 hours. Total mRNA was harvested and PRL and IGFBP1 transcript 
levels were measured using RTQ-PCR analysis. Data are depicted as fold induction 
relative to transcript levels of undifferentiated samples and represent means (± SD) 
of triplicate determinations from three different biological samples. B, Western blot 
analysis on whole cell lysates was carried out to validate catalase overexpression. *, 
P < 0.05. 
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3.4 The kinetics of the NADPH oxidase-dependent ROS production. 
 
Based on reporter assay studies investigating the kinetics of cAMP-dependent 
induction of the decidual PRL (dPRL) promoter activity, initiation of the decidual 
process has been described as a biphasic response characterized by an initial rapid 
but modest induction followed by a sharp rise in promoter activity apparent after 12 
hours of stimulation (73). To shed light on the role of endogenous ROS signalling on 
the kinetics of this initial differentiation response, time-course studies were carried 
out in primary cultures treated with 8-br-cAMP alone or in combination with apocynin, 
and the transcript levels of both decidual markers PRL and IGFBP1 were measured 
using RTQ-PCR. As illustrated in Figure 3.7, PRL and IGBP1 transcript levels rose 
by 8- and 48-fold, respectively, after 3 hours of 8-br-cAMP treatment and the levels 
remained relatively unchanged at 6 hours, before rising sharply after 12 hours of 
treatment. Intriguingly, cotreatment with apocynin somewhat attenuated the early 
response before markedly increasing PRL and IGFBP1 mRNA expression during the 
second phase of this initial cAMP response, starting approximately after 12 hours of 
stimulation.  
 
This observation suggests that apocynin acts as an antagonist to cAMP signalling in 
the first phase of the biphasic response and switches to an agonist in the second 
phase enhancing the magnitude of cAMP-dependent induction of PRL and IGFBP1 
transcript levels. I postulated that the temporal switching of apocynin from acting as 
an antagonist to an agonist might be a result of alteration in the oxidative status of 
the cell. To test this hypothesis, I set out to investigate the kinetics of changes in 
cellular ROS production upon initiation of the decidual process. Primary cultures 
were, therefore, treated with 8-br-cAMP for 3, 6, 12 and 24 hours, loaded with the 
oxidant-sensing fluorescent DCFH-DA probe and the fluorescent signal was 
measured and normalized to that of parallel untreated cultures. Interestingly, a 
triphasic response was observed in all primary cultures tested (n = 4) as illustrated in 
Figure 3.8A. This response was characterized by a modest increase in DCF 
fluorescence upon 3 hours of 8-br-cAMP treatment, followed by a gradual decline by 
12 hours and a subsequent sharp increase between 12 and 24 hours of 8-br-cAMP 
stimulation. The decline in DCF fluorescence observed indicates that the level of 
ROS in 8-br-cAMP stimulated cells is below that of untreated cells. Therefore the 
sharp rise in DCF fluorescence elucidates a burst in cellular ROS between 12 and 24 
hours of 8-br-cAMP stimulation. Interestingly, this burst in ROS coincided with the  
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Fig 3.7 The kinetics of cAMP-dependent induction of PRL and IGFBP1 
transcripts. Cultured HESCs were treated or left untreated with 8-br-cAMPin the 
presence or absence of apocynin (Apo) for 3, 6, 12 and 24 hours. Total RNA was 
harvested and RTQ-PCR was carried out to measure PRL (A) and IGFBP1 (B) 
mRNA expression. Transcript levels were normalized to L19 mRNA. Data are 
depicted as fold induction relative to transcript levels of untreated samples and 
represent means (± SD) of triplicate determinations from three different biological 
samples. *, P < 0.01; **, P < 0.001. 
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induction of the transcript levels of both decidual marker genes PRL and IGFBP1 in 
response to 8-br-cAMP alone or in combination with apocynin. 
 
To confirm that the burst in cellular ROS observed earlier is NADPH oxidase-
dependent, primary cultures were treated with 8-br-cAMP alone or in the presence of 
the NADPH oxidase inhibitor DPI or the NADPH oxidase activator apocynin for 24 
hours. Prior to terminating the treatments, the cultures were loaded with DCFH-DA 
for 25 minutes and the fluorescent signal was measured using a flow cytometer. The 
baseline represents the level of fluorescence of untreated cultures. As expected, 8-
br-cAMP alone, induced cellular oxidation by 24 hours of stimulation and this 
response was further enhanced by cotreatment with apocynin, however, cotreatment 
with DPI abolished the induction of ROS (Fig 3.8B). This finding further confirmed 
that the burst in ROS observed between 12 and 24 hours of 8-br-cAMP treatment is 
NADPH oxidase dependent.  
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Fig 3.8 Kinetics of cAMP-dependent ROS production in decidualizing HESCs. 
A, Primary cultures were treated or left untreated with 8-br-cAMP for 3, 6, 12 and 24 
hours. Cultures were loaded with DCFH-DA for 25 minutes prior to terminating the 
treatments. DCF fluorescence was measured every 2 minutes over a 30-minute 
period using a fluorometer. Data are depicted as the difference in ROS production 
between 8-br-cAMP treated and untreated cultures and represent means (± SEM) of 
sextuplicate determinations from four different biological samples. B, HESCs from 
three different biological samples were untreated or treated with 8-br-cAMP for 24 
hours then pulsed with apocynin (Apo) or DPI for 30 minutes. Subsequently, the cells 
were loaded with DCHF-DA for 25 minutes and DCF fluorescence was measured 
using flow cytometry. **, P < 0.001. 
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3.5 Characterization of the NADPH oxidase complex in HESCs 
 
The catalytic component of the NADPH oxidase complex is the NOX subunit. As 
mentioned in chapter 1, there are four homologues to NOX2, the prototypic NOX 
catalytic subunit of the NADPH oxidase complex, excluding DUOX1 and DUOX2 
(147). As illustrated in Figure 1.8, each catalytic subunit requires different regulatory 
proteins. Further, more than one NOX homologue can be expressed in one cell type 
(147, 221).  
 
To further elucidate the role and mechanism of NADPH oxidase-dependent ROS 
signalling in HESCs, it was important to determine the NOX homologue that is most 
critical in the decidual process. Previous microarray analysis carried out in our 
laboratory comparing gene networks in undifferentiated and decidualizing HESCs, 
identified three different NOX homologues in HESCs: NOX1, NOX4 and NOX5 and 
the NOX cofactor p22PHOX (Fig 3.9) (18). This makes the other two NOXs, NOX2 and 
NOX3, unlikely to be critical for mounting the decidual response.  
 
RAC GTPases are known to activate the catalytic subunits NOX1, NOX2 and to a 
lesser extent NOX3 (147). Moreover, RAC1 is expressed in HESCs where it plays a 
critical role in regulating embryo implantation (271). A process of elimination was 
utilized to determine if NOX1, NOX2 and NOX3 are critical for the initiation of HESCs 
decidualization. To this end, I first examined RAC1 expression by Western blot 
analysis using whole cell lysates from primary cultures left untreated or treated with 
8-br-cAMP for 24 hours. As shown in Figure 3.10A, RAC1 levels were comparable in 
undifferentiating cultures with those treated with 8-br-cAMP for 6, 8, 10, 16 and 24 
hours. Next, primary cultures were first transfected with NT siRNA or siRNA targeting 
RAC1. Two days post transfection, cultures were treated with 8-br-cAMP for the 
various time points. Western blot and RTQ-PCR analysis were carried out to validate 
the efficiency of the knockdown. As illustrated in figure 3.10B, the efficiency of RAC1 
knockdown was high at the mRNA and protein level (B), yet there was no attenuation 
of the induction of PRL and IGFBP1 mRNA expression in response to 8-br-cAMP 
stimulation (C). This indicates that the decidual process at least in the first 24 hours 
is not RAC1-dependent, and therefore it is highly unlikely that NOX1, NOX2 and 
NOX3 are the primary source of ROS production in decidualizing HESCs. 
Chapter 3: Results 1 
 104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.9 The NADPH oxidase profile in HESCs. Primary cultures were left untreated 
or stimulated with 8-br-cAMP and MPA for 72 hours and subjected to microarray 
analysis. Data represents components of the NADPH oxidase complex that were 
identified by the array and represent means (± SD) of triplicate determinations from 
three different biological samples. (Disclaimer: This experiment has been carried out 
by previous members of the laboratory (18), however, the mining of the data was 
carried out by myself). 
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Fig 3.10 RAC1 is not required for the induction of the decidual markers. A, 
Cultured HESCs were untreated or treated with 8-br-cAMP for 6, 8, 10, 16 and 24 
hours. Whole cell lysates were extracted and blotted for RAC1 expression. β-actin 
served as a loading control. B, The Left panel shows RTQ-PCR analysis of RAC1 
transcript levels, normalized to L19 mRNA, in cells transfected with NT or RAC1 
siRNAs and treated 2 days later with 8-br-cAMP for 24 hours. Data are depicted as 
fold change relative to transcript levels of undifferentiated samples and represent 
means (± SD) of triplicate determinations from three different biological samples. The 
right panel shows Western blot analysis of RAC1 expression in protein lysates from 
parallel cultures. β-actin served as a loading control. C, RTQ-PCR analysis for PRL 
and IGFBP1 levels, normalized to L19 mRNA, upon RAC1 silencing. The results are 
fold change relative to transcript levels of undifferentiated samples transfected with 
NT siRNA and represent means (± SD) of triplicate determinations from three 
different biological samples. *, P < 0.01; **, P < 0.001.  
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Having eliminated NOX1, NOX2 and NOX3 indirectly, I focused on the remaining 
NOX4 and NOX5. As mentioned earlier, NOX4 is p22PHOX dependent, whereas 
NOX5 does not require any coregulatory proteins, since its mechanism of action is 
Ca2+-dependent (203, 207). p22PHOX is ubiquitously expressed in different cell types 
and forms a heterodimer with NOX1 - 4.  The formation of the heterodimer is critical 
for the activity and stability of the NOX complex. In addition to NOX5, DOUX1 and 2 
are also p22PHOX-independent in their stability and activity (147, 207, 214). 
 
Manual mining of existing genome-wide gene expression profiling of HESCs treated 
with 8-br-cAMP and MPA for 72 hours, revealed that p22PHOX was significantly 
upregulated upon decidualization (Fig 3.9) (18). Moreover, NOX4 was the only 
upregulated NOX homologue at the transcript level in decidualizing HESCs (Fig 3.9) 
 
These observations, in addition to the fact that NOX5 transcript level is not 
significantly upregulated in decidualizing HESCs (Fig 3.9), led us to postulate that 
NOX4 is the most critical catalytic subunit of the NADPH oxidase complex. 
Consequently, I focused on examining the role of NOX4 and its regulatory 
component p22PHOX in decidualizing HESCs. 
 
To test whether the hypothesis that NOX4 and p22PHOX are required for the initiation 
of the decidual process, I first set out to examine the expression of p22PHOX and 
NOX4 at the protein level in a short time course study. HESCs cells were treated with 
8-br-cAMP for 6, 8, 10, 16 and 24 hours, whole cell lysates were collected and 
blotted for NOX4 and p22PHOX. Interestingly, as shown in Figure 3.11, p22PHOX 
expression at the protein level increased when cells were treated for 16 hours or 
longer with 8-br-cAMP. NOX4 protein expression, on the other hand, did not appear 
to change over this time course. However, this observation was not enough to rule 
out the involvement of NOX4 in the decidual process as an increase in p22PHOX 
protein expression might enhance NOX4 activity. Therefore, to determine if NOX4 
and p22PHOX are critical for the decidual process, siRNA-mediated knockdown of 
those two subunits was carried out independently in HESCs. As shown in Figure 
3.12, the knockdown of both NOX4 and p22PHOX was sufficient to attenuate the 
induction of PRL and IGFBP1 transcripts in cultures treated with 8-br-cAMP for 24 
hours. In fact, siRNA-mediated knockdown of p22PHOX resulted in a reduction of 
cAMP-dependent induction of PRL and IGFBP1 transcripts by 38 and 62%, 
respectively. Similarly, NOX4 knockdown was as effective as p22PHOX silencing in 
attenuating the induction of decidual PRL and IGFBP1 transcripts.  
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Fig 3.11 p22PHOX and NOX4 protein expression in HESCs. Cultured HESCs were 
left untreated or treated with 8-br-cAMP for 6, 8, 10, 16 and 24 hours. Whole cell 
lysates were extracted and blotted for p22PHOX and NOX4 expression. β-actin served 
as a loading control. 
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Fig 3.12 Knockdown of NOX4 and p22PHOX attenuates the cAMP-dependent 
induction of PRL and IGFBP1. A, Validation of p22PHOX knockdown at mRNA (left) 
and protein level (right) in HESCs transfected with NT or p22PHOX siRNA. B, RTQ-
PCR analysis for both PRL and IGFBP1 levels, normalized to L19 mRNA upon 
p22PHOX silencing. C, Validation of NOX4 knockdown at mRNA (left) and protein level 
(right) in HESCs transfected with NT or NOX4 siRNA. D, RTQ-PCR analysis for both 
PRL and IGFBP1 levels, normalized to L19 mRNA upon NOX4 silencing. Data in B 
and D are depicted as fold change relative to transcript levels of samples transfected 
with NT siRNA and represent means (± SD) of triplicate determinations from three 
different biological samples. *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
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To further implicate the involvement of NOX4/p22PHOX complex in the production of 
ROS in decidualizing HESCs, I set out to determine if NOX4/p22PHOX activation 
underpins the burst in ROS observed in HESCs treated with 8-br-cAMP for longer 
than 12 hours. To this end, primary cultures were transfected with either NT siRNA or 
siRNA targeting NOX4 and p22PHOX, and two days later, cultures were left untreated 
or treated with 8-br-cAMP for 24 hours. Prior to terminating the treatments by 25 
minutes, cultures were loaded with the oxidant-sensing DCFH-DA probe, and 
fluorescence was measured every 2 minutes over a 30-minute period. As illustrated 
in Figure 3.13, siRNA-mediated knockdown of NOX4 and p22PHOX abolished the 
burst in ROS previously observed in HESCs treated with 8-br-cAMP for 24 hours, 
indicating that the NOX4/p22PHOX complex is a primary source of ROS involved in 
decidualization.  
Chapter 3: Results 1 
 110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.13 The NOX4/p22PHOX complex underpins the burst in ROS observed in 
HESCs. Primary cultures were transfected with NT siRNA or siRNA targeting 
p22PHOX and NOX4 and treated two days later with 8-br-cAMP for 24 hours. The cells 
were then loaded with DCFH-DA for 25 minutes and DCF fluorescence was 
measured over a 30-minute period. Data are depicted as the difference in ROS 
production between 8-br-cAMP treated and untreated cultures and represent means 
(± SEM) of sextuplicate determinations from three different biological samples. ***, P 
< 0.001. 
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3.6 NADPH oxidase-dependent ROS signalling in HESCs 
 
Amongst the transcription factors and kinases implicated in decidual transformation 
of HESCs, there are some known to be either redox-sensitive or interact with the 
NADPH oxidase complex in other cell systems. This category of transcription factors 
and kinases include FOXO1, STAT5, C/EBPβ and SRC kinase (18, 125, 136, 272). I 
speculated that changes in the redox state of HESCs due to activation or inhibition of 
the NADPH oxidase complex might alter the activity or expression of some key 
signalling intermediates or transcription factors implicated in mounting the decidual 
response, leading to changes in their cellular localization. To test this hypothesis, 
Western blot analysis on cytosolic and nuclear extracts derived from HESCs treated 
with 8-br-cAMP in the presence or absence of apocynin for 24 hours was carried out 
to examine the expression level and cellular localization of FOXO1, STAT5, C/EBPβ 
and SRC kinase. As shown in Figure 3.14, there was no change observed in the 
expression level in either the cytoplasmic or nuclear compartment of FOXO1, STAT5 
and SRC kinase when HESCs were treated with 8-br-cAMP alone or in the presence 
of apocynin. Notably, activation of these signal intermediates in response to decidual 
stimuli tended to be a delayed response, apparent only after 2 or more days of 
differentiation (7). C/EBPβ expression levels, on the other hand, were enriched when 
HESCs were treated with 8-br-cAMP for 24 hours, a response further enhanced by 
apocynin. Interestingly, unlike FOXO1, STAT5 and SRC, C/EBPβ is induced in 
HESCs between 8 to 24 hours of 8-br-cAMP treatment (126). 
 
Next, to validate the notion that endogenous ROS signalling in HESCs impacts on 
C/EBPβ DNA binding activity, electron mobility shift assay (EMSA) was carried out 
on nuclear extracts derived from HESCs treated with 8-br-cAMP alone or in 
combination with apocynin for 24 hours. As represented in Figure 3.15, compared to 
untreated cells, C/EBPβ binding activity is enriched with 8-br-cAMP treatment, a 
response further enhanced when samples were treated with 8-br-cAMP in the 
presence of apocynin.  
 
To further substantiate that C/EBPβ DNA binding activity is specifically regulated by 
the NOX4/p22PHOX complex, I combined siRNA-mediated knockdown with EMSA. 
Thus, HESCs were transfected with siRNA targeting NOX4 and p22PHOX and two 
days post transfection, cells were treated with 8-br-cAMP for 24 hours. EMSA was  
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Fig 3.14 NADPH oxidase-dependent ROS enriches the 8-br-cAMP-dependent 
protein expression of C/EBPβ . Cultured HESCs were left untreated or treated for 
24 hours with 8-br-cAMP in the presence or absence of apocynin (Apo). 
Cytosolic/nuclear extracts were prepared and blotted for SRC, STAT5, FOXO1 and 
C/EBPβ. The expression of Lamin B and α-Tubulin was assessed to confirm the 
integrity of the cell fractionation. As a loading control, samples were blotted for β-
actin.  
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Fig 3.15 NADPH oxidase-dependent ROS enriches the 8-br-cAMP-dependent 
DNA binding activity of C/EBPβ  in HESCs. HESCs were treated for 24 hours with 
8-br-cAMP alone or in combination with apocynin (Apo) and DNA binding activity of 
C/EBPβ contained in the nuclear extracts was analyzed by EMSA. Nuclear lysates 
were incubated with excess of [32P]-labeled C/EBP, OCT1 (xs-non-specific) and 
unlabeled C/EBP (xs-specific) oligonucleotides. Both OCT1 and unlabeled C/EBP 
oligonucleotides served as DNA binding competitors to verify binding specificity. For 
supershift analysis, nuclear extracts were incubated with an antibody against C/EBPβ 
prior to addition of the hot probe. Solid arrowhead indicate position of specific 
complexes, open arrowhead marks the position of uncomplexed DNA probe. 
(Disclaimer: The radioactivity work was handled by Dr. Yun Lee). 
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then carried out on nuclear extracts form the transfected cultures. As shown in Figure 
3.16, silencing of the NOX4/p22PHOX complex decreased the 8-br-cAMP-dependent 
enrichment of C/EBPβ DNA binding activity, the opposite of what was observed 
when the NADPH oxidase complex in HESCs was activated with apocynin.  
  
To provide further evidence that NADPH oxidase-dependent ROS regulate the 
activity of C/EBPβ in HESCs, primary cultures were transfected with a luciferase 
reporter under the control of two cognate response elements. The cells were then 
treated with 8-br-cAMP and/or apocynin for 24 hours and the luciferase activity was 
measured. As illustrated in Figure 3.17, treatment with apocynin alone induced the 
C/EBP-dependent transcription to a similar degree to what is achieved with 8-br-
cAMP treatment. Interestingly, the combined treatment of apocynin and 8-br-cAMP 
yielded a synergistic response.  
 
Taken together, the result demonstrate that modulating the activity of the NADPH 
oxidase complex affects C/EBPβ expression levels as well as its DNA binding 
activity, indicating that C/EBPβ is a mediator of endogenous NOX4/p22PHOX-
produced ROS signalling in HESCs upon 8-br-cAMP treatment. 
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Fig 3.16 Knockdown of the NOX4/p22PHOX complex attenuates the 8-br-cAMP-
dependent enrichment of C/EBPβ  DNA binding activity. Undifferentiated HESCs 
were transfected with NT siRNA or siRNA targeting p22PHOX and NOX4 and treated 
two days later with 8-br-cAMP. DNA binding of C/EBPβ contained in nuclear extracts 
was analysed by EMSA. To verify DNA binding, bindng specificity and for supershift 
analysis, nuclear lysates were incubated with excess [32P]-labeled C/EBP, OCT1 and 
unlabeled C/EBP oligonucleotides. For supershift analysis, nuclear extracts were 
incubated with an antibody against C/EBPβ prior to addition of the hot probe. Solid 
arrowhead indicate position of specific complexes, open arrowhead marks the 
position of uncomplexed DNA probe. (Disclaimer: The radioactivity work was handled 
by Dr. Yun Lee). 
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Fig 3.17 NADPH-oxidase ROS enhances C/EBPβ-dependent transcription in 
HESCs.  Primary cultures were transfected with C/EBP-pGL4, pSG5-C/EBPβ and 
pCH110 (encoding for β-galactosidase). The cells were left untreated or treated with 
8-br-cAMP in the presence or absence of apocynin (Apo) or with apocynin alone for 
24 hours. Subsequently, firefly luciferase activity was measured (N = three different 
biological samples).  * = P < 0.05, ** = P < 0.01. 
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Summary of results 
 
Decidualization denotes the morphological and biochemical differentiation of HESCs 
into decidual cells. Decidualization is critical for a successful pregnancy since 
decidual cells play a critical role in embryo implantation. For instance, decidual cells 
control subsequent trophoblast invasion and placenta formation, regulate the 
recruitment of specialized immune cells, such as uNK cells to the feto-maternal 
interface, protect the early conceptus from environmental stress signals and more 
recently, it has been reported that decidual cells act as biosensors of embryo quality, 
capable of recognizing and responding selectively to developmentally compromised 
blastocysts (8, 18, 40). 
 
Overwhelming evidence suggests that cAMP is the main stimulus for triggering the 
decidual process. It is well established that in vivo, the initiation of the decidual 
process coincides with enrichment in the levels of cAMP as a result of enhanced 
expression of local factors that activate adenylate cyclase in stromal cells such as 
relaxin, corticotrophin releasing hormone and PGE2 (10, 79-85). Furthermore, 
increased in vivo levels of cAMP coincide with the downregulation of PDE4, the 
phosphodiesterase family member that converts cAMP back to AMP (83, 84).  
 
In this chapter, I provide evidence that NADPH oxidase-produced ROS are required 
for the differentiation of HESCs into decidual cells. First, I show that activating the 
NADPH oxidase complex using a chemical activator apocynin, enhances the 
expression level of the decidual markers PRL and IGFBP1. Conversely, DPI, the 
NADPH oxidase inhibitor, attenuates the transcript levels of both decidual markers. 
Next, I validate that the endogenous ROS involved in initiating the decidual process 
are mainly NADPH oxidase-dependent. This was carried out by using inhibitors to 
other sources of endogenous ROS that exist in various cell systems such as NOS 
and XO. It is worth pointing out that activating the NADPH complex alone in HESCs 
is not sufficient to induce the transcript levels of PRL and IGFBP1, indicating that 
endogenous ROS have a synergistic effect with cAMP in triggering the decidual 
phenotype.  
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Most importantly, I show, by measuring the cellular oxidative status of HESCs treated 
with 8-br-cAMP for various time points, that there is a burst in ROS that occurs 
between 12 and 24 hours of treatment. Interestingly, this burst in ROS not only 
coincides with the induction of the transcript levels of PRL and IGFBP1, but also, with 
previously published studies about the timed activation of the dPRL promoter as well 
as with the activation of the transcription factor C/EBPβ (73, 126). 
 
I then provide evidence that the decidual process, at least in the first 24 hours is not 
RAC1-dependent, therefore ruling out NOX1, NOX2 and NOX3 as the prime source 
of endogenous ROS involved in differentiation of HESCs. Further, from time course 
studies, I show that p22PHOX is induced upon decidualization or treating the cells with 
8-br-cAMP for 16 hours or longer. Although NOX4 is not induced at this time point, it 
should not be ruled out as a source of endogenous ROS in HESCs. In fact, 
Edderkaoui et al (2011) recently reported that in pancreatic cancer cells, upregulation 
of p22PHOX increases NOX4/p22PHOX complex formation and subsequent activation of 
the oxidase (211). Therefore, my results point towards NOX4 being the most 
important NOX homologue in the decidual phenotype. I next confirmed this notion by 
carrying out siRNA-mediated knockdown of NOX4 and p22PHOX, which in turn 
attenuated the transcript levels of PRL and IGFBP1. 
 
Examination of the protein expression of redox-sensitive decidual-dependent 
transcription factors and kinases in cytosolic and nuclear extracts of HESCs treated 
with 8-br-cAMP for 24 hours showed that NADPH oxidase-dependent ROS increased 
the cAMP-dependent expression of the C/EBPβ. Furthermore, EMSA carried out on 
nuclear extracts of HESCs treated with 8-br-cAMP alone or in combination with 
apocynin showed that NADPH oxidase-dependent ROS increased the DNA binding 
activity of C/EBPβ. The same analysis carried out on nuclear extracts derived from 
HESCs with silenced NOX4/p22PHOX complex revealed that abolishing of the NADPH 
oxidase-dependent ROS reduces the DNA binding activity of C/EBPβ to basal levels.  
 
Taken together, our data suggests that in addition to the decidual phenotype being 
cAMP-dependent in its initiation, endogenous ROS production primarily produced 
from the NADPH oxidase complex are indispensible for mounting the decidual 
phenotype.  
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Introduction 
 
Various microarray studies have yielded insight into the extent and magnitude of the 
changes in the transcriptome that underpins the morphological and biochemical 
reprogramming associated with decidualization. It is now well established that 
decidualization denotes the sequential reprogramming of distinct but functionally 
related gene networks involved in cell cycle progression, extracellular matrix 
organization, cell adhesion, cytoskeletal organization, metabolism, signal 
transduction, differentiation and apoptosis (18).  
 
Compared to undifferentiated HESCs, decidual cells acquire a remarkable resistance 
to oxidative cell death (35). This resistance upon decidualization is partly 
characterized by induction of various free radical scavengers, most notably SOD2, 
TXN and GPx3, and partly due to the downregulation of the proapoptotic gene 
FOXO3a (18). Furthermore, decidualization is associated with a global 
hyposumoylation, which plays a role in sensitizing HESCs to progesterone signalling 
by attenuating the ligand-dependent SUMO-modification of PR-A (70). 
 
In the previous chapter, we have provided unequivocal evidence that endogenous 
NADPH oxidase-produced ROS signalling is critical for triggering the decidual 
response. We have also illustrated that in the initial stages of decidualization, 
NADPH oxidase-produced ROS exert their effects through affecting the protein 
expression levels and DNA binding activity of the transcription factor C/EBPβ.  
 
In this chapter, we investigate the role of endogenous ROS signalling in mounting a 
prolonged decidual response. We also elucidate the gene networks that are sensitive 
to endogenous ROS signalling in decidualizing HESCs and delineate the effects of 
silencing the NOX4/p22PHOX complex on the decidual response. 
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4.1 The role of NADPH oxidase-dependent ROS in prolonged 
decidualization  
 
I have previously shown that activation and expression of the NOX4/p22PHOX complex 
is a cardinal step in the initiation of the decidual process in HESCs. However, 
whether perpetual activation of this complex is required for the maintenance of 
decidualization is yet unknown. To investigate this conjecture, I first carried out time 
course studies where primary cultures were either left untreated or treated with 8-br-
cAMP and MPA for 1, 3 and 8 days, and looked at the expression of both NOX4 and 
p22PHOX at the transcript level. As shown in figure 4.1, both NOX4 and p22PHOX 
transcript levels were induced with the decidual stimuli and increased by 7 and 2.25 
fold respectively, by day 8 (Fig 4.1A and B).  
 
Similarly, primary cultures were treated with 8-br-cAMP and MPA for the same time-
course, and Western blot analysis was carried out for NOX4 and p22PHOX on whole 
cell lysates. As shown in figure 4.2, there was a remarkable increase in NOX4 and 
p22PHOX protein levels throughout the time course. 
 
The increased expression of NOX4 and p22PHOX at the transcript and protein level 
reaffirmed our hypothesis that perpetual activation of the NOX4/p22PHOX complex 
may be essential throughout the decidual process. Thus, I set out to determine if 
silencing of the NOX4/p22PHOX complex would perturb the decidual phenotype 
beyond the 24-hour time point. As mentioned previously, progesterone is required for 
maintaining and enhancing the decidual process. Therefore, primary cultures were 
transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX and treated with 8-
br-cAMP and MPA for 72 hours. Subsequently, total RNA was collected and the 
transcript levels of both decidual markers PRL and IGFBP1 were measured using 
RTQ-PCR. As shown in figure 4.3, knockdown of the NOX4/p22PHOX complex was 
effective at the protein level and resulted in a marked decrease (> 60%) in the 
expression of both decidual marker genes. However, the perturbation in the induction 
of PRL and IGFBP1 observed here could be a consequence of the impaired initiation 
of the decidual process as, shown in chapter 3. Therefore, to investigate whether 
inhibiting the NOX4/p22PHOX complex in the course of decidualization would impair 
further differentiation, I treated HESCs with 8-br-cAMP and MPA for 48 hours and  
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Fig 4.1 The NOX4/p22PHOX complex is upregulated at the transcript level upon 
prolonged decidualization. A and B, Cultured HESCs were untreated or treated 
with 8-br-cAMP and MPA for 1, 3 and 8 days. Total RNA was harvested and RTQ-
PCR analysis was carried out for NOX4 and p22PHOX. Transcript levels were 
normalized to L19 mRNA. Data are depicted as fold induction relative to transcript 
levels of untreated samples and represent means (± SD) of triplicate determinations 
from three different biological samples. * = P < 0.05, ** = P < 0.01. 
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Fig 4.2 The NOX4/p22PHOX complex is upregulated at the protein level upon 
prolonged decidualization. Cultured HESCs were untreated or treated with 8-br-
cAMP and MPA for 1, 3 and 8 days. Whole-cell lysates were extracted and blotted for 
NOX4 and p22PHOX expression. β-actin served as a loading control. 
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Fig 4.3 Silencing of the NOX4/p22PHOX complex perturbs prolonged 
decidualization. A, Validation of the NOX4 and p22PHOX knockdown at the protein 
level in HESCs transfected with NT or siRNA targeting NOX4 and p22PHOX and 
maintained untreated or treated with 8-br-cAMP and MPA for 72 hours. B, RTQ-PCR 
analysis for both PRL (right) and IGFBP1 (left) levels, normalized to L19 mRNA upon 
NOX4/p22PHOX silencing in HESCs. Data are depicted as fold induction relative to 
transcript levels of untreated samples transfected with NT siRNA and represent 
means (± SD) of triplicate determinations from three different biological samples. * = 
P < 0.05, *** = P < 0.001. 
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Fig 4.4 Perpetual endogenous ROS signalling is required for maintenance of 
the decidual process. Cultured HESCs were treated with 8-br-cAMP and MPA for 
48 hours. Subsequently, cells were treated with 8-br-cAMP and MPA in the presence 
or absence of DPI for another 24 hours. RTQ-PCR analysis was carried out for PRL 
(right) and IGFBP1 (left) mRNA levels normalized to L19 mRNA. Data are depicted 
as normalized transcript levels to those of L19 and represent means (± SD) of 
triplicate determinations from three different biological samples. * = P < 0.05, *** = P 
< 0.001. 
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then refreshed the treatments in the presence or absence of the NADPH oxidase 
inhibitor, DPI. Total RNA was then harvested, and RTQ-PCR analysis was carried 
out for PRL and IGFBP1. As shown in figure 4.4, inhibition of the NOX4/p22PHOX 
complex when the cells already express a decidual phenotype disrupts further 
differentiation, as exemplified by a marked reduction in PRL and IGFBP1 expression. 
Interestingly, the level of inhibition was approximately 60%, a level comparable to the 
reduction attained by disabling the NADPH oxidase complex through siRNA-
mediated knockdown prior to decidualizing the cells.   
 
Taken together, I provide further evidence that activation of the NOX4/p22PHOX 
complex and subsequent endogenous ROS signalling are critical factors for the 
maintenance of the decidual process.  
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4.2 Characterization of NOX4/p22PHOX-dependent genes in decidualizing 
HESCs 
 
To determine the genes that are regulated by the ROS-producing enzyme, I 
combined siRNA-mediated knockdown of the NOX4/p22PHOX complex with 
microarray analysis. HESCs were either transfected with NT siRNA or siRNA 
targeting NOX4 and p22PHOX and two days post-transfection treated with 8-br-cAMP 
and MPA for 72 hours. Total RNA was harvested and subjected to microarray 
analysis using the Affymetrix Gene 1.0 ST arrays (28,926 transcripts, Almac 
Diagnostics). The microarray analysis yielded 400 genes that were regulated in a 
NOX4/p22PHOX manner (Cut off > 1.3 fold, Appendix 2 and 3). Interestingly, the 
majority of those genes (76%) were NOX4/p22PHOX induced genes and therefore 
were downregulated upon the NOX4/p22PHOX silencing. To elucidate the relationship 
between endogenous ROS signalling and decidualization, I mined and cross-
referenced the NOX4/p22PHOX-dependent gene list with genes known to be regulated 
in response to the decidual stimuli 8-br-cAMP and MPA (35). Out of the 400 
NOX4/p22PHOX-dependent genes, 29% were regulated upon decidualization. 
Interestingly, the direction of regulation of 90% of genes responsive to endogenous 
ROS was concordant with decidualization. For instance, 69% of the NOX4/p22PHOX- 
and decidual-dependent genes are NOX4/p22PHOX and decidual repressed genes 
(Fig 4.5). Similarly, 21% of the NOX4/p22PHOX- and decidual-dependent genes are 
NOX4/p22PHOX and decidual induced genes. Interestingly, cross referencing the 
microarray data with the data of Talbi et al (2006) revealed 30% of the 
NOX4/p22PHOX-repressed genes were downregulated and 34% of NOX4/p22PHOX-
induced genes were upregulated in the secretory phase of the menstrual cycle. 
Therefore, the gene expression profile in response to endogenous ROS signalling 
appears to follow the pattern observed upon decidualization. 
 
I used RTQ-PCR analysis to validate novel NOX4/p22PHOX-dependent genes. 
Primary cultures were transfected with NT siRNA or siRNA targeting NOX4/p22PHOX 
and treated with 8-br-cAMP and MPA for 72 hours. Total RNA was harvested and the 
mRNA expression levels of genes of interest were validated using RTQ-PCR. As 
shown in figure 4.6, BIRC5, a member of the inhibitor of apoptosis (IAP) gene family, 
BRCA2, a tumour suppressor gene involved in maintenance of gene stability, and 
COLEC10, a member of the C-lectin family, followed the regulation pattern yielded by 
the microarray.  
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Fig 4.5 The regulation pattern of NOX4/p22PHOX and decidual-dependent genes. 
HESCs were transfected with either NT siRNA or siRNA targeting NOX4 and 
p22PHOX, treated with 8-br-cAMP and MPA for 72 hours and subjected to genome-
wide expression profiling.  The Pie of Bar chart represents the cross-referencing with 
known decidual-dependent genes yielded from previous microarray studies. 
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Fig 4.6 Validation of the NOX4/p22PHOX-dependent gene expression. HESCs 
were transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX, two days 
post transfection cultures were maintained untreated or treated with 8-br-cAMP and 
MPA for 72 hours. RTQ-PCR analysis was carried out for BIRC5 (left), BRCA2 
(middle) and COLEC10 (right) mRNA levels normalized to L19 mRNA. Data are 
depicted as fold induction relative to transcript levels of untreated samples and 
represent means (± SD) of triplicate determinations from three different biological 
samples. * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
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The NOX4/p22PHOX-dependent genes were further annotated in silico using gene 
ontology and Ingenuity Pathways Analysis (IPA) (IPA; Ingenuity Systems, Redwood 
City, CA). This analysis revealed that NOX4/p22PHOX-dependent genes are mainly 
involved in cell cycle progression, cellular assembly and organization, DNA 
replication, recombination and repair, signal transduction and cellular growth and 
proliferation (Table 1-3).  
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Tables 1 - 3 In silico analysis of the microarray data. The above three tables 
represent the top five Associated Network Functions, Molecular and Cellular Function 
and Canonical Pathways that resulted from the in silico analysis of the 
NOX4/p22PHOX-dependent genes. Appendices 4 display the schematic diagrams of 
the top five Associated Network Functions.   
! Top 5 Associated Network Functions 
1 Cell Cycle, Cancer, Skeletal and Muscular Disorders 
2 Cell Cycle, Cellular Assembly and Organization, DNA Replication, 
Recombination, and Repair 
3 Cell-To-Cell Signalling and Interaction, Cell Cycle, DNA Replication, 
Recombination, and Repair 
4 Cellular Assembly and Organization, Cellular Growth and Proliferation, 
Haematological Disease 
5 DNA Replication, Recombination, and Repair, Gene Expression, Cell Cycle 
Table 4.1 The top five associated network functions resulted from the Ingenuity Pathways 
Analysis  
!
! Top 5 Molecular and Cellular Function 
1 Cell Cycle 
2 Cellular Assembly and Organization 
3 DNA Replication, Recombination, and Repair 
4 Cellular Movement 
5 Cellular Compromise 
Table 4.2 The top five molecular and cellular functions resulted from the Ingenuity Pathways 
Analysis 
!
! Top 5 Canonical Pathways 
1 Mitotic Roles of Polo-Like Kinase 
2 One Carbon Pool by Folate 
3 Aryl Hydrocarbon Receptor Signalling 
4 Role of BRCA1 in DNA Damage Response 
5 Cell Cycle: G2/M DNA Damage Checkpoint Regulation 
Table 4.3 The top five canonical pathways resulted from the Ingenuity Pathways Analysis!
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4.3 Characterizing the interaction between the NOX4/p22PHOX complex 
and FOXO1 
 
Strikingly, the functional networks resulting from the in silico analysis of 
NOX4/p22PHOX-dependent genes were similar to the functional networks previously 
shown to be under FOXO1 control in decidualizing HESCs (18). To further analyze 
the microarray, I mined and cross-referenced the gene list with FOXO1-dependent 
genes in decidualizing HESCs. I noticed that 59% of the NOX4/p22PHOX- and 
decidual-dependent genes are known to be FOXO1-dependent (Fig 4.7). 
Surprisingly, none of the NOX4/p22PHOX-dependent genes that are not decidual 
dependent cross-referenced with FOXO1-dependent genes.   
 
Clearly, from the in silico analysis and the manual mining of the NOX4/p22PHOX-
dependent genes, there seem to be a strong interaction between FOXO1 and the 
NOX4/p22PHOX complex in decidualizing HESCs. To investigate the interplay between 
the NOX4/p22PHOX complex and FOXO1, I first set out to determine if silencing of the 
NOX4/p22PHOX complex affects FOXO1 expression on the protein level. HESCs were 
therefore transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX and two 
days later treated with 8-br-cAMP and MPA for 72 hours. As shown in Figure 4.8A, 
Western blot analysis on whole cell lysate revealed that silencing of the 
NOX4/p22PHOX complex does not perturb the induction of FOXO1 in decidualizing 
HESCs. 
 
Next, I set out to examine if activating the NOX4/p22PHOX complex regulates the DNA 
binding activity of FOXO1 in decidualizing HESCs. Thus, HESCs were transfected 
with a luciferase reporter under the control of 6 cognate DNA binding sites (DBS) 
(FOXO1-pGL4) and treated with 8-br-cAMP and/or apocynin for 24 hours. 
Subsequently, firefly luciferase was measured using a luminometer. As illustrated in 
Figure 4.8B, although statistically significant, cotreatment with apocynin only 
marginally enhanced the ability of FOXO1 to transactivate the 6x DBS, suggesting 
that NADPH oxidase-dependent ROS does not regulate the activity of FOXO1 in 
HESCs.  
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Fig 4.7 NOX4/p22PHOX-dependent genes overlap with FOXO1-dependent genes. 
The Pie of Pie chart represents the in silico analysis and manual mining of the 
NOX4/p22PHOX-dependent genes with known FOXO-1 dependent genes that resulted 
from previous microarray studies. 
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Fig 4.8 The NOX4/p22PHOX complex is not upstream FOXO1. A, HESC cultures 
were transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX and two days 
post transfection, cells were maintained untreated or treated with 8-br-cAMP and 
MPA for 72 hours. Whole-cell lysates were extracted and blotted for FOXO1 
expression. β-actin served as a loading control. B, Primary cultures were transfected 
with (FOXO1-pGL4, PSG5-FOXO1, and PCH110 (encoding for β-galactosidase). 
The cells were left untreated or treated with 8-br-cAMP and MPA and/or apocynin for 
24 hours. Subsequently, firefly luciferase activity was measured. N = 3, * = P , 0.05, 
** = P < 0.01, *** = P < 0.001. 
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Since our data so far indicate that the NOX4/p22PHOX complex is not upstream 
FOXO1, I decided to investigate if FOXO1 was upstream the NOX4/p22PHOX 
complex. To do so, I transfected HESCs with NT siRNA or FOXO1 siRNA and two 
days later treated the cells with 8-br-cAMP and MPA for 72 hours. Interestingly, as 
shown in Figure 4.9, silencing of FOXO1 in decidualizing HESCs inhibited the protein 
induction of both components of the NOX4/p22PHOX complex.  
 
To further validate that FOXO1 is upstream the NOX4/p22PHOX complex, I examined 
transcript levels of selected NOX4/p22PHOX-dependent genes upon siRNA-mediated 
knockdown of FOXO1 in HESCs decidualized for 72 hours. The NOX4/p22PHOX-
dependent genes BIRC5 and BRCA2 are known to be FOXO1-dependent, COLEC10 
on the other hand is not. Since FOXO1 is upstream the NOX4/p22PHOX complex, I 
reasoned that the regulation pattern of BIRC5, BRCA2 and COLEC10 transcripts in 
FOXO1-depleted cultures would be similar to that observed upon NOX4/p22PHOX 
knockdown. As expected, RTQ-PCR analysis confirmed that the pattern of regulation 
of these transcripts upon FOXO1 depletion resembles that in response to knockdown 
of NOX4/p22PHOX in HESCs. (Fig 4.10).  
 
Taken together, I have provided unequivocal data that the NOX4/p22PHOX complex is 
downstream FOXO1, and does not negatively or positively feedback onto FOXO1. 
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Fig 4.9 FOXO1 is upstream NOX4 and p22PHOX. HESCs were transfected with NT 
or FOXO1 siRNA and two days post transfection, cells were maintained untreated or 
treated with 8-br-cAMP and MPA for 72 hours. Whole-cell lysates were extracted and 
blotted for FOXO1, NOX4 and p22PHOX expression. β-Actin served as a loading 
control. 
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Fig 4.10 NOX4/p22PHOX-dependent genes are regulated in a similar manner by 
FOXO1. HESCs were transfected with NT siRNA or FOXO1 siRNA, two days post 
transfection cultures were maintained untreated or treated with 8-br-cAMP and MPA 
for 72 hours. RTQ-PCR analysis was carried out for BIRC5 (left), BRCA2 (middle) 
and COLEC10 (right) mRNA levels normalized to L19 mRNA. Data are depicted as 
fold induction relative to transcript levels of untreated samples and represent means 
(± SD) of triplicate determinations from three different biological samples. * = P < 
0.05, *** = P < 0.001. 
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4.4 The effects of NOX4/p22PHOX knockdown in decidualizing HESCs 
 
The in silico analysis of the microarray data indicated that NOX4/p22PHOX knockdown 
perturbs gene networks involved in cell cycle regulation and genome stability. Four of 
the top five associated network functions implicated NOX4/p22PHOX-dependent genes 
in cell cycle and/or genome stability. Further, the cell cycle and DNA replication, 
recombination and repair were in the top three molecular and cellular functions that 
were altered by NOX4/p22PHOX knockdown in decidualizing HESCs as well as in the 
top five canonical pathways. I therefore hypothesized that NOX4/p22PHOX silencing in 
HESCs might alter the activation status of the DNA damage and repair pathway. To 
investigate this conjecture, I monitored H2A.X phosphorylation by 
immunofluorescence in NOX4/p22PHOX-knockeddown and decidualized HESCs. 
Phospho-H2A.X is a marker of checkpoint-mediated arrest of cell cycle progression 
and is required for efficient repair of DNA double strand breaks.  As shown in Figure 
4.11, confocal images of NOX4/p22PHOX-silenced HESCs clearly show an enhanced 
level of p-H2A.X compared to cells transfected with NT siRNA, indicative of DNA 
repair activity.  
 
The analysis of H2A.X phosphorylation, prompted a close examination of the DNA 
damage and repair pathway in decidualized HESCs upon disabling the 
NOX4/p22PHOX complex. To this end, primary cultures were transfected with NT 
siRNA or siRNA targeting NOX4 and p22PHOX, and two days post transfection, 
cultures were left untreated or treated with 8-br-cAMP and MPA for 3 and 8 days. 
Western blot analysis was carried out on whole cell lysates and blotted for p-ATM, p-
ATR, p-CHK1, p-CHK2, p-H2A.X and p-BRCA1. As shown in Figure 4.12, 
decidualization seems to be associated with increased p-BRCA1, p-ATM and p-ATR 
and the level of activation appears transient peaking around 4 days of treatment. 
Surprisingly, knockdown of the NOX4/p22PHOX complex modestly attenuated this 
biphasic phosphorylation, most evident in p-BRCA1 levels. Interestingly, CHK1, 
CHK2 and H2A.X, all of which are downstream of ATM/ATR, were clearly 
phosphorylated upon silencing of the complex in decidualizing cultures, indicating an 
ongoing activation of the DNA damage and repair pathway.   
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Fig 4.11 Silencing of the NOX4/p22PHOX complex induces phosphorylation of 
H2A.X in decidualizing HESCs. Cultures were transfected with NT siRNA or siRNA 
targeting NOX4/p22PHOX and two days later, cells were maintained untreated or 
treated with 8-br-cAMP and MPA for 72 hours. Subsequently, cells were fixed, 
permeabilized, blocked and stained with DAPI and anti-p-H2A.X antibody. 
Subsequently, cells were imaged using confocal microscopy. 
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Fig 4.12 Silencing of the NOX4/p22PHOX complex activates the DNA damage and 
repair pathway in decidualizing HESCs. HESCs were transfected with NT siRNA 
or siRNA targeting NOX4 and p22PHOX, and two days post transfection, cultures were 
maintained untreated or treated with 8-br-cAMP and MPA for 3 and 8 days. Whole-
cell lysates were extracted and blotted for p-ATM, p-ATR, p-BRCA-1, p-CHK1, p-
CHK2 and p-H2A.X expression. β-Actin served as a loading control.   
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These observations are in agreement with the functional in silico analysis of the 
NOX4/p22PHOX-dependent genes. However, as I mentioned previously, the outcome 
of the activation of this pathway could be apoptosis or enhanced repair of DNA 
damage and consequently cell survival. To investigate what might be happening in 
decidualizing HESCs, I first measured cell viability upon NOX4/p22PHOX knockdown. 
To this end, primary cultures were transfected with NT siRNA or siRNA targeting 
NOX4/p22PHOX, and two days post transfection, cultures were treated with 8-br-cAMP 
and MPA for 3 and 8 days. Cell viability was measured using the MTS assay. As 
shown in Figure 4.13A, silencing of the NOX4/p22PHOX complex resulted in a non-
significant decrease in cellular viability. To validate this observation, I used an 
alternative method, which assesses cell viability and cytotoxicity by measuring two 
protease activities, one is a marker of cell viability and is retained within the viable 
cell. It is measured using a fluorogenic, cell-permeant, peptide substrate 
(glycylphenylalanyl-aminofluorocoumarin). The other protease is a marker of 
cytotoxicity or dead cells, and is released from the cell that has lost membrane 
integrity. This protease is measured using a second, fluorogenic cell-impermeant 
peptide substrate. Primary cultures were therefore transfected with NT siRNA or 
siRNA targeting NOX4 and p22PHOX, and two days post transfection, cells were left 
untreated or treated with 8-br-cAMP and MPA for 72 hours. Subsequently, cell 
viability and cytotoxicity were measured. H2O2 was used as a positive control. As 
illustrated in Figure 4.13B, there was no significant change in cell viability or increase 
in cell cytotoxicity in undifferentiated and decidualizing HESCs with disabled 
NOX4/p22PHOX complex compared to HESCs with intact complex, confirming the 
previous observation that silencing of the NOX4/p22PHOX complex does not lead to 
cell death in decidualizing HESCs.  
 
These observations suggested that disabling of the NOX4/p22PHOX complex might 
lead to illicit activation of the DNA repair pathway. In other words, it appeared 
possible that lack of coordinated endogenous ROS signalling perturbs cellular 
homeostasis in such a way that the DNA repair pathway is activated in the absence 
of activated DNA damage. To test this hypothesis, I carried out the Comet assay on 
HESCs transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX and 
treated with 8-br-cAMP and MPA for 3 days. Interestingly, as shown in Figure 4.14, 
there was no visible DNA damage in HESCs with disabled NOX4/p22PHOX complex, 
further indicating that activation of the DNA repair pathway is a result of imbalance in 
the cellular and redox homeostasis of decidualizing HESCs rather than actual DNA 
damage.   
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Fig 4.13 Silencing of the NOX4/p22PHOX complex does not induce cell death in 
decidualizing HESCs. A, HESCs were transfected with NT siRNA or siRNA 
targeting NOX4 and p22PHOX and two days post transfection, cells were left untreated 
or treated with 8-br-cAMP and MPA for 1, 3 and 8 days. Cell viability was measured 
using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega) and 
according to manufacturer protocol. Data are depicted as means (±  SD) of 
sextuplicate measurements (N = 3). B, HESCs were transfected with NT siRNA or 
siRNA targeting NOX4/p22PHOX and two days post transfection, the cells were 
maintained untreated or treated with 8-br-cAMP and MPA for 72 hours. Cell viability 
and cytotoxicity was then measured using the Apo Tox-GloTM Triplex Assay 
(Promega) according to manufacturer protocol (N = 3). 
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Fig 4.14 Knockdown of the NOX4/p22PHOX complex does not induce DNA 
damage in HESCs. HESCs were transfected with NT siRNA or siRNA targeting 
NOX4 and p22PHOX, and two days post transfection, cultures were maintained 
untreated or treated with 8-br-cAMP and MPA for 3 days. Subsequently, the comet 
assay was carried out. Epirubicin was used to induce DNA damage in HESCs. (Note: 
the comet assay was carried out in collaboration with Dr. Keiji Kudro, Lara Monteiro 
and Prof. Eric Lam).   
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4.5 Lack of endogenous ROS signalling disrupts redox homeostasis in 
decidualizing HESCs 
 
Although our data confirms the absence of DNA damage upon knockdown of the 
NOX4/p22PHOX complex in primary HESCs, I decided to first look at the oxidative 
status of the decidualizing HESCs upon abolishing endogenous ROS production. 
Thus, HESCs were transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX 
and treated with 8-br-cAMP for 1, 3 and 8 days. Prior to terminating the treatments, 
cells were loaded with DCFH-DA for 25 minutes. Subsequently, ROS measurement 
was taken every 2 minutes over a 30-minute period. As shown in Figure 4.15, 
decidualizing HESCs with functional NOX4/p22PHOX complex, as I have previously 
published, show an initial burst in ROS at the 1-day time point, which then recedes 
during the decidual process. Upon disabling the NOX4/p22PHOX complex, however, 
the initial burst in ROS is eliminated but there is a gradual increase of ROS as the 
cells decidualize (Fig 4.15).  
 
I postulated that the paradoxical but gradual increase of endogenous ROS upon 
disabling the NOX4/p22PHOX complex post the 1 day time-point, might be responsible 
for disrupting the redox homeostasis of decidualizing HESCs and consequently 
inducing cellular stress signals, which might lead to activation of the DNA damage 
pathway. To test this hypothesis, I decided to look at some markers of stress and 
hallmarks of decidualization such as the status of global sumoylation, PR level, 
MKP1 and p-JNK in HESCs with disabled NOX4/p22PHOX complex. To this end, 
primary cultures were transfected with NT siRNA or siRNA targeting NOX4 and 
p22PHOX and two days post transfection treated with 8-br-cAMP and MPA for 72 
hours. Western blot analysis was carried out on whole cell lysates and blotted for 
global SUMO, PR, MKP1, p-JNK and t-JNK. As illustrated in Figure 4.16, silencing of 
the NOX4/p22PHOX complex in decidualizing HESCs induced a hypersumoylation 
response, which is the reverse of the well-established hyposumoylation normally 
observed upon decidualization (70). The effect of this hypersumoylation response 
was reflected in the striking stability of PR, which is known to be downregulated upon 
decidualization. Activation of p-JNK, which is normally switched off in decidualizing 
HESCs, was another consequence of the silencing of the complex. MKP1, another 
stress-related marker, was induced and serves as another indicator that all the 
changes observed upon knockdown of NOX4 and p22PHOX are due to HESCs 
subjected to redox imbalance and stress conditions. 
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Fig 4.15 Knockdown of the NOX4/p22PHOX complex alters the redox status of 
decidualizing HESCs. HESCs were transfected with NT siRNA or siRNA targeting 
NOX4 and p22PHOX. Two days post transfection, Cultures were maintained untreated 
or treated with 8-br-cAMP and MPA for 1, 3, and 8 days. Cultures were loaded with 
DCFH-DA 25 minutes before terminating the treatments. DCF fluorescence 
measurements were taken every 2 minutes over a 30-minute period using a 
fluorometer. The baseline represents untreated cells. Data are depicted as the 
difference in ROS production between treated and untreated cultures and represent 
means (± SEM) of sextuplicate determinations. N = 3, * = P < 0.05, *** = P < 0.001. 
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Fig 4.16 Knockdown of the NOX4/p22PHOX complex induces stress signals in 
decidualizing HESCs. HESCs were transfected with NT siRNA or siRNA targeting 
NOX4 and p22PHOX, and two days post transfection cultures were maintained 
untreated or treated with 8-br-cAMP and MPA for 72 hours. Whole-cell lysates were 
extracted and blotted for SUMO, PR, MKP1, p-JNK and JNK expression. β-actin 
served as a loading control. 
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Oxidative stress and alteration in the oxidative status of the cells may point towards 
an imbalance between the amount of endogenous ROS, and the antioxidant 
enzymes that are part of the cellular defence mechanism. It is well established that 
decidualization is associated with increased expression of antioxidant enzymes such 
as SOD2, TXN and GPx. To test if the induction of those antioxidant enzymes is 
perturbed in decidualizing HESCs with a disabled ROS-producing complex, primary 
cultures were transfected with NT siRNA or siRNA targeting NOX4 and p22PHOX. Two 
days post transfection, cells were treated with 8-br-cAMP and MPA for 72 hours. 
Total RNA was harvested and RTQ-PCR analysis was carried out to look at the 
transcript levels of SOD2, TXN and GPx. As shown in Figure 4.17, all the antioxidant 
enzymes showed a significant increase upon decidualization. Interestingly, silencing 
of the NOX4/p22PHOX complex in decidualizing cells significantly attenuated the 
induction of SOD2, TXN and GPx. This observation suggests that silencing of the 
NOX4/p22PHOX complex upon decidualization perturbs the oxidative status of HESCs 
disrupting the homeostasis between endogenous ROS and the antioxidant defence 
enzymes. 
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Fig 4.17 Antioxidant enzymes are attenuated upon knockdown of the 
NOX4/p22PHOX complex in decidualizing HESCs. HESCs were transfected with NT 
siRNA or siRNA targeting NOX4 and p22PHOX and two days post transfection cultures 
were maintained untreated or treated with 8-br-cAMP and MPA for 72 hours. RTQ-
PCR analysis was carried out for SOD2 (left), TXN (middle) and GPx3 (right) mRNA 
levels normalized to L19 mRNA. Data are depicted as fold induction relative to 
transcript levels of untreated samples and represent means (± SD) of triplicate 
determinations. * = P < 0.05, *** = P < 0.001. 
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Summary of results 
 
I have previously shown in chapter 3 that the NADPH oxidase complex is the main 
source of ROS in HESCs and that the NOX4/p22PHOX complex, specifically, is 
required for initiation of the decidual response. 
 
In this chapter, I provide further evidence that implicate the NOX4/p22PHOX complex in 
maintenance of the decidual process. Several lines of evidence led to this 
conclusion. First, both transmembrane components of the NOX4/p22PHOX complex 
are upregulated at the transcript and protein level upon decidualizing HESCs for 8 
days. Second, siRNA-mediated knockdown of NOX4 and p22PHOX resulted in a 
marked attenuation of the decidual markers PRL and IGFBP1 at the transcript level. 
Third, inhibiting the activity of the NADPH oxidase complex by administering DPI, the 
NADPH oxidase inhibitor in the midst of decidualization, also resulted in a marked 
attenuation of PRL and IGFBP1 transcript levels. Interestingly, the attenuation in the 
induction of PRL and IGFBP1 transcripts as a result of siRNA-mediated knockdown 
of the complex was comparable to that achieved by inhibiting the complex using DPI 
(~ 60%). Therefore, this data strongly implicate NOX4/p22PHOX-dependent ROS 
signalling in prolonged decidualization and maintenance of this differentiation 
process. 
 
Microarray analysis comparing decidualizing HESCs with and without siRNA-
mediated knockdown of the NOX4/p22PHOX revealed that ~ 29% of the NOX4/p22PHOX 
dependent genes are decidual dependent. Interestingly, the pattern of regulation in 
response to the NOX4/p22PHOX-dependent ROS, of  ~ 90% of those genes is in the 
same direction as that observed in response to decidual stimuli. It is not surprising 
therefore that disabling the NOX4/p22PHOX complex perturbs the decidual process.  
 
One of the most striking findings of this chapter is the overlap between the 
NOX4/p22PHOX-dependent and the FOXO1-dependent genes. This observation led to 
the finding that FOXO1 is upstream of the NOX4/p22PHOX complex. Several lines of 
evidence confirmed this observation. First, the in silico analysis of the NOX4/p22PHOX-
dependent genes revealed similar network, molecular and cellular functions to that 
attained by in silico analysis of the FOXO1-dependent gene list. Second, 62% of the 
NOX4/p22PHOX- and decidual-dependent genes are also FOXO1-dependent and 
share the same pattern of regulation. Third, siRNA-mediated knockdown of the 
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NOX4/p22PHOX complex does not alter FOXO1 expression at the protein level, 
whereas knockdown of FOXO1 attenuates the induction of NOX4 and p22PHOX 
observed upon decidualizing HESCs. Fourth, based on reporter studies, 
NOX4/p22PHOX-dependent ROS production upon stimulation with apocynin, alone or 
in combination with 8-br-cAMP, only marginally enhance the DNA binding activity of 
FOXO1. One should interpret this finding with caution. Although the marginal 
increase is statistically significant, it is very low and therefore negligible when put in 
context of reporter studies and artificial systems. Therefore, although one might be 
inclined to interpret the result as NADPH oxidase-produced ROS might feedback on 
FOXO1, further experimental work is required to investigate this angle. 
 
Several lines of evidence strongly suggested that disrupting the NOX4/p22PHOX-
dependent ROS signalling perturbs the redox homeostasis of decidualizing HESCs. 
First, siRNA-mediated knockdown of the NOX4/p22PHOX complex activates the DNA 
repair pathway in decidualizing HESCs without apparent DNA damage or apoptosis. 
This suggests that activation of the DNA repair pathway is not a response to DNA 
damage but a consequence of an imbalance of the redox homeostasis in 
decidualizing HESCs. 
 
Second line of evidence is paradoxical. Disabling the NOX4/p22PHOX complex led to a 
shift in the amount of endogenous ROS in decidualizing HESCs in favour of 
prooxidant. One might have expected a decrease in the amount of endogenous ROS 
production upon disabling the NOX4/p22PHOX complex. However, the increase in 
ROS production over time might be a result of attenuation of the induction of the anti-
oxidant enzymes upon knockdown of NOX4 and p22PHOX. Normally, antioxidant 
enzymes like SOD2, TXN and GPx are markedly upregulated in decidualizing 
HESCs with fully-active NADPH oxidase complex.  
 
Third, disrupting the NOX4/p22PHOX-dependent ROS signalling induces stress signals 
in decidualizing HESCs characterized by a hypersumoylation response, induction of 
MKP1 and activation of p-JNK. Interestingly, the hypersumoylation response goes 
hand in hand with the increase stability of PR. It is known that sumoylation of steroid 
hormone receptors decrease their turnover and increase their stability and is 
associated with attenuated activity and response to ligand (113, 118-120).  
 
Interestingly, the hypersumoylation response, the PR stability and the activation of p-
JNK are not only characteristics of stress signals but also characteristics of 
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undifferentiated HESCs. It is not surprising therefore, that disabling the 
NOX4/p22PHOX complex disrupts the decidual phenotype and perturbs genes involved 
in DNA repair and cell cycle regulation as the in silico analysis of the microarray 
revealed. 
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Introduction 
 
 
Endometriosis is a condition in which endometrium-like tissue is found primarily on 
the pelvic peritoneum and ovaries. It occurs in 6 – 10% of women of reproductive age 
and is believed to be mainly the result of retrograde menstruation and subsequent 
transplantation of eutopic endometrial tissue fragments and cells to the peritoneum. 
(237, 238). 50% of women with pelvic pain and/or infertility have endometriosis. 
Infertility in this context may be due to several factors, one of which is abnormal 
eutopic endometrium with compromised embryonic implantation (238, 258). 
 
Several studies utilizing microarray analysis and comparing endometrial tissue from 
women with and without endometriosis revealed abnormalities in the proliferative-to-
secretory phase transition normally observed in the menstrual cycle. Other studies 
revealed that the most profound perturbation is observed in the secretory phase of 
the cycle in patients with endometriosis but not confined to it. Aberrant gene 
expression has also been observed in the proliferative phase in diseased patients.  
 
Moreover, as mentioned previously in the introduction, eutopic endometrium from 
patients with endometriosis is associated with the “progesterone resistance” theory, 
which is attributed to the observation that a subset of progesterone-dependent genes 
are perturbed in eutopic endometrium from diseased patients (257). It is noteworthy 
to mention that “progesterone resistance’ not only refers to perturbation in 
progesterone-dependent gene expression but encompasses signal transduction and 
the expression of downstream target genes. Importantly, increasing amount of 
evidence suggests that progesterone-resistance in vivo is recapitulated in vitro in 
primary HESCs obtained from the eutopic endometrium of patients with 
endometriosis. For instance, Aghajanova et al. (2010) revealed that primary cultures 
of eutopic endometrium from diseased patients compared to control groups almost 
fail to induce progesterone-dependent genes upon being stimulated with the steroid 
hormone (273).   
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Although the “progesterone resistance” theory may hold true, progesterone signalling 
is not the only perturbation observed in the endometrium of patients with 
endometriosis. In fact, as mentioned previously in chapter 1, emerging evidence 
suggests that basal gene expression in undifferentiated HESCs from diseased 
patients, responsiveness to hCG and cAMP signalling are also perturbed in 
endometriosis.  
 
Endometriosis is also associated with chronic inflammation. Reactive oxygen species 
(ROS) are key players in inflammation and are known to be proinflammatory 
mediators that modulate cell proliferation. A recent study demonstrated that cellular 
redox status is impaired in endometriotic cells characterized by higher endogenous 
oxidative stress with an increase in ROS production, alterations in ROS detoxification 
pathways, a drop in catalase levels in addition to increased cellular proliferation and 
activation of ERK1/2 (172). 
 
As outlined in the previous chapters, the NOX4/p22PHOX complex not only critically 
regulates redox signalling in HESCs but also determines cellular responses to 
differentiation signals. Hence, I postulated that impaired cycle-dependent expression 
of NOX4 or p22PHOX in eutopic endometrium of patients with endometriosis might 
contribute to the pathogenesis of the disease. 
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5.1 Endometrial p22PHOX and NOX4 expression in patients with or 
without endometriosis 
 
Endometriosis is associated with chronic inflammation. ROS are key players in 
inflammation and are known to be proinflammatory mediators that modulate cell 
proliferation. I therefore postulated that the NOX4/p22PHOX complex might be 
deregulated in the eutopic endometrium from patients with endometriosis. 
 
I focused on examining the expression of p22PHOX and NOX4, in the secretory phase 
of the menstrual cycle. Several considerations underpin this decision. First, 
decidualization occurs in the secretory phase of the cycle. Second, I showed in 
Figures 4.1 and 4.2, that NOX4 and p22PHOX expression at the protein and transcript 
level is upregulated in decidualizing HESCs. Third, disabling the activity of the 
complex by siRNA-mediated knockdown of NOX4 and p22PHOX or by administering 
chemical inhibitors to decidualizing HESCs perturbs the decidual process and 
attenuates the induction of PRL and IGFBP1 transcripts. Fourth, HESCs from eutopic 
endometrium of patients with endometriosis fail to fully decidualize and show blunted 
response to decidual stimuli (236).   
 
The biological samples used for this study came from two different sources. The 23 
cDNA samples I used to look at the transcript levels of NOX4, p22PHOX and FOXO1; 
and the tissue sections used for immunohistochemistry were a kind gift from Dr. Matti 
Poutanen (University of Turku, Finland). This group of sample consisted of 11 control 
samples and 12 samples of eutopic endometrium obtained from patients with 
endometriosis. The endometriosis patients and the control groups were aged 
between 22 and 46 years of age. Endometrial histology confirmed that each biopsy 
taken was normal secretory.  
 
The 39 tissue biopsies that were used to extract proteins were received locally. This 
group of sample consisted of proliferative and secretory eutopic endometrial tissue. 
The proliferative group of samples consisted of 7 tissue biopsies of eutopic 
endometrium from patients with the disease and an equal number of biopsies from 
control patients. The secretory group consisted of 13 samples from patients with 
endometriosis and 12 samples from control patients.  All samples were taken at the 
time of laparoscopy for either pelvic pain or infertility exploration. The endometriosis 
patients and the control groups were aged between 20 and 44 years of age. 
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To characterize the NOX4/p22PHOX complex in patients with endometriosis, I first 
compared the transcript levels of NOX4 and p22PHOX in samples from diseased 
patients with those from a control cohort. As shown in Figure 5.1, both p22PHOX and 
NOX4 transcript levels appeared to be lower in diseased patients compared to the 
control group. However, p22PHOX alone proved to be significantly lower. 
 
Next, I carried out Western blot analysis for NOX4 and p22PHOX on protein samples 
prepared from eutopic secretory endometrial tissue biopsies obtained from patients 
with proven endometriosis and patients without evidence of pelvic endometriosis. As 
shown in Figure 5.2A, there is a striking downregulation of p22PHOX protein levels in 
patients with endometriosis compared to the control group. NOX4 protein expression, 
on the other hand, does not seem to be deregulated in diseased patients. 
Furthermore, densitometry analysis carried out on the Western blot results for both 
p22PHOX and NOX4, confirmed that p22PHOX was significantly lower in eutopic 
endometrial tissue biopsies from patients with endometriosis compared to the control 
group, whereas NOX4 showed consistent protein levels in control and diseased 
patients (Fig 5.2B).   
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Fig 5.1 NOX4 and p22PHOX transcript levels in patients with endometriosis. RTQ-
PCR analysis was carried out to compare the transcript level of NOX4 and p22PHOX in 
secretory phase eutopic endometrium from patients without laparoscopic evidence of 
pelvic endometriosis (SE NE) to secretory eutopic endometrial samples from patients 
with proven endometriosis (SE E+). **, P < 0.01. 
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Fig 5.2 NOX4 and p22PHOX protein expression levels in endometriosis. A, 
Western blot analysis for NOX4 and p22PHOX protein expression in SE NE and SE E+ 
samples. B, Densitometry analysis comparing and quantifying the protein expression 
level of NOX4 and p22PHOX in SE NE and SE E+ samples. ***, P < 0.001. 
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5.2 Regulation of the NOX4/p22PHOX complex in the secretory phase of 
the menstrual cycle 
 
The observation that p22PHOX is downregulated in the secretory phase of the 
menstrual cycle in samples from patients with endometriosis was very striking. The 
onset of the secretory phase is on day 14 of the menstrual cycle, and is not a 
homogenous phase. As mentioned previously in the introduction, the secretory phase 
can be segregated into three functionally distinct stages: ESE, MSE and LSE.  
 
Therefore, I decided to examine if p22PHOX cellular distribution is regulated throughout 
the different phases of the menstrual cycle. In other words, I wondered if p22PHOX 
was subjected to temporal and spatial regulation through the ESE, MSE and LSE 
phases of the menstrual cycle. To do so, I carried out immunohistochemistry staining 
for p22PHOX on eutopic endometrial tissue sections from patients with and without 
endometriosis taken in ESE, MSE and LSE phases of the menstrual cycle. 
Interestingly, as illustrated in Figure 5.3, in patients without the disease, p22PHOX 
levels in the ESE phase are low and restricted to the stroma, as it is completely 
absent from the glands. In the MSE phase of the cycle, p22PHOX staining increases in 
the stromal compartment and starts to appear in the uterine glands as well. By the 
LSE phase of the menstrual cycle, p22PHOX staining levels are markedly increased in 
the stroma, glands and the epithelial compartments.  
 
Surprisingly, the mirror effect was observed in patients with endometriosis. p22PHOX 
staining is at its highest levels in the ESE phase of the menstrual cycle and is found 
in the stromal compartments, uterine glands as well as the epithelial cells. By the 
MSE phase of the cycle, however, p22PHOX staining levels are markedly decreased 
and where it is expressed, it appears to coagulate. A similar pattern of p22PHOX 
staining in the MSE phase was observed in LSE phase tissue sections of diseased 
patients (Fig 5.3).  
 
Next, I carried out the same immunohistochemistry analysis for NOX4. Although 
NOX4 was highly present in eutopic endometrial tissue sections from patients with 
and without endometriosis, it does not appear to be regulated throughout the different 
stages of the secretory phase (Fig 5.4). Moreover, there does not seem to be any 
differences in NOX4 staining between tissue sections from control and diseased 
patients throughout the secretory phase of the menstrual cycle.  
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The observation that p22PHOX, but not NOX4, is misregulated in patients with 
endometriosis compared to the control group further validates our findings that 
p22PHOX alone is downregulated at the transcript and protein level in the secretory 
phase of the menstrual cycle in diseased patients.     
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Fig 5.3 Immunohistochemistry analysis for p22PHOX in patients with and without 
endometriosis. Immunohistochemistry staining for p22PHOX carried out on SE NE 
and SE E+ eutopic endometrial tissue sections taken at the three different stages of 
the menstrual cycle: ESE, MSE and LSE. (Immunohistochemistry was carried out in 
collaboration with Dr. Jenny Steel). 
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Fig 5.4 Immunohistochemistry analysis for NOX4 in patients with and without 
endometriosis. Immunohistochemistry staining for NOX4 carried out on SE NE and 
SE E+ eutopic endometrial tissue sections taken at the three different stages of the 
menstrual cycle: ESE, MSE and LSE. (Immunohistochemistry was carried out in 
collaboration with Dr. Jenny Steel). 
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5.3 Characterization of the NOX4/p22PHOX complex in the proliferative 
phase of the menstrual cycle 
 
So far, I have strong data suggesting that p22PHOX alone is downregulated in the 
secretory phase of diseased patients compared to individuals without the disease. 
NOX4 expression, on the other hand, was consistent at the protein and transcript 
levels. This hypothesis led me to postulate that p22PHOX protein levels might be 
generally downregulated throughout the menstrual cycle in patients with 
endometriosis.  
 
To test this hypothesis, I carried out Western blot analysis to look at the expression 
levels of both NOX4 and p22PHOX in samples taken from patients with and without 
endometriosis. Interestingly, as illustrated in figure 5.5, p22PHOX protein levels proved 
to be lower in diseased patients compared to the control group, suggesting that 
p22PHOX protein expression is generally lower in patients with endometriosis. On the 
contrary, NOX4 protein levels remained unchanged between the two groups, further 
confirming my previous observation that p22PHOX alone is downregulated in eutopic 
endometrium of patients with the disease. 
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Fig 5.5 NOX4 and p22PHOX protein expression in the proliferative phase of the 
menstrual cycle. A, Western blot analysis for NOX4 and p22PHOX on proliferative 
eutopic endometrium form patients without endometriosis (PE NE) and with the 
disease (PE E+). B, Densitometry analysis comparing and quantifying the protein 
expression level of NOX4 and p22PHOX between diseased patients and the control 
group. *, P < 0.05. 
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5.4 NOX4/p22PHOX expression profiling in eutopic HESCs from patients 
with and without endometriosis 
 
I have shown that p22PHOX is downregulated in tissue samples obtained from patients 
with endometriosis. I hypothesized that this observation might be recapitulated in 
vitro in cultured HESCs taken from diseased patients. 
 
To test this conjecture, HESCs from diseased and control patients were put in culture 
until they reach confluency. Subsequently, the medium was changed from 10% DCC 
to 2% DCC and cells were left in culture for 24 hours. Subsequently, total mRNA was 
harvested and RTQ-PCR analysis was carried out for p22PHOX and NOX4. As shown 
in Figure 5.6, p22PHOX transcript levels continued to be significantly lower in patients 
with endometriosis compared to control group. On the other hand, there was no 
significant difference in the mRNA expression of NOX4 between the two groups.  
 
I have shown in the previous two chapters that cAMP induces a burst in ROS 
between 12 and 24 hours of treatment, which coincides with the induction of the 
decidual markers PRL and IGFBP1 as well as with the activation of the transcription 
factor C/EBPβ. I further went to show that this burst in ROS is not only cAMP-
dependent, but also NOX4/p22PHOX dependent.  
 
NOX4 and p22PHOX are known to form a heterodimer that is essential for the stability 
and the activity of the complex. Therefore, my finding that p22PHOX is in fact lower in 
tissue samples and primary cultures derived from patients with endometriosis 
compared to control samples, led me to postulate that the kinetics of ROS upon 
treatment with cAMP might also be aberrantly regulated in HESCs obtained from 
diseased patients. 
 
To test this hypothesis, primary cultures from patients with endometriosis were 
treated with 8-br-cAMP for 6, 12 and 24 hours. Prior to ending the treatments, the 
oxidant sensing DCFH-DA was loaded in the cells for 25 minutes and subsequently 
ROS measurements were taken every 2 minutes over a 30-minute period. 
Interestingly, as shown in Figure 5.7, although at the 6-hour treatment there 
appeared to be higher amount of ROS in 8-br-cAMP treated cells, 
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the cAMP-dependent burst in ROS normally observed between the 12 to 24 hour 
time-point was abolished. This observation mimicked what I observed earlier when 
cellular oxidation in primary cultures with an siRNA-mediated knockdown of NOX4 
and p22PHOX was measured, indicating that the NOX4/p22PHOX is misregulated in 
primary cultures from patients with endometriosis not only at the expression level, but 
also at the functional level.  
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Fig 5.6 Basal transcript expression of NOX4/p22PHOX complex in primary 
HESCs. HESCs from patients with and without endometriosis were cultured in vitro 
(N = 5). Total RNA was harvested and RTQ-PCR analysis was carried for p22PHOX 
and NOX4 and the transcript levels were normalized to L19 mRNA. Data are 
depicted as normalized transcript levels and represent means (± SD) of triplicate 
determinations. *, P < 0.05. 
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Fig 5.7 The oxidative status of eutopic HESCs with or without endometriosis. 
Four biologically different primary cultures from patients with and without 
endometriosis were left untreated or treated with 8-br-cAMP for 6, 12 and 24 hours. 
Cultures were loaded with DCFH-DA for􏰐25 minutes prior to terminating the 
treatments. DCF fluorescence was measured every 2 minutes over a 30-minute 
period using a fluorometer. Data are depicted as the difference in ROS production 
between 8-br-cAMP treated and untreated cultures and represent means (± SEM) of 
sextuplicate determinations. ***, P < 0.001. 
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5.5 FOXO1 expression in patients with endometriosis 
 
The consistent downregulation of p22PHOX observed in patients with endometriosis 
was very striking. I have provided strong evidence, in chapter 4 of this thesis, that 
FOXO1 is upstream the NOX4/p22PHOX complex. I therefore postulated that the 
downregulation observed in p22PHOX might be a consequence of downregulation in 
FOXO1 in patients with endometriosis. 
 
To test this conjecture, I first compared the transcript levels of FOXO1 in samples 
from diseased patients with those from a control cohort. As shown in Figure 5.8, 
there was no difference of FOXO1 mRNA expression between patients with and 
without endometriosis.  
 
Next, I carried out immunohistochemistry staining for FOXO1 on eutopic endometrial 
tissue sections, from the ESE, MSE and LSE phases of the menstrual cycle from 
patients with and without endometriosis. Interestingly, as illustrated in Figure 5.9, the 
expression pattern of FOXO1 appears to be similar in tissue sections from patients 
with and without the disease. In both patient groups, the lowest reactivity with 
FOXO1 is observed in the ESE phase of the cycle. By the MSE phase, FOXO1 
reactivity increases and FOXO1 staining is also visible in the glands. During the LSE 
phase of the cycle, a marked increase in FOXO1 reactivity is observed in the stromal 
and glandular compartments in both groups of patients.  
 
Taken together, I concluded that downregulation of FOXO1 is not the mechanism 
that underpins the aberrant regulation of p22PHOX in the endometrium of patients with 
endometriosis. 
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Fig 5.8 FOXO1 mRNA expression in patients with endometriosis. RTQ PCR 
analysis was carried out to compare the transcript level of FOXO1 in secretory phase 
eutopic endometrium from SE NE and SE E+ tissue samples. 
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Fig 5.9 Immunohistochemistry analysis for FOXO1 in patients with and without 
endometriosis. Immunohistochemistry staining for NOX4 carried out on SE NE and 
SE E+ eutopic endometrial tissue sections taken at the three different stages of the 
menstrual cycle: ESE, MSE and LSE. (Immunohistochemistry was carried out in 
collaboration with Dr. Jenny Steel). 
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Summary of Results 
 
Endometriosis is a chronic inflammatory disorder associated with resistance to 
progesterone signalling in the endometrium and an impaired decidual response, 
which normally leads to implantation failure and consequently infertility. More recent 
data, however, suggests that the “progesterone resistance” dogma is not entirely the 
prime reason for the impaired decidual response in patients with endometriosis. In 
fact, the general basal transcriptome in eutopic endometrium of patients with the 
disease might be misregulated. One underlying reason for this misregulation is 
aberrant epigenetic re-programming of the steroid hormone responses in the 
endometrium (248).  
 
In this chapter I provide preliminary data, which shed light on a potentially different 
angle that may contribute to the endometriotic phenotype. I provide strong evidence 
that the NOX4/p22PHOX complex is deregulated at the expression and functional level 
in patients with endometriosis. My striking observation that p22PHOX, the NOX4 
cofactor, is downregulated in endometriosis is the result of four different lines of data. 
First, I show that p22PHOX is downregulated at the transcript level in secretory 
endometrial biopsies derived from patients with endometriosis. Second, I provide 
evidence that p22PHOX is significantly downregulated at the protein level in 
endometrial tissue from diseased patients. Third, the immunohistochemistry results 
not only show that p22PHOX is regulated throughout the menstrual cycle, but also that 
there is low immunoreactivity in tissue section from eutopic endometrium obtained 
from patients with endometriosis in the MSE and LSE phase of the menstrual cycle. 
Next, I show that p22PHOX is downregulated at the protein level in the proliferative 
phase of tissue samples with endometriosis compared to control samples, 
suggesting that the low expression of p22PHOX is a general characteristic of 
endometriosis. 
 
Strangely, NOX4 does not appear to be misregulated in patients with endometriosis. 
My data so far cannot provide an explanation for such observation. There might be 
an underlying mechanism that stabilizes the expression of NOX4 regardless of the 
low expression of p22PHOX at both the protein and the mRNA level. Regardless 
though of NOX4 normal expression levels, I show that the cAMP-induced 
NOX4/p22PHOX-dependent burst in ROS seen in control tissue between 12 and 24  
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hours of treatment with cAMP, is depleted in primary cultures derived from patients 
with endometriosis, indicating that the NOX4/p22PHOX complex is functionally 
perturbed in patients with the disease. 
 
I further show that the downregulation observed in tissue biopsies from patients with 
endometriosis can be recapitulated in vitro. Culturing primary HESCs obtained from 
diseased patients and subsequently looking at the transcript levels of both NOX4 and 
p22PHOX yielded the same results as that observed when the same analysis was 
carried out on tissue biopsies. p22PHOX continued to be downregulated in 
endometriosis samples compared to control.  
 
Further, I provide data indicating that downregulation of p22PHOX is FOXO1-
independent. FOXO1 transcripts have been reported to be lower in patients with 
endometriosis (257, 274, 275). Despite these reports, I provide evidence suggesting 
that FOXO1 expression at the protein level is not aberrant in diseased patients. 
 
Taken together, in this chapter I provided preliminary evidence that the 
NOX4/p22PHOX complex and consequently the cellular redox status are perturbed in 
eutopic endometrium of patients with endometriosis. However, to come up with 
conclusive interpretation on these data, and to understand the underlying 
mechanisms that stabilises NOX4, a bigger sample comprised of timed biopsies 
would be critical. Moreover, it might be essential to also investigate if the observation 
that p22PHOX downregulation is confined to the clinical condition endometriosis and 
does not hold true for other clinical conditions like recurrent miscarriages. This would 
confirm that downregulation of p22PHOX is specific to endometriosis and can 
potentially be a marker distinguishing eutopic endometrium from patients with 
endometriosis. 
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Discussion  
 
Decidualization of the endometrial stromal compartment is an essential differentiation 
process in all species in which implantation involves breaching of the luminal 
endometrial epithelium by the embryo (1, 276). Decidualized HESCs acquire 
specialized characteristics that enable them to act as biosensors of embryo quality 
and capable of rejecting developmentally compromised blastocysts (40, 41, 277). 
The process of endometrial decidualization is also critical for trophoblast invasion, 
placental formation and for protecting the early conceptus from environmental stress 
cues (35, 278). Importantly, decidual cells regulate the recruitment of uNK cells to the 
feto-maternal interface, suggesting that they play an integral part in conferring 
immunotolerance to the fetal semiallograft (8). Failure to mount an adequate decidual 
response, therefore, results either in implantation failure or contributes to a spectrum 
of pregnancy complications, such as early pregnancy loss, preeclampsia, preterm 
labour and fetal growth restriction (1).  
 
Decidualization is a progressive process that is under extensive temporal and spatial 
regulation. Its onset is first apparent in stromal cells adjacent to the spiral arteries of 
the superficial endometrial layer and, in case of pregnancy, it progressively 
encompasses the whole endometrium (5, 9). Initiation of the decidual process in vivo 
coincides with elevated endometrial cAMP levels, which is thought to be a 
consequence of increased expression of local factors that activate adenylate cyclase 
in stromal cells, such as RLX, CRH, pituitary gonadotrophins and PGE2. In addition, 
decidualization coincides with a downregulation of phosphodiesterase-4 expression, 
an enzyme that converts cAMP to AMP (10, 79-84, 279, 280). cAMP stimulation 
sensitizes HESCs to progesterone signalling. Once initiated, decidualizing HESCs 
become dependent on continuous progesterone stimulation for survival (5).  
 
In this thesis, I provide several lines of evidence implicating NADPH oxidase-
dependent ROS production in the decidual process.  My observations suggest that 
this differentiation process is highly dependent on cross-talk involving cAMP, 
progesterone and endogenous ROS production and signalling. Further, I present 
evidence that NADPH-oxidase complex governs several cellular functions in 
decidualizing HESCs, including redox homeostasis. Importantly, I provide preliminary 
data indicating that deregulation of the NOX4/p22PHOX complex and attenuated 
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endogenous ROS production in HESCs is associated with endometriosis, a chronic 
inflammatory gynecological disorder.  
 
6.1 Endogenous ROS production is critical for initiating the decidual response 
 
As mentioned briefly in the Introduction, PRL in the endometrium and lymphocytes is 
transcribed from an alternative promoter upstream of a non-coding exon, located 
approximately 6 kb upstream of the pituitary-specific transcriptional start-site (281). 
Its expression is under control of a transposable element, termed MER20, which 
emerged in evolution upon divergence of eutherian (placental) from non-placental 
mammals (282, 283). MER20 is located at -395/-148 relative to the decidual PRL 
transcription start-site and contains response elements for many transcription factors 
indispensable for decidualization and pregnancy, including FOXO1, the homeobox 
protein HOXA11, ETS1, C/EBPβ, and PR (284). In fact, MER20 enhancer regions 
are found in the vicinity of many decidua-specific genes. Although it is not yet fully 
elucidated, PRL expression is thought to involve sequential and highly coordinated 
actions of specific transcription factors. 
  
A sustained rise in intracellular cAMP levels is the primary signal for PRL expression 
in HESCs, although the transcriptional response is biphasic.  The initial weak 
response to cAMP stimulation is attributed to the binding of CREB to a non-
palindromic CRE at position -12 of the decidual PRL promoter (74), thus located 
outside the MER20 enhancer region. However, binding of C/EBPβ to a core 
sequence within MER20 triggers a more pronounced response, apparent after 12 
hours of cAMP stimulation. C/EBPβ in turn has been shown to bind FOXO1 (121) 
and recruitment of FOXO1 to MER20, which converts HOXA11 from a repressor to a 
strong activator of the promoter (284).  
 
Here, I present several lines of evidence that implicate redox signalling in the 
initiation of the decidual process. First, I demonstrated that apocynin, a formidable 
inducer of endogenous ROS production in HESCs, strongly enhances cAMP-
dependent decidual PRL and IGFBP1 expression in primary cultures whereas DPI, 
AEBSF, and catalase had the opposite effect. Notably, the effect of apocynin on PRL 
and IGFBP1 transcription was a delayed response, apparent only after 12 hours of 
cAMP stimulation. Treatment with apocynin alone did not induce the expression of 
these decidual markers nor did it sensitize the cells to MPA; thus reinforces the fact 
that heightened cAMP signalling is indispensable in the decidual process.  
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Second, HESC differentiation in response to cAMP signalling triggered rapid but 
complex changes in the redox status of the cell, as measured by DCF fluorescence. 
Such rapid and complex changes in cellular ROS levels are not unusual. For 
example, Sehiah et al. (2002) reported a biphasic change in ROS production in 
vascular smooth muscle cells within 30 minutes of stimulation H2O2 (285). However, 
the DCF results should be interpreted with some caution. For instance, DPI had no 
discernible effect on DCF oxidation in undifferentiated HESCs, indicating that basal 
ROS production is low. However, treatment with 8-br-cAMP triggered first a reduction 
in DCF fluorescence prior to a marked increase between 12 and 24 hours of 
treatment. It is possible that rapid cAMP effects on the cytoskeleton and secretome 
of HESCs interfere with the uptake or retention of the probe, thereby accounting for 
the initial rise and decline in DCF fluorescence. On the other hand, the subsequent 
increase in cellular oxidation fits well with the upregulation of p22PHOX observed upon 
treating HESCs with 8-br-cAMP for 16 hours and beyond. Furthermore, siRNA-
mediated knockdown of NOX4/p22PHOX complex had no effect on the initial transient 
fluctuations in DCF fluorescence but abolished the rise in cellular oxidation by 24 
hours of differentiation. Interestingly, an increase in endogenous ROS concentrations 
has been associated with adipocytes differentiation (165).   
 
Next, I showed that knockdown of either p22PHOX or NOX4 is sufficient to impair PRL 
and IGFBP1 expression in differentiating HESCs. In contrast, RAC1 silencing had no 
discernible effect, rendering it unlikely that NOX1, NOX2 or NOX3 are major sources 
of cAMP-dependent ROS production in differentiating HESCs. However, one cannot 
exclude a role for these homologues in regulating other aspects of the decidual 
process, an angle that should be explored further.  
 
Finally, I demonstrated that C/EBPβ is a major downstream target of the activated 
NOX4/p22PHOX complex. C/EBPβ is not only essential for reproduction in all eutherian 
mammals tested to date (136, 286-288), but also is a key regulator of differentiation 
in numerous other cell types, perhaps most prominently so in adipocytes (289). 
Interestingly, a recent study demonstrated that low levels of ROS trigger 
phosphorylation and activation of C/EBPβ in 3T3-L1 pre-adipocytes, which in turn 
promotes mitotic clonal expansion and terminal adipocyte differentiation (289). As 
reported for an increasing number of cell types, NOX4 was subsequently identified as 
a major source of ROS production during adipocyte and vascular smooth muscle cell 
differentiation (197, 198). Combined with my findings, these observations suggest 
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that NOX4-dependent redox regulation of C/EBPβ activity may be a highly conserved 
mechanism that controls differentiation of very diverse cell types. 
 
It is noteworthy to point out that apocynin strongly activated a luciferase reporter 
driven by consensus C/EBP response elements in undifferentiated HESCs, yet it was 
insufficient to elicit endogenous PRL or IGFBP1 expression. Thus, cAMP signalling 
must exert additional effects that couple ROS-dependent C/EBPβ activation to the 
expression of decidual genes. 
 
6.2 Continuous NOX4/P22PHOX-dependent ROS signalling in decidualizing 
HESCs 
 
I showed that NOX4 and p22PHOX are both upregulated upon prolonged 
decidualization of HESCs, suggesting a role for the complex beyond initiation of this 
differentiation process. In agreement, inhibiting the NADPH-oxidase complex before 
or after the cells were decidualized with cAMP and MPA was equally deleterious in 
terms of expression of decidual marker genes. 
 
Knockdown experiments combined with genome-wide microarray analysis indicated 
that the NOX4/p22PHOX complex governs a myriad of genes in differentiating HESCs, 
a subset of which are known decidual genes (18). Gene ontology analysis indicated 
that redox signalling in decidualizing HESCs impacts predominantly on DNA 
replication, recombination and repair, and cell cycle regulation. This is not entirely 
surprising as, depending on concentration and duration, ROS can either promote cell 
cycle progression or induce arrest, which in turn may be transient, coupled to repair 
processes, or permanent (158, 177, 290). Therefore, an imbalance in endogenous 
ROS production as a result of disabling the NOX4/p22PHOX complex is bound to 
perturb the precise and timely regulation of the cell cycle. 
 
Several lines of evidence indicated that NOX4/p22PHOX complex in decidualizing 
HESCs is under the control of FOXO1. First, a comparison of available microarray 
data revealed that over 60% of the decidual- and NOX4/p22PHOX-dependent genes 
are also FOXO1-dependent. Importantly, the direction of perturbation of decidual-
dependent genes upon NOX4/p22PHOX knockdown followed that of FOXO1 silencing. 
Second, siRNA-mediated knockdown of FOXO1 inhibited upregulation of NOX4 and 
p22PHOX at the protein level in differentiating HESCs. In fact, mining of gene 
expression data identified NOX4 as a bona fide FOXO1 target gene. In contrast, 
Chapter 6: Discussion 
 179 
expression of CYBA, which encodes for p22PHOX, was not affected upon FOXO1 
knockdown in decidualizing HESCs (18). In agreement, while induction of p22PHOX is 
a relatively early event in the decidual process, the kinetics of NOX4 expression 
follow that of FOXO1, with upregulation of both proteins apparent only after two to 
three days of stimulation with cAMP and MPA. The fact that FOXO1 knockdown 
lowers p22PHOX levels in differentiating HESCs may reflect increased turnover of the 
cofactor in response to attenuated NOX4 expression (210, 211, 220).  
 
Together, these lines of data indicate that induction and activation of the 
NOX4/p22PHOX complex is an important mechanism through which FOXO1 regulates 
the expression of specific gene networks in decidual cells. However, there was no 
evidence of a direct feedback mechanism that couples NOX4/p22PHOX-dependent 
ROS signalling to FOXO1. For example, siRNA-mediated knockdown of the 
NOX4/p22PHOX complex did not affect FOXO1 levels in decidualizing HESCs. Further, 
activation of the NADPH oxidase complex with apocynin, alone or in combination 
with cAMP, had little effect on the ability of overexpressed FOXO1 to trans-activate a 
reporter construct. However, these results should be interpreted with caution. While 
endogenous ROS signalling may have little direct effect on the intrinsic transcriptional 
activity of FOXO1, indirectly it may have a profound impact, for example by 
enhancing the DNA-binding activity of C/EBPβ, a major transcriptional partner of 
FOXO1, or by altering the subcellular localization of FOXO1.  
 
The effect of disabling the NOX4/p22PHOX complex in prolonged decidualizing HESCs 
by siRNA-mediated knockdown was very striking. First, disabling this source of 
endogenous ROS triggered activation of the DNA repair pathway without apparent 
DNA damage or apoptosis. Second, knockdown of the NOX4/p22PHOX resulted in a 
paradoxical increase in cellular oxidation, which was accounted for by a decrease in 
the expression of various antioxidant enzymes. Third, the imbalance in endogenous 
ROS induced a cellular stress response in decidualizing HESCs, exemplified by a 
global hypersumoylation response and the paradoxical induction of MKP1 together 
with JNK activation.  
 
Decidualization is associated with global changes in cellular sumoylation 
characterized by a profound hyposumoylation response (70) and uncoupling of the 
SUMO pathway from environmental stress signals (65). This uncoupling was shown 
to be important for maintaining cellular responsiveness to progesterone under 
oxidative stress conditions and mediated by silencing of the JNK pathway through 
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induction of pathway-specific phosphatases, such as MKP1 (65). Therefore, the 
global hypersumoylation response, increased PR stability and enhanced JNK 
phosphorylation observed upon disabling the NOX4/p22PHOX complex are not only 
characteristics of a cellular stress response but also of a more undifferentiated 
cellular phenotype. This observation ties in nicely with the attenuation of PRL and 
IGFBP1 expression in decidualizing HESCs observed upon knockdown of the 
complex.  
 
Interestingly, JNK activation is a feature of oxidative stress response, induced by 
endogenous or exogenous free radicals (65, 164, 291). The activated JNK pathway 
in turn facilitates the translocation of FOXO1 to the nucleus (292, 293). This ROS-
JNK-FOXO axis has been widely implicated in insulin resistance and an increased 
lifespan in worm, fly and rodents (292, 293).    
 
FOXO1 is associated with longevity and tumour suppression (294). Induction and 
increased transcriptional activity of FOXO proteins is one of the main mechanisms 
the cell uses to counteract oxidative stress (295). Major targets of FOXO1 in various 
biological systems are SOD2, catalase and GADD45 (295). When mammalian cells 
are exposed to oxidative stress, FOXO proteins can either induce apoptosis or trigger 
an adaptive recovery response, characterized by induction of antioxidant enzymes 
and/or DNA repair response (296-299). It is therefore not surprising, that FOXO1 acts 
as a regulator of the cellular homeostasis in many biological systems, ranging from 
osteoblasts to HESCs (295, 299). FOXO1 is also indispensable for differentiation of a 
variety off cell types, including osteoblasts, hepatocytes and muscle cells (299-303). 
Knockdown of FOXO1 in decidualizing HESCs leads to increased proliferation and 
perturbs the expression of differentiation markers (18, 301). Importantly, several 
FOXO1 target genes are intermediates in upstream regulatory pathways, including 
insulin receptor (INSR), and bone morphogenic protein and activin-membrane-bound 
inhibitor (BAMBI), suggesting the presence of complex feedback mechanisms that 
enables FOXO1 to fine-tune the cell’s response to its microenvironment (18, 295).  
Interestingly, knockdown of NOX4/p22PHOX in differentiating HESCs deregulated a 
subset of previously identified FOXO1-dependent genes resulting in concomitant 
shutdown and activation of two major cellular defense mechanisms: free radical 
scavenging and the DNA repair pathway, respectively.  
 
In other words, my findings suggest that FOXO1 maintains the redox homeostasis of 
decidualizing HESCs via regulation of the NOX4/p22PHOX complex. As knockdown of 
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FOXO1 abolishes the burst in ROS production in decidualizing cells, it seems logical 
to postulate that endogenous free radical signalling is responsible for the induction of 
antioxidant enzymes, such as SOD2, TXN and GPx. This might explain why 
knockdown of the NOX4/p22PHOX complex triggers a paradoxical prooxidant response 
in decidualizing HESCs. These observations further suggest that heightened 
endogenous free radical production in differentiating HESCs might serve as a 
“hormetic” or a “preconditioning” adaptive mechanism that protects the cells from 
further insults by switching on the cellular defense mechanisms against oxidative 
stress. Hormesis is a phenomenon that occurs in various physiological processes like 
aging, whereby exposure to relatively low levels of stress cues protects the cells from 
further stronger insults (304, 305). In fact, Droge (2002) reported that elevated ROS 
concentrations induce the expression of genes that encode for proteins with 
antioxidant properties in a variety of cells and proposes that this is a mechanism, 
conserved in eukaryotes as well as prokaryotes, by which cells maintain redox 
homeostasis (149). For instance, bacterial cells possess different signalling pathways 
that respond to increase concentrations of ROS or a shift in the cellular redox status 
(149, 306-308). In Escherichia coli, the transcription factor OxyR responds to low 
levels of H2O2 and activates the expression of antioxidant defence genes (309, 310). 
It should be pointed out the OxyR is just one of many transcription factors bacterial 
cells posses to regulate and maintain their redox homeostasis (306-308). The 
budding yeast Saccharomyces cerevisiae also maintains its redox homeostasis 
through oxidative activation of the transcription factor yAP-1 which in turn induces the 
expression of genes that encode for proteins with antioxidant properties, including 
SOD, catalase and glutathione reductase (149, 311, 312). Interestingly, Droge (2002) 
refers to the oxidative burst as a regulatory event that leads to a temporary 
imbalance in the cellular redox status in order to switch on the antioxidant defence 
mechanism, which is critical for maintaining cellular competence (149). 
 
6.3 Deregulation of the NADPH oxidase complex in endometriosis 
 
Endometriosis is a condition associated with chronic inflammation and blunted 
response to cAMP and progesterone signalling in eutopic and ectopic endometrium. 
The consequences of disruption of the NOX4/p22PHOX complex in decidualizing 
HESCs yielded a number of characteristics that are common to endometrial cells of 
patients with endometriosis.  
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First, the paradoxical increase in cellular oxidation has also been reported in the 
eutopic endometrium of patients with endometriosis (172). However, it should be 
pointed out that an increase in endogenous ROS concentration, especially in ectopic 
lesions, could reflect infiltration of immune cells capable of producing large amounts 
of ROS upon interaction with cytokines or foreign particles (165, 292). Second, 
endometriosis is associated with impaired immunosurveillance and affected patients 
have an increased incidence of atopic and autoimmune disorders (249, 254-256). 
The loss of either NOX4 or p22PHOX causes defects in the innate immune system 
(147, 194, 203). In fact, growing evidence implicates NADPH oxidase enzymes in 
signalling following pathogen recognition by toll like receptors and in the modulation 
of dendritic cell functions, two key aspects of innate immunity. This raises the 
question whether the relatively low levels of p22PHOX in patients with endometriosis 
might contribute to the chronic inflammation that characterizes the ectopic implants. 
Third, p22PHOX deficiency and the lack of the oxidative burst in differentiating HESCs 
fit well with the blunted response to cAMP and progesterone signalling observed in 
this condition (238, 257). In fact, my finding that knockdown of NOX4 and p22PHOX 
induces a hypersumoylation response, which in turn stabilizes and represses the 
liganded PR (65), may provide a mechanistic explanation for the apparent 
endometrial progesterone-resistance in affected patients.  
 
As mentioned previously in the introduction, decidualization of HESCs is an intriguing 
example of MET. Combining the effects obtained upon disabling the NOX4/p22PHOX 
in decidualizing HESCs, the consistent loss of p22PHOX observed in endometriosis 
and the characteristics of endometriotic cells, my results might suggest that 
NOX4/p22PHOX-dependent ROS signalling play a role in MET/EMT dynamic transition 
of HESCs. Endometriotic cells are motile and migrate out of the endometrium 
through retrograde menstruation. This might indicate that the MET is perturbed in 
such a condition. MET/EMT processes are dynamic; thereby the loss of the 
NOX4/p22PHOX complex may tip the balance towards EMT in endometriosis. This is 
similar to what has been observed in metastatic cancerous cells (27). In fact, EMT in 
tumourogenesis is a response to microenvironment signals and is required for cancer 
cell survival through acquiring motile and invasive properties (28, 313-315). 
Interestingly, several studies have demonstrated both direct and indirect evidence 
linking the role of endogenous ROS in EMT/MET (316).  
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6.4 Endometrial hormesis and endometriosis 
 
The prolonged cellular stress in decidualizing HESCs as a consequence of disruption 
of the NOX4/p22PHOX complex was associated with activation of the DNA repair 
pathway in the absence of discernible DNA damage or apoptosis. Since the 
NOX4/p22PHOX complex is deregulated in eutopic endometrium from patients with 
endometriosis, this illicit activation of the DNA repair pathway may convey a survival 
advantage for HESCs at the time of menstruation by increasing resistance to 
environmental stressors, thereby facilitating implantation of endometrial cells at 
ectopic sites, such as the peritoneal cavity. In fact, activation of the DNA repair 
pathway is an integral part of hormesis and ischemic preconditioning (317, 318).  
 
The concept of hormesis does not only apply to cells and organs but also to the 
whole organism. For example, a limited reduction of nutritional calorie uptake, so-
called calorie restriction, has been shown to increase cellular ROS, stress resistance 
and ultimately longevity in a variety of species and model organisms (319-321). 
Exposure of Ceanorabiditis elegans to stress conditions that induces ROS 
concentration resulted in increased life span (322, 323). Conversely, co-treatment of 
nematodes with several different antioxidants, which inactivate ROS fully, abolishes 
the life-extending effects of calorie restriction, providing direct evidence for an 
essential role of increased ROS formation in extension of life span (324).  
 
Whether or not these observations are translatable to human health has been a 
matter of ongoing debate. Two prospective investigations of the effects of calorie 
restriction on long-lived nonhuman primate species began nearly 25 years ago and 
are still under way. While still preliminary, prolonged calorie restriction appears to 
extend the lifespan of rhesus monkeys, slow the rate of muscle loss with age, and 
lower incidence of neoplasia, cardiovascular disease, type 2 diabetes mellitus, and 
apparently endometriosis (325). The latter observation, if confirmed, appears to 
contradict that endometrial hormesis in response to impaired NADPH-oxidase 
function, contributes to the formation of ectopic implants. On the other hand, 
increasing amount of evidence have associated low amount of endogenous ROS 
with physiological function and high amount of endogenous ROS with detrimental 
and pathological events. The amount of endogenous ROS observed upon 
knockdown of the NOX4/p22PHOX seems beneficial on a cellular level as it confers 
resistance through activation of the DNA repair pathway and protection against 
apoptosis, yet pathological on the organism level if it manifests in a gynecological 
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disorder like endometriosis. Interestingly, this scenario is observed in 
tumourogenesis.  
 
The consistent loss of p22PHOX in patients with endometriosis raises the most obvious 
question about the mechanism that underpins such loss. The consistent low levels of 
p22PHOX transcript rule out the option that the loss observed at the protein level is a 
result of a post transcription modification. Loss of p22PHOX could be a result of a 
single nucleotide polymorphism (SNP). SNPs can predispose to various diseases, 
however, genome-wide association studies have not implicated p22PHOX 
polymorphism with endometriosis. Polymorphism in p22PHOX may explain the 
associated defective immunosurveillance in patients with endometriosis. The other 
two mechanisms that can account for the loss of p22PHOX is misregulation by 
microRNA (miRNA) or aberrant epigenetics marks. Altered regulation of miRNA and 
miRNA-regulated pathways have been associated with ectopic and eutopic 
endometrium of patients with endometriosis (326, 327). Interestingly, various studies 
have associated aberrant methylation with endometriosis. Aberrant epigenetic 
regulation has been reported for PR-B, E-cadherin, HOXO10, ER-β and SRC1 (36, 
37, 248). Deregulation in DNMTs, which are enzymes that incorporate a methyl 
group onto a 5’-carbon position of cytosine bases in CpG islands, have also been 
reported in endometriosis (248). This suggests that p22PHOX methylation state might 
be aberrantly regulated in endometriosis resulting in low expression at the mRNA 
and protein level.     
 
Despite reports linking downregulation of FOXO1 in endometriosis, my results 
suggest that endometriosis is only associated with the consistent loss of p22PHOX 
(257, 274, 275). FOXO1 levels, on the contrary, appear normal. If this observation 
holds true, then the presence of FOXO1 might be what distinguishes endometriosis 
from endometrial cancer, since FOXO1 expression in the latter appears low (328, 
329). There are a number of similarities in the cellular characteristics between the 
two clinical conditions (Figure 6.1). First, both cancerous cells and endometriotic cells 
are able to migrate and invade different tissues in different parts of the body (330). 
Second, both conditions are associated with high level of ROS (170, 172, 330). Third, 
cancerous cells and endometriotic cells are both associated with increased survival. 
Fourth, in both conditions, cellular phenotype seems in favour of EMT rather than 
MET. Finally, the DNA damage and repair pathway in both clinical conditions 
appears to be deregulated. The major difference between the two conditions though 
lies in the fact that endometriosis is a benign condition whereas cancer, if not 
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controlled, is fatal. This difference may be attributed to the presence of normal levels 
of FOXO1 in endometriosis but not in cancer. To elucidate the mechanism behind 
this, extensive experimental work is required. However, this preliminary observation 
and following hypothesis could be attributed to the activation of the DNA repair 
pathway, in endometriosis, in the absence of DNA damage. Interestingly, alterations 
in the DNA has been linked with cell fate regulation and reproductive disorders. 
Hapangama et al. reported increased in telomere length in women with reproductive 
failure compared to control groups (331).  
 
In conclusion, here I present conclusive evidence that NOX4/p22PHOX dependent 
ROS signalling introduces a different level of cross-talk in decidualization. 
Endogenous ROS signalling is not only critical for initiating the decidual process but 
also plays a role in maintaining this differentiation and may contribute to the MET 
process. Further, knockdown of the NOX4/p22PHOX complex disturbs the redox 
homeostasis of the cell but confers resistance to DNA damage by activating the DNA 
repair pathway. Linking these observations with the loss of p22PHOX in endometriosis, 
I hypothesize that downregulation of the NOX4/p22PHOX complex tips the redox 
balance in favour of prooxidants which leads to activation of the DNA damage 
pathway in the absence of DNA damage, reversal of the epithelial phenotype to 
mesenchymal characteristics with increased cell motility and invasiveness and 
induction of inappropriate survival of stressed cells, which in turn can manifest in 
reproductive system disorders like endometriosis. 
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Fig 6.1 Similarities between endometriosis and endometrial cancer. The 
diagram illustrates the similarities and differences between the two clinical conditions. 
The lightening bolts indicate perturbations FOXO1 appears to be deregulated in 
endometrial cancer but not in endometriosis.   
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Appendix 1 
 
RTQ-PCR primer pairs 
 
Gene Forward Primer Reverse Primer 
BIRC5 GGACCACCGCATCTCTACAT GTCTGGCTCGTTCTCAGTGG 
BRCA2 TGGTATGTGGGAGTTTGTTTCA ATCAGGATCCACCTCAGCTC 
COLEC10 TCCAGGAGAAGAGGGAAAGC CTTGCCAATATTGCCCTGAT 
FOXO1 TGGACATGCTCAGCAGACATC TTGGGTCAGGCGGTTCA 
GPx3 GAAGTAACTGAAGGCCGTCTCATC CACGGATTTCTTCCTGAACAAAG 
IGFBP1 CGAAGGCTCTCCATGTCACCA TGTCTCCTGTGCCTTGGCTAAAC 
L19 GCGGAAGGGTACAGCCAA GCAGCCGGCGCAAA 
NOX4 AGCAACATTTGGGGTTCATC GGCAGAATTTCGGAGTCTTG 
PRL AAGCTGTAGAGATTGAGGAGCAAAC TCAGGATGAACCTGGCTGACTA 
P22PHOX ATGACCGCCGTGGTGAAG GGCACCGAGAGCAGGAGA 
RAC1 TGCAGACACTTGCTCTCCTATGTAG GAGTTCAATGGCAACGCTTCA 
SOD2 AATTGCTGCTTGTCCAAATCAG TCCCCAGCAGTGGAATAAGG 
TXN TGTGGATGACTGTCAGGATGTTG TGTCCCTTCTTAAAAAACTGGAATG 
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Appendix 2 
 
NOX4/p22PHOX-repressed genes 
 
Gene Name Description Fold-Change 
BIRC5* baculoviral IAP repeat-containing 5  4.22 
CENPF* centromere protein F, 350/400ka (mitosin)  3.66 
NCAPG non-SMC condensin I complex, subunit G 3.36 
ANLN* anillin, actin binding protein  3.16 
TYMS* thymidylate synthetase  3.15 
ASPM* asp (abnormal spindle) homolog, microcephaly 
associated  
3.09 
DLGAP5 discs, large (Drosophila) homolog-associated protein 5 3.07 
CEP55 centrosomal protein 55kDa 2.95 
HMMR* hyaluronan-mediated motility receptor (RHAMM)  2.95 
NUSAP1* nucleolar and spindle associated protein 1  2.87 
NDC80 NDC80 homolog, kinetochore complex component 2.86 
MLF1IP* MLF1 interacting protein  2.82 
TOP2A* topoisomerase (DNA) II alpha  2.80 
PRC1* protein regulator of cytokinesis 1  2.70 
DTL denticleless homolog)  2.67 
KIF11* kinesin family member 11  2.65 
MKI67 antigen identified by monoclonal antibody Ki-67 2.62 
NUF2 NUF2, NDC80 kinetochore complex component, homolog 2.58 
KIAA0101* KIAA0101  2.56 
EBF1 early B-cell factor 1 2.47 
AOX1 aldehyde oxidase 1  2.45 
TPX2* TPX2, microtubule-associated, homolog (Xenopus laevis)  2.45 
ATAD2 ATPase family, AAA domain containing 2  2.43 
CASC5 cancer susceptibility candidate 5  2.42 
BUB1B* budding uninhibited by benzimidazoles 1 homolog beta  2.37 
KIF20A* kinesin family member 20A  2.36 
MELK* maternal embryonic leucine zipper kinase  2.34 
REV3L REV3-like, catalytic subunit of DNA polymerase zeta  2.32 
SORBS1 sorbin and SH3 domain containing 1  2.30 
CLSPN claspin homolog (Xenopus laevis)  2.20 
CCNB1* cyclin B1  2.18 
CCNB2* cyclin B2  2.18 
RRM2 ribonucleotide reductase M2  2.18 
BTN3A3* butyrophilin, subfamily 3, member A3  2.16 
KIF4A* kinesin family member 4A  2.16 
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MELTTL7A methyltransferase like 7A 2.16 
NEK2* NIMA (never in mitosis gene a)-related kinase 2  2.14 
SHCBP1 SHC SH2-domain binding protein 1  2.14 
CENPE* centromere protein E, 312kDa 2.13 
CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1  2.12 
NFIA* nuclear factor I/A  2.10 
THNSL1* threonine synthase-like 1  2.09 
KIF18A kinesin family member 18A  2.07 
SPC25 SPC25, NDC80 kinetochore complex component, 
homolog 
2.07 
SNORD21 small nucleolar RNA, C/D box 21 2.05 
BUB1* budding uninhibited by benzimidazoles 1 homolog (yeast)  2.03 
CKAP2L cytoskeleton associated protein 2-like 2.02 
FAM111B family with sequence similarity 111, member B 2.02 
KIF20B kinesin family member 20B 2.02 
ITGA6* integrin, alpha 6  1.99 
RACGAP1* Rac GTPase activating protein 1  1.97 
CENPK CENPK // centromere protein K 1.96 
JAZF1* JAZF zinc finger 1  1.96 
BARD1* BRCA1 associated RING domain 1  1.94 
MLLT6 myeloid/lymphoid or mixed-lineage leukemia  1.94 
CCNE2 cyclin E2  1.93 
HSD17B6 hydroxysteroid (17-beta) dehydrogenase 6 homolog  1.93 
PRKG1 protein kinase, cGMP-dependent, type I  1.93 
P2RY1 purinergic receptor P2Y, G-protein coupled, 1  1.92 
FAM72D family with sequence similarity 72, member D  1.91 
MAD2L1* MAD2 mitotic arrest deficient-like 1 (yeast)  1.89 
LRRC4C leucine rich repeat containing 4C  1.88 
RAD51AP1* RAD51 associated protein 1  1.88 
SNORD61 small nucleolar RNA, C/D box 61 1.88 
PLK4 polo-like kinase 4  1.86 
C14orf143 chromosome 14 open reading frame 143  1.85 
SNORD30 small nucleolar RNA, C/D box 30 1.84 
PRIM1 primase, DNA, polypeptide 1 (49kDa)  1.83 
CACNB2 calcium channel, voltage-dependent, beta 2 subunit  1.79 
DEPDC1* DEP domain containing 1  1.79 
TSHZ1 teashirt zinc finger homeobox 1 1.79 
TTK* TTK protein kinase  1.79 
CD109* CD109 molecule  1.78 
IRAK3 interleukin-1 receptor-associated kinase 3  1.78 
NRXN3* neurexin 3  1.78 
TXNRD3IT1 thioredoxin reductase 3 intronic transcript 1 1.78 
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TAF7L TAF7-like RNA polymerase II, TATA box binding protein 1.77 
ELMO1 engulfment and cell motility 1  1.76 
ACE2 angiotensin I converting enzyme (peptidyl-dipeptidase A) 1.75 
CNR1 cannabinoid receptor 1 (brain)  1.74 
FAM65B family with sequence similarity 65, member B 1.74 
FGGY FGGY carbohydrate kinase domain containing 1.74 
CDC2* cell division cycle 2, G1 to S and G2 to M  1.73 
TRAF5 TNF receptor-associated factor 5  1.73 
C8orf79 chromosome 8 open reading frame 79 1.72 
ALDH1L2 aldehyde dehydrogenase 1 family, member L2  1.70 
SLC39A8* solute carrier family 39 (zinc transporter), member 8  1.70 
TRPC4 transient receptor potential cation channel, subfamily C,  1.69 
ALS2CR8 amyotrophic lateral sclerosis 2 (juvenile) chromosome 
region candidate 8 
1.68 
DCLRE1B DNA cross-link repair 1B  1.68 
FBXO5* F-box protein 5  1.68 
NRIP3 nuclear receptor interacting protein 3  1.68 
SKA3 spindle and kinetochore associated complex subunit 3 1.68 
DHFR* dihydrofolate reductase  1.67 
PRR11 proline rich 11 1.67 
LDB2* LIM domain binding 2  1.65 
PCDH19* protocadherin 19  1.65 
CCNA2* cyclin A2  1.64 
HSPB1 heat shock 27kDa protein 1  1.64 
PSMB9* proteasome (prosome, macropain) subunit, beta type, 9  1.64 
PTTG1* pituitary tumor-transforming 1  1.64 
NUP37 nucleoporin 37kDa  1.63 
SGOL1 shugoshin-like 1 (S. pombe)  1.63 
SP110 SP110 nuclear body protein  1.63 
ARHGEF6 Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6  1.62 
FABP5 fatty acid binding protein 5 (psoriasis-associated)  1.62 
PLK1 polo-like kinase 1 (Drosophila) 1.62 
RNASEH2A* ribonuclease H2, subunit A  1.62 
DHFR* dihydrofolate reductase  1.59 
NPAS2 neuronal PAS domain protein 2  1.59 
SNAI2 snail homolog 2 (Drosophila)  1.59 
C6orf173* chromosome 6 open reading frame 173  1.58 
KIAA1524 KIAA1524  1.58 
PLXNA4 plexin A4  1.57 
UBE2C* ubiquitin-conjugating enzyme E2C  1.57 
ADAM32 ADAM metallopeptidase domain 32 1.56 
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ALG6 asparagine-linked glycosylation 6, alpha-1,3-
glucosyltransf 
1.56 
ANKRD13B ankyrin repeat domain 13B  1.56 
RGS2 regulator of G-protein signalling 2, 24kDa  1.56 
BRIP1* BRCA1 interacting protein C-terminal helicase 1  1.55 
DNA2 DNA replication helicase 2 homolog (yeast)  1.55 
KIF15 kinesin family member 15  1.55 
MARVELD2 MARVEL domain containing 2  1.55 
MSL3L2 male-specific lethal 3-like 2 1.55 
DRAM1 DNA-damage regulated autophagy modulator 1 1.54 
KIF14* kinesin family member 14  1.54 
LASS6 LAG1 homolog, ceramide synthase 6  1.54 
BCAT1 branched chain aminotransferase 1, cytosolic  1.53 
EBPL emopamil binding protein-like  1.53 
LOC10028961
2 
arsenic transactivated protein 1 1.53 
ZNF311 ZNF311 // zinc finger protein 311 1.52 
ACSS2 acyl-CoA synthetase short-chain family member 2  1.51 
C15orf41 chromosome 15 open reading frame 41 1.51 
APOBEC3F apolipoprotein B mRNA editing enzyme, catalytic polypep 1.50 
C6orf192* chromosome 6 open reading frame 192  1.50 
NRCAM* neuronal cell adhesion molecule  1.50 
POLH* polymerase (DNA directed), eta  1.50 
SCARNA9L small Cajal body-specific RNA 9-like (retrotransposed) 1.50 
C11orf1 chromosome 11 open reading frame 1  1.49 
DPH5 DPH5 homolog  1.49 
S100A4 S100 calcium binding protein A4  1.49 
TCF19 transcription factor 19  1.49 
HOXA13 homeobox A13  1.48 
MPHOSPH9* M-phase phosphoprotein 9  1.48 
NBN nibrin  1.48 
S100A10* S100 calcium binding protein A10 1.48 
SNORA14B small nucleolar RNA, H/ACA box 14B 1.48 
SPRY2 sprouty homolog 2 (Drosophila)  1.48 
AHCY* adenosylhomocysteinase  1.47 
APOBEC3C* apolipoprotein B mRNA editing enzyme, catalytic polypep 1.47 
FOXM1* forkhead box M1 1.47 
NCAPD2 non-SMC condensin I complex, subunit D2 1.47 
NSUN6* NOL1/NOP2/Sun domain family, member 6  1.47 
PMCH pro-melanin-concentrating hormone  1.47 
RNF39 ring finger protein 39 1.47 
SAMD13 sterile alpha motif domain containing 13  1.47 
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VGLL3 vestigial like 3 1.47 
SMC2* structural maintenance of chromosomes 2  1.47 
STXBP6* syntaxin binding protein 6 (amisyn)  1.47 
CADPS2* Ca++-dependent secretion activator 2  1.46 
MOSC2 MOCO sulphurase C-terminal domain containing 2 1.46 
PIK3C2B phosphoinositide-3-kinase, class 2, beta polypeptide  1.46 
XRCC6BP1 XRCC6 binding protein 1 1.46 
DENND2C DENN/MADD domain containing 2C  1.45 
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ 
dependent) 
1.45 
ACLY* ATP citrate lyase  1.44 
CHCHD6 coiled-coil-helix-coiled-coil-helix domain containing 6 1.44 
OBFC1 oligonucleotide/oligosaccharide-binding fold containing 1  1.44 
PARG poly (ADP-ribose) glycohydrolase  1.44 
SIAE sialic acid acetylesterase 1.44 
SNORA7B small nucleolar RNA, H/ACA box 7B 1.44 
TCEANC transcription elongation factor A (SII) N-terminal 1.44 
VAMP5 vesicle-associated membrane protein 5 (myobrevin)  1.44 
ZNF470 zinc finger protein 470 1.44 
CCDC111 coiled-coil domain containing 111 1.43 
LRIG3 leucine-rich repeats and immunoglobulin-like domains 3  1.43 
SLC25A37 solute carrier family 25, member 37  1.43 
CKAP2* cytoskeleton associated protein 2  1.42 
DISP1 dispatched homolog 1 (Drosophila)  1.42 
PRIM2 primase, DNA, polypeptide 2 (58kDa)  1.42 
SAMD4A sterile alpha motif domain containing 4A 1.42 
STK39* serine threonine kinase 39  1.42 
TNIP2 TNFAIP3 interacting protein 2  1.42 
ALDH18A1* aldehyde dehydrogenase 18 family, member A1  1.41 
FIGNL1* fidgetin-like 1  1.41 
GBP1 guanylate binding protein 1, interferon-inducible, 67kDa  1.41 
HARBI1 harbinger transposase derived 1 1.41 
KLF7 Kruppel-like factor 7 (ubiquitous)  1.41 
LOC644714 hypothetical protein LOC644714 1.41 
NEFL neurofilament, light polypeptide  1.41 
NUP85 nucleoporin 85kDa 1.41 
PTCD2* pentatricopeptide repeat domain 2 1.41 
ZNF876P zinc finger protein 876 (pseudogene) 1.41 
C4orf21 chromosome 4 open reading frame 21 1.40 
GYG1 glycogenin 1 1.40 
MYC v-myc myelocytomatosis viral oncogene homolog (avian)  1.40 
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TMEM194B transmembrane protein 194B 1.40 
BIRC5* baculoviral IAP repeat-containing 5  1.39 
STIL SCL/TAL1 interrupting locus 1.39 
IMPDH2 IMP (inosine monophosphate) dehydrogenase 2  1.38 
KDELR3* KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein  1.38 
NEIL3 nei endonuclease VIII-like 3 1.38 
BLM Bloom syndrome, RecQ helicase-like  1.37 
HTRA2 HtrA serine peptidase 2  1.37 
INPP1 inositol polyphosphate-1-phosphatase  1.37 
OR2A9P olfactory receptor, family 2, subfamily A, member 9  1.37 
CDCA2* cell division cycle associated 2  1.36 
HRSP12 heat-responsive protein 12  1.36 
INTS3 integrator complex subunit 3 1.36 
LASP1 LIM and SH3 protein 1  1.36 
SATB2 SATB homeobox 2  1.36 
TRIP13* thyroid hormone receptor interactor 13  1.36 
TUBG2 tubulin, gamma 2  1.36 
ZNF471 zinc finger protein 471  1.36 
CDC42EP4 CDC42 effector protein (Rho GTPase binding) 4  1.35 
DCAF11 DDB1 and CUL4 associated factor 11 1.35 
FANCI Fanconi anemia, complementation group I 1.35 
HSPA4L heat shock 70kDa protein 4-like  1.35 
MTBP Mdm2, transformed 3T3 cell double minute 2, p53 binding 
protein 
1.35 
RBM43 RNA binding motif protein 43 1.35 
SDR39U1 short chain dehydrogenase/reductase family 39U, 
member 1 
1.35 
RMI1 RMI1, RecQ mediated genome instability 1, homolog 1.35 
SPAG5* sperm associated antigen 5  1.35 
TARSL2 threonyl-tRNA synthetase-like 2  1.35 
ACTN1* actinin, alpha 1  1.34 
C15orf42 chromosome 15 open reading frame 42 1.34 
C3orf31 chromosome 3 open reading frame 31 1.34 
TMEM216 transmembrane protein 216 1.34 
ZNF383 zinc finger protein 383  1.34 
ZNF518A zinc finger protein 518A 1.34 
CCDC99 coiled-coil domain containing 99 1.33 
FOXN2 forkhead box N2 1.33 
MCM10 minichromosome maintenance complex component 10  1.33 
MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ 
dependent) 
1.33 
NDRG3 NDRG family member 3  1.33 
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PHKA2 phosphorylase kinase, alpha 2 (liver)  1.33 
POLA1 polymerase (DNA directed), alpha 1, catalytic subunit 1.33 
PPIL3* peptidylprolyl isomerase (cyclophilin)-like 3  1.33 
RPL39L ribosomal protein L39-like  1.33 
RPP40 ribonuclease P/MRP 40kDa subunit 1.33 
SGOL2 shugoshin-like 2 (S. pombe)  1.33 
VCL* vinculin  1.33 
AASS aminoadipate-semialdehyde synthase  1.32 
ARL9 ADP-ribosylation factor-like 9 1.32 
APAF1 apoptotic peptidase activating factor 1  1.32 
BIVM* basic, immunoglobulin-like variable motif containing  1.32 
BTN3A1 butyrophilin, subfamily 3, member A1  1.32 
CCDC6 coiled-coil domain containing 6  1.32 
E2F4 E2F transcription factor 4, p107 1.32 
MLLT10 myeloid/lymphoid or mixed-lineage leukemia  1.32 
PSTK phosphoseryl-tRNA kinase 1.32 
PTPLA protein tyrosine phosphatase-like  1.32 
PTTG3P pituitary tumor-transforming 3 1.32 
QARS glutaminyl-tRNA synthetase  1.32 
SGMS1 sphingomyelin synthase 1 1.32 
SHMT2 serine hydroxymethyltransferase 2 (mitochondrial)  1.32 
TRERF1* transcriptional regulating factor 1  1.32 
WDR5B WDR5B  1.32 
ATP8B4 ATPase, class I, type 8B, member 4  1.31 
BRCA2 breast cancer 2, early onset  1.31 
C14orf43 chromosome 14 open reading frame 43  1.31 
CDH13 cadherin 13, H-cadherin (heart)  1.31 
GPR88 G protein-coupled receptor 88  1.31 
HIST1H2AM histone cluster 1, H2am 1.31 
HMGB1 high-mobility group box 1  1.31 
KCNMB4 potassium large conductance calcium-activated channel  1.31 
KDM4C lysine (K)-specific demethylase 4C 1.31 
LRRC9 leucine rich repeat containing 9 1.31 
NUDT10 nudix (nucleoside diphosphate linked moiety X)-type motif 1.31 
PLP2 proteolipid protein 2 (colonic epithelium-enriched)  1.31 
PRDM8 PR domain containing 8 1.31 
RNF39 RNF39 // ring finger protein 39 1.31 
RPS27L ribosomal protein S27-like  1.31 
TDRD3 tudor domain containing 3  1.31 
ZCCHC7* zinc finger, CCHC domain containing 7  1.31 
ZNF30* zinc finger protein 30  1.31 
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MYO9A myosin IXA  1.30 
NUP205 nucleoporin 205kDa  1.30 
OIP5* Opa interacting protein 5  1.30 
OR5K2 olfactory receptor, family 5, subfamily K, member 2 1.30 
SF3A2 splicing factor 3a, subunit 2, 66kDa 1.30 
 
Key: 
Red: Decidual-induced genes 
Blue: Decidual-repressed genes 
Italics: FOXO1-induced 
*: Genes identified by Talbi et al (2006) to be repressed during the secretory 
phase of the menstrual cycle  
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Appendix 3     
 
NOX4/p22PHOX-induced genes 
 
Gene Name Description Fold-Change  
MYO15B myosin XVB pseudogene -1.30 
PAPOLG* poly(A) polymerase gamma  -1.30 
CNTN4* contactin 4  -1.31 
GAN gigaxonin -1.31 
IGF1R* insulin-like growth factor 1 receptor  -1.31 
NR1D2 nuclear receptor subfamily 1, group D, member 2  -1.31 
WDSUB1 WD repeat, sterile alpha motif and U-box domain  -1.31 
ZNF441 zinc finger protein 441  -1.31 
CSNK1E casein kinase 1, epsilon  -1.32 
CYTH2 cytohesin 2 -1.32 
ELF4 E74-like factor 4 (ets domain transcription factor)  -1.32 
TTLL7 tubulin tyrosine ligase-like family, member 7 -1.32 
ZBTB38 zinc finger and BTB domain containing 38  -1.32 
CCL22 chemokine (C-C motif) ligand 22 -1.33 
PHF16* PHD finger protein 16  -1.33 
POM121L9P POM121 membrane glycoprotein-like 9 (rat) pseudogene -1.33 
RHBDD2 rhomboid domain containing 2 -1.33 
TNFRSF21* tumor necrosis factor receptor superfamily member 21 -1.33 
ZNF708 zinc finger protein 708  -1.33 
EML5 echinoderm microtubule associated protein like 5  -1.34 
HS3ST3B1* heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1  -1.34 
RHBDD1 family with sequence similarity 100, member B -1.34 
BEX1 brain expressed, X-linked 1  -1.35 
CD46 CD46 molecule, complement regulatory protein -1.35 
IFNAR2* interferon (alpha, beta and omega) receptor 2  -1.35 
LRRC37B leucine rich repeat containing 37B -1.35 
PARP9 poly (ADP-ribose) polymerase family, member 9  -1.35 
PDCD6IP programmed cell death 6 interacting protein  -1.35 
RBBP6* retinoblastoma binding protein 6  -1.35 
NAG18 NAG18 mRNA -1.36 
PLK3 polo-like kinase 3 (Drosophila) -1.36 
ZBTB34* zinc finger and BTB domain containing 34  -1.36 
ARHGDIA* Rho GDP dissociation inhibitor (GDI) alpha  -1.37 
C110RF61 chromosome 11 open reading frame 61 -1.37 
DUSP22 dual specificity phosphatase 22  -1.37 
FOSL2* FOS-like antigen 2 -1.37 
MEX3B mex-3 homolog B -1.37 
SLC7A11 solute carrier family 7 -1.37 
UBE2D1* ubiquitin-conjugating enzyme E2D 1  -1.37 
ACPP* acid phosphatase, prostate -1.37 
ARL6IP1 ADP-ribosylation factor-like 6 interacting protein 1 -1.38 
SIK1 salt-inducible kinase 1 -1.38 
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E2F6 E2F transcription factor 6  -1.39 
EYA1 eyes absent homolog 1 -1.39 
NETO1 neuropilin (NRP) and tolloid (TLL)-like 1  -1.39 
TTC7B* tetratricopeptide repeat domain 7B  -1.39 
ZNF720 zinc finger protein 720 -1.39 
COL24A1 collagen, type XXIV, alpha 1  -1.40 
KLF3* Kruppel-like factor 3 (basic)  -1.40 
KU-MEL-3 KU-MEL-3  -1.40 
SNCAIP* synuclein, alpha interacting protein  -1.40 
SOX4* SRY (sex determining region Y)-box 4  -1.40 
MAML3 mastermind-like 3 (Drosophila)  -1.41 
GPR137B G protein-coupled receptor 137B -1.41 
CUL4B cullin 4B  -1.42 
SLC20A1* solute carrier family 20 (phosphate transporter)  -1.42 
AGPAT9 1-acylglycerol-3-phosphate O-acyltransferase 9 -1.43 
DDX60L DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like -1.43 
LRRC8A leucine rich repeat containing 8 family, member A  -1.43 
RAB30 RAB30, member RAS oncogene family  -1.43 
RFK* riboflavin kinase  -1.43 
ATXN7L1 ataxin 7-like 1  -1.45 
IFITM1* interferon induced transmembrane protein 1 (9-27)  -1.45 
WHAMML1 WAS protein homolog associated with actin, golgi membran -1.45 
MYO10 myosin X  -1.45 
CDKN2B* NM_078487 cyclin-dependent kinase inhibitor 2B -1.46 
EMP2 epithelial membrane protein 2 -1.46 
CPEB4* cytoplasmic polyadenylation element binding protein 4  -1.49 
RHOH* ras homolog gene family, member H -1.49 
C10orf58* chromosome 10 open reading frame 58  -1.50 
DDI2 DDI1, DNA-damage inducible 1, homolog 2  -1.50 
AGPAT5 1-acylglycerol-3-phosphate O-acyltransferase 5  -1.52 
CD68 CD68 molecule  -1.53 
ZDHHC2 zinc finger, DHHC-type containing 2  -1.53 
ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9  -1.54 
HTRA3 HtrA serine peptidase 3  -1.54 
DYNC1I2 dynein, cytoplasmic 1, intermediate chain 2 -1.55 
NTRK2 neurotrophic tyrosine kinase, receptor, type 2  -1.56 
SNCA synuclein, alpha  -1.56 
SYT11* synaptotagmin XI  -1.56 
BAMBI* BMP and activin membrane-bound inhibitor homolog  -1.57 
CEP135 centrosomal protein 135kDa -1.57 
PARP4 poly (ADP-ribose) polymerase family, member 4  -1.57 
ZNF704 zinc finger protein 704 -1.57 
AKD1 adenylate kinase domain containing 1 -1.58 
PHACTR2* phosphatase and actin regulator 2  -1.60 
TCF4* transcription factor 4  -1.61 
ASPN asporin  -1.62 
LIMCH1 LIM and calponin homology domains 1 -1.63 
SMAP2 small ArfGAP2 -1.63 
FOXP1* forkhead box P1  -1.64 
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SNX30 sorting nexin family member 30 -1.64 
ADAM22 ADAM metallopeptidase domain 22  -1.65 
ARSE* arylsulfatase E (chondrodysplasia punctata 1)  -1.65 
RGL1 ral guanine nucleotide dissociation stimulator-like 1  -1.67 
TMEM35* transmembrane protein 35  -1.69 
ZSWIM5 zinc finger, SWIM-type containing 5  -1.69 
SLC2A12 solute carrier family 2 -1.70 
VLDLR very low density lipoprotein receptor 4  -1.70 
TREM1 triggering receptor expressed on myeloid cells 1 -1.72 
RAPH1* Ras association (RalGDS/AF-6) and pleckstrin homology doma -1.74 
EPHA7 EPH receptor A7  -1.76 
NID2* nidogen 2 (osteonidogen)  -1.76 
PLSCR1* phospholipid scramblase 1  -1.77 
TOX thymocyte selection-associated high mobility group box  -1.77 
MAP2 microtubule-associated protein 2  -1.78 
F13A1 coagulation factor XIII, A1 polypeptide  -1.81 
ITGA11 integrin, alpha 11  -1.82 
RFTN1 raftlin, lipid raft linker 1 -1.82 
HAP1* huntingtin-associated protein 1 -1.83 
ZNF217 zinc finger protein 217  -1.83 
OLFML2B* olfactomedin-like 2B  -1.86 
CNKSR2* connector enhancer of kinase suppressor of Ras 2 -1.88 
TNFAIP6 tumor necrosis factor, alpha-induced protein 6  -1.89 
MYO5A* myosin VA (heavy chain 12, myoxin)  -1.90 
PLAGL1* pleiomorphic adenoma gene-like 1  -1.91 
PRRG4* proline rich Gla (G-carboxyglutamic acid) 4  -1.91 
SCARA3* scavenger receptor class A, member 3  -1.92 
CLU* clusterin  -1.98 
ATRNL1 attractin-like 1  -2.05 
CAPNS2 calpain, small subunit 2 -2.10 
STMN2 stathmin-like 2  -2.15 
ERBB3* v-erb-b2 erythroblastic leukemia viral oncogene homolog 3  -2.36 
RARB retinoic acid receptor, beta  -2.37 
LRIG1 leucine-rich repeats and immunoglobulin-like domains 1  -2.40 
EFTUD1 elongation factor Tu GTP binding domain containing 1  -2.43 
VIT vitrin  -2.62 
SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin) -2.71 
ABI3BP ABI family, member 3 (NESH) binding protein  -2.93 
ATP8A1* ATPase, aminophospholipid transporter (APLT), class I  -3.22 
TMEM154 transmembrane protein 154 -3.29 
COLEC10 collectin sub-family member 10 -4.17 
 
Key: 
Red: Decidual-induced genes 
Blue: Decidual-repressed genes 
Italics: FOXO1-induced 
*: Genes identified by Talbi et al (2006) to be induced during the secretory 
phase of the menstrual cycle  
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Appendix 4 
 
The top five associated networks resulted from the in silico analysis of 
the NOX4/p22PHOX-dependent genes. 
 
The genes shaded in green were downregulated upon knockdown of NOX4 and 
p22PHOX, whereas the molecules shaded in red were upregulated upon the 
knockdown. 
 
Network 1: Cell Cycle, Cancer, Skeletal and Muscular Disorders  
 
Source: Ingenuity® Systems 
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Network 1
 © 2000-2010 Ingenuity Systems, Inc. All rights reserved.
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Network 2: Cell Cycle, Cellular Assembly and Organization, DNA Replication, 
Recombination, and Repair  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Ingenuity® Systems 
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 © 2000-2010 Ingenuity Systems, Inc. All rights reserved.
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Network 3: Cell-To-Cell Signalling and Interaction, Cell Cycle, DNA Replication, 
Recombination, and Repair  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Ingenuity® Systems 
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 © 2000-2010 Ingenuity Systems, Inc. All rights reserved.
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Network 4: Cellular Assembly and Organization, Cellular Growth and Proliferation, 
Haematological Disease  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Ingenuity® Systems 
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Network 5: DNA Replication, Recombination, and Repair, Gene Expression, Cell 
Cycle  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Ingenuity® Systems 
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